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First trimester vomiting affects f if ty percent of pregnant women and in 0.3 
% of all pregnancies - hyperemesis gravidarum, severe vomiting causes loss 
of fluid and electrolytes, resulting in dehydration, electrolyte imbalance, 
weight loss and acidosis. The etiology is still unclear, but may result f rom 
excessive secretions f rom the upper gastrointestinal tract (UGIT), causing 
distension and mechanoreceptors located therein subsequently triggering the 
vomiting reflex. Since first trimester vomiting coincides with high 
circulating levels of human chorionic gonadotropin (hCG), a likely secretory 
agent, hCG may directly act on the UGIT to cause vomiting. The aim of this 
project was to investigate the possibility that hCG is a secretory agent, which 
i • directly acts on the gastrointestinal tract, leading to secretion of fluid and 
electrolytes. 
In the in vitro experiments, hCG caused a prompt release of iodide from 
African Green Monkey kidney cells (COS-l ) transfected with luteinizing 
hormone-chorionic gonadotropinAhyroid stimulating hormone chimera 
receptors (MCl+2) , and both the release and the inhibition o f t h e uptake of 
tetraphenylphosphonium (TPP _ a lipophilic cation whose uptake is related 
to intracellular chloride) by Murine Leydig Tumor cells (MLTC-1) 
possessing native luteinizing hormone-chorionic gonadotropin receptors 
(LH-CGR). These results along with other published data suggests that anion 
secretion by cells with functional LH-CGR is a universal response to hCG. 
A specific hCG binding protein was found in the rat duodenum and 
pancreas, which from the physicochemical and immunoblotting studies 
appears to be similar to LH-CGR. Later LH-CGR was localized 
immunohistochemically in exocrine tissue and blood vessels o f t h e pancreas, 
and in smooth muscle, mucosal epithelium, crypt cells and blood vessels of 
duodenum. In the in vivo perfusion studies, injection of hCG stimulated the 
i 
secretion of bicarbonate and potassium ions f rom the pancreas and/or 
duodenum. Ovariectomised rats had decreased circulating sodium 
concentration, compared with either the estradiol and progesterone replaced 
ovariectomised or normal cycling female rats. There was no difference in the 
sodium concentration between the normal cycling and ovariectomised rats 
j given sex steroid replacement. The decrease in sodium concentration upon 
ovariectomy was most likely due to the increase in LH levels. Unreplaced 
ovariectomised rats also had decreased levels of circulating amylase, as well 
as a lower amylase content in the pancreas (although the difference was 
insignificant); a decrease in zymogen granules and a lower pH of the 
pancreatic extract. These results imply that long term exposure to high levels 
of LH/CG may have stimulated the pancreatic exocrine secretions including 
bicarbonate and sodium ions, which further support the secretory function of 
hCG in the UGIT. 
With the tentative findings, we hypothesize that emesis/hyperemesis 
gravidarum is induced by hCG interacting with secretory cells in the UGIT 
through LH-CGR, stimulating copious secretion of electrolytes (and fluid), 
resulting in distension of the UGIT and the mechanoreceptors located 
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Glycoprotein hormones and their receptors 
FSH follicle-stimulating hormone 
FSHR follicle-stimulating hormone receptors 
H C G human chorionic gonadotropin 
LH luteinizing hormone 
LH-CGR luteinizing hormone-chorionic gonadotropin receptors 
TSH thyroid stimulating hormone 
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I.U. International Unit 
kV kilovolt 
Others 
BSA bovine serum albumin 
cAMP adenosine 3' ,5'-cyclic monophosphate 
cDNA complementary deoxyribonucleic acid 
DMEM Dulbecco, s modified Eagle, s medium 
DT diphtheria toxoid 
EDTA ethylenediaminetetraacetic acid 
ELISA enzyme-linked immunosorbent assay 
GIT gastrointestinal tract 
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HBSS Hank 's balanced salt solution 
HEPES N-2-hydroxyethylpiperazine-N'-2-ethanesulphonic acid 
HPBR HEPES-phosphate-buffered-Ringer solution 
I.D. inner diameter 
IEF isoelectric focusing 
Kd equilibrium dissociation constant (affinity constant) 
O.D. outer diameter 
N E M N-ethylmaleimide 
PEG polyethylene glycol 
pI isoelectric point 
PMSF phenylmethyl sulphonylflouride 
TIP total inositol phosphate 
TPP tetraphenylphosphonium 
Tris Tris[hydroxymethyl]aminomethane 






Vomiting during pregnancy encompasses a wide spectrum, with ten percent 
experiencing no discomfort, ninety percent of pregnant subjects having 
nausea symptoms, f i f ty percent having vomiting to some degree and 0.3 % 
having vomiting that is so severe leading to dehydration, electrolyte 
imbalance, nutrient deficiency and acidosis. Hyperemesis can then be 
considered as the case at an extreme end of a continuum. Although 
emesis/hyperemesis gravidarum has been recognized for almost four 
thousand years, the exact pathophysiological mechanism is still unknown. It 
has been considered as a classical example involving the interplay of 
biological, psychological and sociological variables. Recently, 
hyperolfaction has been proposed as a contributory factor. Since 
emesis/hyperemesis involves the loss of fluid and electrolytes, and has its 
prevalence during the first trimester, the most likely causal agent is thought 
to be human chorionic gonadotropin (hCG). It has been suggested that hCG 
triggers emesis by stimulating the chemoreceptor triggering zone in brain. 
However, a direct interaction between hCG and the gastrointestinal tract 
(GIT) leading to excessive secretion of fluid and electrolytes has not been 
i 
investigated. The aim of the project was to investigate the possibility that 
hCG triggers vomiting by directly acting on the GIT which leads to the 
secretion of fluid and electrolytes, which culminates in vomiting of 
pregnancy. The anion secretory properties of hCG in stimulating electrolyte 
secretion was investigated in vitro using cell line models. The presence of 
hCG receptors along the female rat GIT was studied. Finally, the capability 
of hCG in stimulating electrolyte secretion in the UGIT in vivo was 
investigated using female rats as an animal model. 
1 
Review of the literature 
I 
2 
Incidence and historical background 
Nausea and vomiting are one of the many complaints of pregnancy. Emesis 
gravidarum is a clinical term used to describe the common occurrence of 
nausea and vomiting in the first trimester of pregnancy, which usually 
discontinues by the end of the first trimester. Ninety percent of pregnant 
women have nausea. Emesis occurs in f if ty percent of pregnancyi. Since 
emesis occurs mainly after waking up, it is commonly referred to as 
"Moming Sickness". In ninety percent of the patients, vomiting occurs 
during the first three months of pregnancy. Only in 3 % of pregnancies, 
vomiting occurs in the 3rd trimester^. Vomiting rarely lasts beyond the 20th 
week of gestation. In about 10 % of the cases, vomiting persists into the 
3 second trimester . 
Hyperemesis gravidarum refers to a severe form of vomiting which can 
result in dehydration, electrolyte imbalance, nutrient deficiency, weight loss 
and acidosis. The reported frequency of hyperemesis gravidarum is 0.02 -
1.6 % of deliveries, with an average of 0.35 % ^. Among the Chinese 
pregnant women, the incidence is 0.2 % ^ Majority of the hyperemetic 
patients are admitted to the hospital during the 8th to 12th week of 
gestation^ 
Fairweather (1968) was the first researcher to extensively review the issue of 
emesis/hyperemesis gravidarum, starting from the historical perspective, 
epidemiology, etiology to the clinical manifestations^ He pointed out that 
vomiting during early pregnancy was first described in a papyrus dating 
about 2000 B.C., which was part of Petrie Collection. About 200 A.D. the 
first reference to it, called Soranus' Gynaecology appeared. Despite its long 
history, it is still difficult to define hyperemesis gravidarum. Recently, Hod 
et al. (1994) have tried to modify Fairweather's definition of hyperemesis 
3 
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gravidarum and defined it as a condition characterized by vomiting that 
occurs for the first time before 20th week of gestation, causes weight loss, 
fluid and electrolyte imbalance and acidosis, which is not associated with the 
coincidental conditions listed in Table A^. 
Table A. Causes of excessive vomiting in pregnancy^ 
Causes ofvomiting not due to pregnancy 





Biliary tract disease 
Pancreatitis 
Appendicitis 




Twisted ovarian cyst 
\ Red degeneration of fibroids i 
Miscellaneous 
Drug toxicity 
Metabolic disorders, such as diabetic ketosis 
I Hyperthyroidism 
Central nervous system lesions 
I Vestibular disorders 
Conditions of pregnancy associated with increased vomiting 
i Hydatidiform mole 
: Twin pregnancy 
Hydramnios (due to fetal hydrops) 







Emesis gravidarum does not cause any harm to the body. The associated 
disorders, such as sleep disturbances, fatigue and irritability, usually 
disappear by the fourth month of gestation^. On the other hand, vomiting 
during early pregnancy has been considered as a positive predictor of 
pregnancy outcome. The risk of abortion during the first trimester is higher 
in women who do not vomit^'^. In hyperemesis gravidarum, the clinical 
disorder includes dehydration, electrolytes and fluid disturbances, nutritional 
deficiency, weight loss, acidosis, ketosis, and ketonuria. Dehydration is the 
first major problem the hyperemetic patients present with, as a result of 
vomiting. Vomiting also causes the loss of electrolytes. With the loss of 
electrolytes, acid-base imbalance occurs. Hyperemesis associated acidosis is 
partly due to the loss o f b a s e s during the ejection of alkaline intestinal ju ice^ 
and partly as a result of metabolic ketosis. The effect of hyperemesis on 
pregnancy outcome is not conclusive. In general, hyperemesis does not 
affect the mother and fetal mortality, i f t h e mother 's physiological disorders 
are properly managed^. Although rare cases of congenital abnormalities have 
been reported, e.g. web toe, the cause and effect between the congenital 
abnormalities and hyperemesis is still uncertain^. 
！ 
Theories on etiology of emesis/hyperemesis gavidarum 
Despite its long history and frequent occurrence, there is still a lack of a well 
established hypothesis on the etiology. In the 19th century, many different 
hypotheses were put forward, amongst which were reflexogenic, neurotic, 
and toxemic. In 1897, it was first suggested that hyperemesis gravidarum 
was caused by the action of secretion of abnormally persistent 
corpus luteum^ During the 20th century, abnormal hormone levels 
have been regarded as the major cause of emesis/hyperemesis gravidarum. 
HCG, estrogens, progestogens, cortisol, etc. have all been linked with the 
5 
etiology2. Although a lot of endocrine factors have been suggested, the exact 
etiology is still not well established. Different researchers have yielded 
contradictory results with regard to the correlation between the endocrine 
factors and degree of vomiting during early pregnancy. Some reported that 
higher plasma levels o f h C G were found in the hyperemetic patients than the 
non-emetic pregnant women9,io ii, but others have reported no difference 
between these groupsi2i3. Similar inconsistency occurred when people 
studied the plasma levels ofprogestogens and estrogens^^'^l 
Some researchers correlated emesis/hyperemesis gravidarum with social 
and/or psychological status. Hyperemesis gravidarum has been thought as a 
classical example of illness involving the interplay of biological, 
psychological and sociological variables. Early theories suggested that 
nausea and vomiting during early pregnancy represented an unconscious 
attempt to reject an unwanted child, and stopped once a mother accepted the 
fact^. Farkas and Farkas (1972) regarded hyperemesis gravidarum as a 
psychological protest reaction against pregnancy because of the presence of 
psychological conflicts, especially f rom family and home environments^. 
However, Farkas and Farkas,s theory is in contrast to the phenomenon that 
pregnant women with emesis gravidarum have lower incidence of 
psychiatric disorders than those wi thout� . Recently, hyperolfaction has been 
proposed as a new contributing factor for the etiology^^. Hyperolfaction 
during early pregnancy has been suggested to be a mechanism for the mother 
to seek a cleaner, quieter and more temperate environment to increase the 
survival chance. Nausea and vomiting are often preceded by exposure to 
common background odours such as washing detergents, perfumes, etc. 
However, how hyperolfaction can lead to nausea and vomiting is unknown. 
The incidence of nausea, vomiting and hyperemesis can be regarded as a 
continuum with incidence ranging from 90 % to 0.3 %. Although nausea is 
6 
purely a feeling of a need to vomit, emesis and hyperemesis result in loss of 
fluid an electrolytes. The former would suggest the involvement of 
psychological factors, whereas the latter would suggest the involvement of 
hormonal factors which stimulate processes leading to the secretion of fluid 
and electrolytes and subsequent vomiting. Therefore, there should be a 
underlying biological basis for emesis/hyperemesis gravidarum. 
Mechanism of vomiting 
Vomiting is a forceful expulsion of upper gastrointestinal contents through 
the mouth. The whole process starts with salivation and the sensation of 
nausea. The glottis closes to prevent aspiration of vomitus into the trachea 
with the breath held in mid-inspiration. Vomiting is achieved by the sudden, 
powerful contraction of the respiratory muscles and, at the same time, a 
relaxation of the upper esophageal sphincter and the perioesophageal 
diaphragm. The external oblique muscles overlying the stomach contract and 
the lower esophageal sphincter relaxes. The abdominal and diaphragmatic 
[ 
muscles then contract and the increased intra-abdominal and intra-thoracic 
pressure propels gastric contents from the stomach to the mouth in a single 
motioni5,i6,i7. 
Including the mechanical action, vomiting reflex can be divided into three 
major steps: (i) activation of emetic detectors, (ii) signal integration in the 
vomiting center and (iii) generation o fmo to r outputs. 
There are two types of emetic detectors, i.e. chemical (chemoreceptors) and 
mechanical (mechanoreceptors) detectors. Chemoreceptors are located in the 
braini7 and upper GIT (UGIT)^^ In the brain, a region known as 
"chemoreceptor trigger zone" (CTZ), is located in the area postrema in 
animals that vomit^^. The area postrema in man is a U-shaped structure, a 
few millimeters in length located in the caudal part of the fourth ventricle in 
7 
the region of obex and is one of the circumventricular organs of the brain 
outside the blood-brain barrier and the cerebrospinal fluid-brain barrier^^ 
The CTZ is a highly vascular region, receiving arterial supply f rom the 
vertebral arteries. The vascular supply terminates in the fenestrated 
capillaries that are richly supplied with nerve endings, which are accessible 
to the polar molecules in the blood or cerebrospinal fluid". The elaborate 
chemoreceptors monitor the systemic blood and cerebrospinal fluid for 
noxious substances, such as L-dopa, apomorphin, bromocriptine, etc^^. In the 
upper gut, there are both types of emetic detectors (i.e. chemoreceptors and 
mechanoreceptors)i5. Mechanoreceptors are located in the muscular wall of 
the guti5 i7 They can be activated by both distension and contraction o f t h e 
gut. Distension of the gastric antrum (e.g. by over-eating), or proximal small 
• • 15 17 
intestine (e.g. by obstruction) may induce nausea and vomiting，• 
Chemoreceptors are located in the intraluminal mucosal regions^^. They can 
be stimulated by mucosal stroking, acids, alkali, hypertonic solutions, 
temperature, irritants and intraluminal bacterial toxin, such as staphylococcal 
enterotoxini5'. 
The signals generated by the emetic receptors are transmitted to "vomiting 
1 � 1 n 
centers" in the brain ‘ . The vomiting centers are located in the medulla 
i 11 
oblongata, composed of a number of separate nuclei . Signal integration 
takes place there, and emesis only occurs when these nuclei are activated in 
a unique pattem^^. The centers then send out a number of well coordinated 
visceral reflexes, which integrate together to form the emetic reflex^^'^^. 
Besides directly stimulating the emetic detector, vomiting reflex can be 
triggered indirectly. For example, unpleasant tastes^^, smells^^ or sights^^ can 
sometimes trigger vomiting. Motion of the body can induce vomiting 
through the Vestibular labyrinthine system in the inner ear^^. In addition, 
‘ there are central causes for emesis. Increased intracranial pressure^^, e.g. due 
‘ 
to the presence of a tumor in the brain, emotional stress^^ or psychological 
problem like anorex ia" can cause nausea or vomiting. Furthermore, 
vomiting can be a presenting features of a lot of clinical disorders, such as 
thyrotoxicosis^^ and hypona t r emia�� . 
Humoural agents such as hCG^ ' ' ' ' ' ' ' ' ' ' ' ' ' ' and steroid ho rmones ' ' ' ' ' ' ' ' ' have 
been suggested to be involved in the pathophysiological mechanism of 
emesis/hyperemesis gravidarum. The basis of the existing hypotheses 
concerning these endocrine factors can be divided into two categories, 
i) direct and ii) indirect stimulation o f t h e vomiting reflex. For the former, it 
has been suggested that hCG elicits the vomiting reflex by directly binding 
to the hCG receptor in CTZ of the area postrema in the b r a i n " For the 
latter, vomiting has been considered as a secondary association of other 
• 2 21 
clinical disorders. Functional stress on liver owing to high steroid l oad，， 
and hCG induced thyrotoxicosis^^'^^'^^ have been suggested. Hyperemesis 
has also been attributed to the presence of corpus luteum in the right ovary, 
whereby steroid hormones drained directly into the liver via the portal vein, 
resulting in a higher steroid load in liver^^ 
Temporal association between hCG and emesis/hvperemesis 
gravidarum 
F.J. Schoeneck (1936) was the first to associate the temporal relationship 
between the high levels of hCG and the occurrence of vomiting^ Maximum 
I concentration of hCG is reached towards the end of the first trimester of 
pregnancy25 (i.e. 8th to 12th week of gestation, figure A1). This period 
overlaps with the period when emesis/hyperemesis gravidarum is most 
frequent^ (i.e. 8th to 12th week of gestation, figure A2). HCG levels start to 
drop around the 17-20th week of gestation, which also coincides with 
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Figure A2. Distribution of 217 cases of hyperemesis gravidarum by weeks 
of gestation at time of admission to the hospital (Fairweather, 1968)\ 
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beginning of the second trimester^. It has been suggested that h C G acts on 
the CTZ located in the area postrema of the brain^^'^^. Recently it has been 
shown that hCG receptors are present in the area postrema�?. However, the 
exact function o f t h e s e receptors has not been elucidated. 
In the past, measurements of serum and urine hCG in pregnant women with 
hyperemesis gravidarum have yielded conflicting results^'^^'^^'^^'^^'^^ Using a 
bioassay in which the effect of hCG on the enlargement of prostate in intact 
I 
immature male rats were measured, Fairweather and Loraine (1962) reported 
lower urinary hCG levels in hyperemetic patients f rom the 7th to 15th week 
of pregnancy compared to normal pregnant women similarly matched for 
gestational age�&. Kauppila et al (1979) reported higher h C G levels in 
hyperemesis patients at 7-8th week, 9 - l l t h week, and 12-14th week, but not 
at 15-20th week, with the use of radioimmunoassay with an anti_P_hCG 
antiserum^. Soules et al (1980) using radioimmunoassay, reported no 
difference in hCG levels between the hyperemetic and normal pregnant 
•t r \ 
women in the first 16 weeks of pregnancy . Masson et al (1985) using anti-
P-hCG radioimmunoassay, reported higher hCG levels in nausea and 
vomiting group than in asymptomatic group at 9 to 16th week of 
pregnancyio. Depue et al (1987) reported no difference in immunoreactive 
hCG between hyperemetic patients and control subjects matched for age and 
gestational age^^. In a more recent report, with age, weight and gestational 
age matched hyperemetic patients and controls, Goodwin et al (1994) 
reported higher levels of intact hCG and P-hCG in the patient group, but a -
hCG was indifferent". The inconsistent findings can be due to the intrinsic 
problem in the measurement of hCG. Discordant results in human chorionic 
gonadotropin immunoassays have been reported^^^. The differences in 
recognition of nicked hCG, free P-hCG, and hCG variants cause the 
discordance in hCG immunoassay results^^^'^^^, which may explain the 
conflicting results found in the literature. Furthermore, the presence of hCG 
1 2 
variants due to the different degree of glycosylation of the h C G protein core 
may be another factor contributing to the discrepancy. The degree of 
glycosylation influences the degree of stimulation of the "stimulatory" G 
protein, Gs, in the intracellular signal transduction pathway^^ Therefore, 
there may be only certain hCG variants involved in triggering 
emesis/hyperemesis. Recently, Tsuruta et al (1995) reported that fractions of 
hCG with high mannose and hybrid-type carbohydrate chains (but not the 
total hCG) was significantly higher in hyperemetic group^^ This finding 
supports that the first trimester vomiting is caused by hCG. As the total 
immunoreactive hCG was measured in most of the past studies^'^^'^^'^^'^^ the 
complexity of the phenomenon due to the presence of hCG variants may 
explain why the correlation between hCG and degree of vomiting is poorly 
established. That also may explain why Fairweather and Loraine (1962) 
reported lower urinary hCG levels in hyperemetic patients instead of higher 
levels when using a bioassay in which the effect of hCG on the enlargement 
of prostate in intact immature male rats were measured^^. The specific hCG 
variant for stimulating prostate enlargement may be different f rom that for 
triggering vomiting. 
Thyroid function and emesis/hyperemesis gravidarum 
Because hyperthyroidism can cause vomiting^^, some researchers have 
• • 31 32 • 
regarded hyperemesis as a presenting feature o f t r u e thyrotoxicosis，，but it 
has also been speculated that hyperemesis gravidarum is an expression of 
transient pregnancy associated hCG-induced thyrotoxicosis in these 
patients2i，22,23,24，25 
hCG and thyrotropin (TSH) both belong to the glycoprotein hormone group. 
Like hCG, TSH is a heterodimer composed of an a-subunit and a P_subunit. 
The receptors for hCG and TSH are also very similar. In vitro binding assay 
has shown that hCG is able to bind the thyrotropin receptor (TSHR) and 
1 3 
stimulate signal transduction^\ The similarity between h C G receptor and 
TSHR has been further supported by artificially constructing a LH-CG/TSH 
chimera receptor ( M C l + 2 ) composed of TSH receptor with the N-terminal 
end of the extracellular domain replaced with the corresponding region of 
hCG receptor, which can be stimulated by both TSH and hCG^^. That can 
explain why hCG has thyrotropic activity. 
Although hCG has been shown to be able to stimulate the thyroid gland, 
hyperthyroidism is rare among pregnant women. Among Chinese 
hyperemesis patients, only about 30 % were found to have biochemical 
hyperthyroxinaemia35 36. Furthermore, no correlation was found between the 
concentrations of hCG and the concentrations of free T4 and hTSH in 
• 37 
patients with hCG-producing non-seminomatous testicular cancer . 
Although it is possible that thyroid hormones may be involved in the 
etiology of hyperemesis gravidarum in about 30 % of these patients, the 70 
0/0 with normal thyroid function would suggest otherwise. 
With regard to thyrotropic activity of hCG, it has become more clear that 
only the basic variants (i.e. asialo-hCG) can stimulate the TSHR^^, and can 
stimulate human thyroid follicles to incorporate iodide, stimulate de novo 
3 9 • a 
synthesis of thyroid hormones and cause in vitro release , but not the acidic 
hCG variants. These findings were further supported by a phenomenon that a 
fraction o fbas i c variants (but not the total hCG) were significantly higher in 
the gestational thyrotoxicosis group^^. In the hyperemetic group, the fraction 
of hCG with high mannose and hybrid-type carbohydrate chains was 
significantly higher^^. These findings strongly suggest that hCG-induced 
gestational thyrotoxicosis is a matter not only related to the levels of hCG, 
but also the quality o f h C G , which is affected by the degree of glycosylation. 
As a result, gestational thyrotoxicosis may not be the cause of hyperemesis 
丨 1 4 
gravidarum, but may share a similar pathophysiological mechanism with 
emesis/hyperemesis gravidarum. 
Steroid hormone and emesis/hyperemesis gravidarum 
During early pregnancy, progesterone is mainly produced by the corpus 
luteum under the stimulation f rom hCG, and estrogens are produced both by 
the corpus luteum and placenta. Steroid hormones - estrogens and 
progestogens, have been suspected of a direct role in emesis during early 
pregnancy2 i3 2i. This hypothesis is supported by the fact that nausea during 
pregnancy, as well as during the first use of oral contraceptives, is usually 
^ confined to the first few months of these events . It has been suggested that 
sudden increase in estrogen and progesterone levels in the liver causes a 
， 0 1 
functional stress on the liver, leading to nausea， . However, direct 
relationship between the degree of emesis and the levels of steroid hormones 
has not been proved successfully. Masson et al (1985) could not find any 
significant difference between the levels of estradiol, progesterone and 
progesterone/estradiol ratios, of the pregnant women with or without 
vomitingio. However, with 35 case-control pairs, Depue et al (1987) found 
that mean levels of total estradiol and sex hormone binding-globulin binding 
capacity were 26 % and 37 % higher, respectively, in patients with 
1 o hyperemesis gravidarum than in control subjects . 
Hyperemesis caused bv Corpus luteum in Right Ovary 
The position of the corpus luteum has also been linked to the etiology of 
hyperemesis gravidarum. It was found that nausea and vomiting in early 
pregnancy was associated with a corpus luteum being located in the right 
ovary2i it was proposed that high levels of sex steroids produced by the 
right-sided corpus luteum, drained to the liver via the inferior vena cava and 
the portal system, and the overloading of the liver with steroid thus caused 
nausea and vomiting� . However, Thorp et al (1991) reported a case of 
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hyperemetic woman who had the corpus luteum located in the right ovary, 
but upon removal of the right ovary, the vomiting persis ted^. In the case 
reported by Thorp, nausea and vomiting only resolved following the 
evacuation of the uterus, thereby suggesting the site of the causative agent to 
be within the uterus. 
Formulation of a new hypothesis for emesis/hyper-
emesis gravidarum : 
“hCG stimulated electrolyte and fluid secretion in the 
UGIT, leading to pregnancy associated vomiting" 
Although many factors have been linked with emesis/hyperemesis 
I gravidarum for many years, only hCG appears to show the greatest 
association with vomiting. In the past few years, with more knowledge about 
the production and the properties of hCG and its variants, increased total 
hCG has been reported in hyperemetic pregnant women than in control 
subjects with comparable gestational age^'^^'^^ It has also been suggested 
that the hCG variants with high mannose and hybrid-type carbohydrate 
chains may be responsible for triggering vomiting^®. Therefore, hCG appears 
to be the most likely endocrine factor, which plays a role in the 
pathophysiological mechanism of emesis/hyperemesis gravidarum. 
The most popular nechanisms for hCG stimulated vomiting until now are as 
follows: i) hCG stimulates vomiting reflex by directly acting on the CTZ in 
the area postrema of the brain^^, and ii) hCG acts as thyrotropic hormone 
I • 22 23 24 
inducing thyrotoxicosis, which in tum results in hyperemes i s，， . 
Nevertheless, direct effect of hCG in CTZ in triggering vomiting has not 
been shown, and biochemical hyperthyroxinaemia is only present in thirty 
^ c Q ^ percent ofhyperemetic pregnant w o m e n， . The fact that seventy percent of 
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hyperemetic women do not have abnormal thyroid function suggests that the 
latter mechanism may not be a cause, but a co-incidental finding. 
Furthermore, the fact that f i f ty percent of pregnant women vomit, without 
any obvious factor having been identified, also suggests that h C G may be the 
丨 factor responsible for emesis/hyperemesis gravidarum. 
Hyperemesis inevitably involves the loss of fluid and electrolytes\ resulting 
[ 
in hypokalaemia and chloride depletioni. For treatment of severe vomiting 
generally, hydration therapy, involving the administration of intravenous 
fluids, and nutrients, as well as pharmacological support may be given^\ In 
the treatment of hyperemesis gravidarum, besides hydration and nutrition 
treatments, the correction of electrolyte imbalance especially potassium, and 
acid-base imbalance are of paramount importance^'^. This is similar to the 
treatment of secretory diarrhea, but not for the osmotic diarrhea^^ because in 
secretory diarrhea, dehydration, acidosis and massive loss of body sodium, 
potassium and chloride are usually seen^^. Comparing emesis/hyperemesis 
gravidarum with secretory diarrhea, it is logical to suspect that active 
secretion of electrolytes in the UGIT may occur in the emetic/hyperemetic 
pregnant women. Since distension of the UGIT can trigger vomiting by 
activating the mechanoreceptors located therein^^'^^, it is possible that the 
active secretion of electrolytes and fluid leads to the distension of the UGIT, 
which in tum causes vomiting. It therefore stands to reason that, whatever 
agent is inducing vomiting, mediates its action via receptors located on 
secretory cells in the GIT. The respective activated second messenger 
cascade mediates the cellular electrolyte secretion. Water is secreted in 
parallel with the electrolyte secretion, leading to a distension of the UGIT. 
The mechanoreceptors activated by the distension generate signals for 
vomiting. Although it is possible that hCG may elicit vomiting by acting on 
the brain chemoreceptors, it is also possible that the primary site of action 
may be the UGIT, where hCG leads to the secretion of fluid and electrolytes 
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into the gut lumen. In the following paragraphs, circumstantial evidence 
supporting the contention that hCG triggers vomiting via direct stimulation 
of electrolyte and fluid secretion by the GIT is presented. 
Is hCG a humoural secretory agent ？ 
Duchatelle & Joffre (1990) reported gonadotropin induced chloride 
conductance from Leydig cells, but the physiological significance in 
I steroidogenesis is unclear43. In a preliminary photometric study using a 
chloride sensitive probe, 6-methoxy-N-(3-sulphoproyl)quinolinium, chloride 
efflux f rom rat epidydimal cells by hCG was demonstrated^^. In another 
preliminary experiments, hCG was able to decrease the uptake of an 
lipophilic cation, tetraphenylphosphonium (TPP) by African Green Monkey 
kidney cells (COS-7) transiently expressing M C l + 2 LH-CG/TSH chimera 
recepto/5. The uptake of TPP has been related to intracellular chloride 
levels46 47. Because the chloride secretion is related to the secretion of 
cations and fluid48, the findings of Duchatelle & Joffre and our preliminary 
experiments suggested that hCG might be a secretory agent involved in 
electrolyte secretion. 
Can hCG stimulate the secretion of fluid and electrolytes from the 
GIT? 
Functions of hormones are mediated by cellular second messenger(s) and/or 
synthesis of prostaglandin(s). The former elicits sequential changes within 
the cell. The latter is secreted out of the cell and acts as an 
autocrine/paracrine agent. If hCG is a secretory agent for the GIT, hCG has 
to be able to stimulate the second messager pathway(s) and/or synthesis of 
prostaglandin(s) which mediates the electrolyte and fluid secretion by the 
GIT secretory cells. 
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For the second messenger pathway, it has been shown that after binding of 
h C G to LH-CGR, the ligand-receptor complex couples with the Gs protein 
and triggers the GTPase activity, which in t u m leads to an increase of 
cAMp49 5o. The participation of the adenylate cyclase-cAMP signaling 
pathway in the action of LH in the gonads is well accepted. In rat Leydig 
cell, LH-CGR responds to LH with an increase in cAMP and testosterone 
production^� . The ability of cAMP to induce rapid and reliable water and 
chloride secretion has been demonstrated in intestine. In T84 cells, a human 
colonic cell line, cAMP increased electrogenic chloride secretion, suggesting 
an increase in apical chloride permeability^\ In addition to the effect on the 
apical chloride conductance, cAMP may regulate the basolateral membrane 
sodium-potassium-chloride (Na-K-Cl2) cotransporter^\ Moreover, cAMP 
has been shown to be an important second messenger in regulating the 
pancreatic exocrine secretion. For example, secretin (a gut peptide 
hormone), whose action is mediated by cAMP, stimulates pancreatic ductal 
bicarbonate and water secretion^^. cAMP has also been shown to be the main 
mediator of bicarbonate ion secretion of the duodenal villus and crypt 
epithelial cells under the stimulation of vasoactive intestinal peptide (VIP) or 
dopamine^^. 
There is evidence that LH/CG may exert their functions through the 
stimulation of the phospholipase C (PLC) pathway. LH has been shown to 
increase both the synthesis and degradation of phosphoinositides (i.e. IPi, 
IP2, IP3) in rat granulosa cells isolated from mature follicles^^. IP3 is another 
intracellular secondary messenger involved in the regulation of electrolyte 
2+ 2+ secretion. IP3 triggers the release of Ca from the non-mitochondrial Ca 
/^ 1 • pools. High level of intracellular Ca stimulates chloride secretion in 
c 1 )_j_ 
epithelial cells . The mechanism by which Ca regulates chloride secretion 
is uncertain, but it has been suggested that calcium-calmodulin complex 
，_!_ c 1 (Ca -CaM) induced phosphorylation is involved in rabbit ileum . In 
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pancreas, calcium mediated signal transduction is also important in the 
regulation of exocrine secretion. For example, the action of cholecystokinin 
(CCK) on acinar enzyme secretion is mediated by intracellular calcium^^. 
Calcium signal transduction pathway is also important in mediating the 52 • 
action of acetylcholine in pancreatic ductal secretion . Besides IP3, 
activation of PLC pathway leads to the production of diacylglycerol. 
Diacylglycerol stimulates the activity of protein kinase C in the presence of 
phosphatidylserine and C a�+，w h i c h in t um phosphorylates specific 
intracellular proteins. Protein kinase functions in many cell types to regulate 
electrolyte transport^ 1. 
In addition to the second messages in the cAMP and PLC pathways, the 
binding of hCG to LH-CGR will stimulate the production of prostaglandins, 
j H C G stimulated production of prostaglandins have been shown in human 
fallopian tube^^ and umbilical cords^^. Prostaglandins are also involved in 
57 • 
regulation of electrolyte and fluid movement in the GIT . Prostaglandin E2 
(PGE2) has been shown to increase proximal duodenal bicarbonate secretion 
in unanesthetized rats^^. It has been shown that indomethacin decreased 
jejunal fluid secretion in addition to the luminal release of PGE2 in patients 
with acute cholera, which suggests that Cholera toxin can induce the 
production of PGE2, which is probably involved in the stimulation of fluid 
secretion59. The sharing of similar signal transduction pathways and 
prostaglandin production with gastrointestinal hormones, makes hCG a 





Are LH-CGR present in the GIT ？ 
！ HCG is a glycoprotein hormone which is produced in large amounts by 
syncytiotrophoblastic cells of human placenta during pregnancy^^'^^. The 
major role of hCG in early pregnancy is considered to be the stimulation of 





estradiol25. Progesterone is necessary for the maintenance o f t h e integnty of 
the endometrium and a quiescent state of the myometrium^^'^^ H C G also 
functions as an immunosuppressive agent to allow the immunologic 
tolerance by the uterus of invading embryonic trophoblast tissue^^'^^'^^ 
Moreover, hCG is an important regulator of the development of the fetal 
adrenal and gonad during the first trimester�^. It may play an important role 
25 in male sexual development . 
Besides being produced by the placenta, hCG is produced by the pituitary 
gland in low amount^^'^^ Interestingly, a hCG-like substance has been 
shown to be widely distributed in normal human tissues, including spleen, 
kidney, lung, liver, small intestine, stomach, adrenal gland, testes, ovary, 
pituitary gland and placenta^^. However, it is not yet known if the hCG-like 
substances are produced locally or transported to the site where it is 
entrapped by tissue receptors for hCG. The known hCG producing organs 
demonstrated the highest concentrations, placenta - 5,396 nanograms hCG 
per gram tissue and pituitary gland - 20,847 ng/g. The classic target organs 
displayed very low hCG content, testes - 19.93 ng/g and ovary - 5.55 ng/g, 
which probably reflected the amount of hCG bound to the receptors. The 
human small intestine showed a concentration of 10.75 ng/g. Although the 
production of hCG by the small intestine cannot be excluded, the low tissue 
content similar to that of known target tissues suggest entrapment by 
receptors for hCG. 
j The wide spread distribution of the hCG-like substance (probably hCG) 
allows us to suggest the wide spread distribution of receptors for hCG. 
Recently, reports of the presence of hCG receptors in non-gonadal tissues 
have appeared. In the past, it was thought that the target sites for hCG were 
only the gonads - testis and ovary. This is because hCG binds to the same 
receptor as LH. This allows hCG to take over the role of LH in maintaining 
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the stimulation of steroid hormone production by corpus luteum during early 
pregnancy when pituitary LH levels wane as result of negative feedback 
f rom progesterone^^ In the testis, luteinizing hormone/chorionic 
gonadotropin receptors (LH-CGR) were shown to be present on the Leydig 
cells64. In the ovary, LH-CGR were shown to be present on luteal cells^^ 
theca cells and, to varying degrees, on granulosa cells according to their 
stage of maturation50 66 67 68 69 Follicular maturation is associated with the 
appearance of LH-CGR in the granulosa cells, which bind LH and initiate 
the cellular processes leading to luteinization^^'^^. 
LH-CGR have been shown to be present not only in the gonads, but also 
I 
I different regions of the human female reproductive system including 
fallopian tubes^^ uterus^^, umbilical cord^^, human placenta?。，fetal 
membranes7o and decidua?� . High affinity LH-CGR have also been found in 
rat7i, pig72 and rabbit uterus^^. LH-CGR are also located in the endometrial 
glands, myometrial smooth muscle, endometrial and myometrial blood 
vessels7o. HCG has been shown to have a quiescent effect on the contraction 
ofmyometrium74, and acts as a stimulator for the growth of myometr ium”. 
In the uterine blood vessels, LH-CGR are located in the vascular smooth 
muscles as well as in the endothelium?�"& LH-CGR were shown to be 
present in the ampulla, isthmus, mucosa, smooth muscle, epithelial cells, and 
the tubal blood vessels of the fallopian tube^^ It has been suggested that 
hCG functions as a secretory agent in the fallopian tube^^ Functional LH-
CGR have also been found in the human umbilical cord, especially in the 
blood vessels56. The universal appearance of LH-CGR in the blood vessels 
I； of the reproductive tissues regardless of the regions, strongly suggest that 
.|. 
regulation of blood flow may be an important function of hCG. Effect of 
I hCG on ovarian, uterine and liver blood flow in cycling rats has been 丨  
I demonstrated by Hill et al (1996)??. Moreover, LH-CGR have been i' 
f i ^ ^ ^ Q demonstrated in both cytotrophoblast and syncytiotrophoblast，. In the r 
i ‘ 
;.| 2 2 /i 
placenta, hCG acts both as an autocrine and paracrine agent to stimulate the 
78 
differentiation of cytotrophoblastic cells into syncytiotrophoblastic cells 
and auto-regulate its own levels^^ In the term rat placenta, h C G has a 
stimulatory role on prorenin secretion^^ In the fetal membranes, h C G can 
up-regulate the expression of cyclooxygenase-1 gene although the exact 
function is not known^i Recently, functional LH-CGR have been shown to 
只 2 , 83 
be present in the rat prostate and epidydimis . 
Besides the reproductive tissues, LH-CGR have been reported in non-
reproductive tissues. LH-CGR have been found to be present in rat, bovine， 
and human brains�?. LH-CGR are present in rat hippocapmus, dentate gyrus, 
hypothalamus, cerebellum, choroid plexus, ependymal cells of third, fourth, 
and lateral ventricles, cortex, brainstem, bovine hypothalamus, and area 
postrema27. Lymphocytes f rom pregnant women^^ and the zona reticularis of 
human ademal gland^^ have also been shown to possess LH-CGR. The 
presence of LH-CGR in the brain, ademal gland and on the lymphocytes 
I strongly suggests the ubiquitousness of LH-CGR. 
Reports demonstrating expression of LH-CGR in hCG producing cells have 
appeared. LH-CGR are co-expressed with hCG in the fallopian tubes^^ 
placenta7Q 79 8o and anterior pituitary gland^ '^^ '^^ ^ The co-expression of a 
ligand and the respective receptor in a tissue enables the autocrine/paracrine 
function(s) of the ligand^^'^^'^^ amongst which is the regulation of LH or 
hCG biosynthesis79 86. Braunstein et al (1979) demonstrated an hCG-like 
/d 
^ substance in the human small intestine . A similar ligand-receptor 
relationship may also exist in the GIT. As production of hCG has been 
1 suggested to be auto-regulated, excess secretion of hCG by a tumor implies 
an inactivation of the receptor mediated auto-feedback control, which is the 
case for choriocarcinoma^^. Interestingly, tumors of the GIT have been 
0 ^  ! associated with high circulating levels of ectopic hCG . Pancreatic tumors 
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also have been reported to produce h C G and/or P_subunit， . The 
inactivation of the LH-CGR mediated auto-feedback control may be the 
underlying cause of excess hCG secretion by the gastrointestinal tumor. 
I Can electrolyte and fluid secretion in the UGIT lead to vomiting 
during pregnancy ？ 
It is generally believed that gastric tone and motility of the GIT are lower 
during pregnancy. Gastric atony has been suggested to be responsible for 
vomiting9o. H a n s e n (1937) s h o w e d that the empty ing t ime of s t o m a c h w a s 
longer during pregnancy, as monitored by the disappearance of dye, 
Methylene Blue^^. On the other hand, the GIT motility monitored with 
mercury-loaded capsule, showed the mean transit time f rom stomach to 
caecum was 57.9 土 12.1 hours in normal pregnant women at between 12 and 
20 weeks of gestation compared to 51.7 土 9.6 hours in non-pregnant 
women9i. It should be noted that the emptying time of stomach is regulated 
by the inhibitory mechanisms regulated by chemoreceptors in the duodenum 
and je junum (i.e. upper small intestine) in response to osmolarity, pH, and 
Q/^  
fat content of chyme . Interestingly, hCG has been suggested to be involved 
in the regulation of smooth muscle tone and contractility. In the uterine 
myometrium, hCG decreases the contractility^^. This implies that an inter-
relationship among hCG, emesis gravidarum and slow GIT motility may be 
present. The low motility of the UGIT may facilitate the accumulation of 
fluid and electrolytes (probably stimulated by hCG) during early pregnancy. 
The resulting distension then triggers the vomiting reflex. 
HCG and regulation of electrolyte and fluid movement 
The aforementioned information only allows us to speculate about the 
possibility of hCG in regulating electrolyte and fluid movement in the UGIT 
and its possible relationship with emesis/hyperemesis gravidarum. However, 
2 4 
regulation of electrolyte and fluid balance in the body is actually one of the 
important physiological functions of hCG. 
During pregnancy, it is believed that h C G is involved in osmoregulation by 
decreasing the osmotic thresholds for thirst and arginine vasopressin 
secretion. Injection of h C G into non-pregnant women having saline infusion 
correlated with a lower plasma osmolality required for triggering the sense 
of thirst and increasing the plasma arginine vasopressin levels^^ Moreover, 
h C G is capable of exacerbating ovarian hyperstimulation syndrome (OHSS), 
which demonstrates clinical features of severe fluid and electrolyte 
imbalance with massive accumulation of extravascular fluid and 
hemoconcentration, during pharmacological induction of multiple follicular 
development and multiple ovulation^^. It has been suggested that h C G 
|i 
potentiates OHSS by stimulating the ovarian-renin-angiotensin system, 
|i 
causing enhanced secretion of ovarian angiotensin l f \ H C G has also been 
reported to stimulate the production of ovarian vascular endothelial growth 
;i 
factor (VEGF), also known as vascular permeability factor (VPF), and high 
'i g ^ 
concentrations of VEGF/VPF were found in ascites f rom OHSS patients . 
Since vomiting is one of the clinical features of OHSS, it is not known 
whether hCG is the cause of vomiting in OHSS patient, which may be via a 
similar pathological mechanism as emesis/hyperemesis gravidarum, or other 
j mechanisms like activation of ovarian-renin-angiotensin system, or increased 
levels o f V E G F / V P F . 
Gut-gonad axis 
The physiological link between the gonads and the GIT has been proposed 
by Singh and Thompson (1987)^^. Changes in pancreatic function, including 
an increase in the ratio of endocrine and exocrine tissue, P cell hypertrophy, 
i： 
3 cell hyperplasia, increased secretory activity of p cells, swollen 
2 5 
mitochondria, increased amount of light P granules, and increased incidence 
of rough endoplasmic reticulum has been observed during pregnancy. 
Gonadal, adrenal, and placental hormones are thought to be responsible for 
these changes97. Steroid hormone receptors have been reported to be present 
in rat pancreas^ and reported to affect exocrine func t ion^ ^ . Ovariectomy in 
rats caused a decrease in acinar cell zymogen content^^. Administration of 
estrogens lowered the protein, zinc and bicarbonate levels and raised the 
amylase and lipase activity in pancreatic juice of dogs^^. Interestingly, 
gallbladder emptying is impaired and the fasting and residual gallbladder 
volumes during early pregnancy are much larger^^^. Probably, gonadotropins 
or/and sex steroid hormones are involved. From all the persisting findings, it 
is strongly implied that the functions of the GIT are under the regulation of 
sex hormones. The presence of gut-gonad axis strongly support the 
possibility of direct interaction between hCG and the UGIT. 
i 








The objectives o f t h i s project are to: 
1) show that hCG can stimulate the efflux of anions f rom cells with 
functional LH-CGR in vitro\ 
2) show the presence of LH-CGR in the UGIT f rom where the 
secretion of electrolytes and fluid may occur; 
3) show the in vivo secretion of electrolytes and fluid f rom the UGIT 
in response to hCG; 




Section 1 hCG and in vitro secretion of anions 
from cells with functional LH-CGR -
A cell model 
Introduction 
Anion secretion is the pre-dominant basis for the biological secretions48'5i, 
which promotes the secretion of cations and fluid by paracellular pathways 
in gastrointestinal s y s t e m i o � I n the small intestine, massive C1" eff lux f rom 
mucosal crypt cells can lead to simultaneous massive water secretion^\ 
Hyperemesis gravidarum inevitably involves the loss of fluid and 
electrolytes, probably due to active secretion, resulting in hypokalaemia and 
chloride depletion^'^. Because electrolyte and fluid secretion may trigger 
vomiting via the distension of the UGIT, we suspect that h C G stimulated 
anion secretion may be the pathophysiological basis for pregnancy 
associated vomiting. In preliminary experiments, hCG induced chloride 
secretion was shown in epidydimal cells^^, and hCG has also been shown to 
inhibit the uptake of tetraphenylphosphonium (TPP) by COS-7 cells 
expressing M C l + 2 LH-CG/TSH chimera receptor^^ TPP is a lipophilic 
cation, and the uptake of a similar lipophilic cation, 
triphenylmethylphosphonium, has been linked to the intracellular chloride 
status of the cells^^. Furthermore, Duchatelle and Joffre (1990) found that 
gonadotropins caused chloride conductance from rat Leydig cells and 
queried the functional significance of such secretions^^. From these 
I observations we reasoned that hCG might be causing chloride efflux. It is 
possible that hCG may be acting directly on the gut cells to promote the 
secretion of anions. 
Before answering whether hCG can stimulate electrolyte secretion by the 
GIT, the effect of hCG on anion secretion by cells with functional receptors 
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for h C G was further investigated to prove whether h C G is a potent secretory 
humoural agent. We began our studies by looking for LH-CGR in some cell 
lines (T84, FHs74 int and PANC-1 cells) f rom the GIT, which have been 
used as cell models for secretion of electrolytes. T84 is a colonic tumor cell 
line of epithelial cell origin with cryptlike features, which has been widely 
used for the study of the electrolyte movements, especially chloride 
effluxio2 io3 FHs74 Int is a fetal small intestinal cell line with an epithelial-
like morphology, although definite evidence for epithelial character is 
lacking. PANC-1 is a pancreatic tumor cell line of a ductal cell o r i g i n ^ . 
These cell lines were tested for the presence of LH-CGR with a 
I radioreceptor assay. However, none of the cell lines tested were shown to 
have receptors for hCG. Therefore we tumed to investigate the effect o f h C G 
on chloride secretion by COS-1 cells transfected with the functional 
receptors ( M C l + 2 LH-CG/TSH chimera receptors) for hCG, and by murine 
Leydig tumor cells (MLTC-1) with wild type LH-CGR in nature^^^ The • • 102 
chloride movement was indirectly monitored with the efflux of iodide and 







Materials and Methods 
.j 
Materials 
hCG (3000 IU/mg) and Coming cultureware were obtained f rom Sigma 
Chemical Co (St. Louis USA). Iodine-125 for iodination (iodide in N a O H 
solution, specific activity 17.2 mCi/ug), myo [^U] inositol (specific activity 
16.6 Ci/mmol) and [^U] tetraphenylphosphonium bromide (specific activity 
25 Ci/mmol) were obtained f rom Amersham International PLC (Amersham, 
England). Iodogen was obtained f rom Pierce (Rockford, USA). TANDEM-E 
hCG immunoenzymetric assay kit was obtained from Hybritech Incorporated 
(San Diego, USA). Fine Sephadex G-25 gel was obtained f rom Pharmacia 
(Sweden). Dowex-anion exchange resin, gene pulser transfection apparatus 
(162-2075) and gene pulser cuvettes (0.4 cm electrode gap) were obtained 
from Bio-rad (Hercules, USA). Growth media were obtained f rom either 
Gibco (Gaithersburg, USA) or Sigma Chemical Co. (St. Louis, Missouri, 
USA). T84 cells (colon, carcinoma, Human), FHs74 Int. cells (small 
I I： intestine, fetal, normal, Human), PANC-1 cells (pancreas, epitheloid 
I carcinoma, Human) and MLTC-1 cells (testis, Leydig carcinoma, Murine) 
j 
I were obtained from American Type Tissue Collection (Rockville, Maryland, 
USA) and COS-1 cells (a SV 40 transformed Monkey kidney cell lines) were 
丨. 
I obtained from Dr Karl Tsim, Department of Biology, the Hong Kong 
University of Science and Technology. The chimera receptor DNA M C l + 2 
composed of cDNA of hTSHR with residues 1 - 165 substituted with the 
I corresponding region of LH-CGR and the control (pSG5) plasmids in an 
expression vector (pSG5 plasmid) were provided by Dr L.D. Kohn, Chief, 
i Sect ion on cell Regulation, LBM, NIDDK, National Institutes of Heal th , 
Besthesda, USA. All other chemicals and reagents were analytical grade and 
I 
purchased from British Drug House Chemicals Ltd. (BDH, Poole, UK), 
Merck (Darstadt, Germany) and Sigma Chemical Co. 
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Methods 
1. Test for the presence of LH-CGR in human gastrointestinal cell lines 
Scatchard analysis for LH-CGR was performed by incubating cells with 
different amount of labeled h C G without or with excess unlabeled hCG. The 
number of LH-CGR per cell and the affmity (Kd) of the detected LH-CGR 
towards hCG was calculated with the program LIGAND, a versatile 
computerized approach for characterization of ligand-binding systems^^^ 
！ 
(NIH). MLTC-1 cells with wild type LH-CGR^^^ was used as the positive 
control in this experiment. H C G was labeled with radioactive iodide, so that 
1 
the amount of labeled protein molecules bound was quantified easily by 
gamma counting. 
Cell culture ofT84 cells 
T84 cells were cultured in 1:1 mixture of Ham's F12 medium and 
Dulbecco's modified Eagle 's medium (DMEM) supplemented with 5 % fetal 
calf serum, L-glutamate and antibiotics (penicillin and streptomycin), pH 7.3 
2 
at 37 °C in 5 % CO2 incubator. The cells were initially grown in a 75 cm 
flask. Upon reaching confluency, the cells were disaggregated with 0.05 % 
trypsin-EDTA solution and subcultured. 
Cell culture of FHs74 Int cells 
FHs74 Int cells were cultured in D M E M supplemented with non-essential 
amino acids, 0.5 m M sodium pyruvate, 1.0 m M oxalacetic acid, 0.2 units/ml 
bovine insulin, 10 % fetal calf serum, L-glutamate and antibiotics (penicillin 
！ and streptomycin), pH 7.3 at 37 °C in 5 % CO2 incubator. The cells were 
^ initially grown in a 75 cm flask. Upon reaching confluency, the cells were 
! disaggregated with 0.025 % trypsin-EDTA solution and subcultured. 
j 
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Cell culture ofPANC-1 cells 
PANC-1 cells were cultured in D M E M supplemented with 10 % fetal calf 
serum, L-glutamate and antibiotics (penicillin and streptomycin), pH 7.3 at 
3 7 � C in 5 % CO2 incubator. The cells were initially grown in a 75 cm^ 
flask. Upon reaching confluency, the cells were disaggregated with 0.025 % 
trypsin-EDTA solution and subcultured. 
Cell culture ofMLTC-1 cells 
MLTC-1 cells were cultured in RPMI-1640, 25 m M N-2-
hydroxyethylpiperazine-N‘ -2-ethanesulphonic acid (HEPES) supplemented 
with 10 % fetal calf serum, L-glutamate and antibiotics (penicillin and 
streptomycin), pH 7.3 at 37 T in 5 % CO2 incubator. The cells were 
initially grown in a 75 cm^ flask. Upon reaching confluency, the cells were 
disaggregated with 0.025 % trypsin-EDTA solution and subcultured. 
Radiolabeling of hCG 
a) Preparation of iodogen reaction vessel: 
10 ul iodogen reagent (1 ug/ul CHCl3) was added to the bottom of a 12 x 75 
mm glass test tube and dried to a f ihn under a stream of nitrogen. The 
reaction vessel was prepared just before iodination. 
b) Iodination 
10 ug of highly purified hCG (14 IU/ug) in 10 ul O.lM sodium phosphate 
！ buffer and 10 ul Na^^^ (~ lmCi) were added to the reaction vessel and 
incubated at room temperature for 10 min. The reaction was stopped by 
transferring the reaction mixture to another glass test tube containing 20 ul 1 
0/0 BSA in phosphate buffer and the final mixture was transferred to a 110 x 
13 mm Sephadex G-25 desalting column equilibrated with the phosphate 
buffer (Pharmacia). The tracer was eluted by repeated addition and 
collection of 1 ml phosphate buffer. 10 ul of each fraction was used for 
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measuring the radioactivity with a gamma counter (Cobra auto-gamma, 
Packard Instrument Co. Inc., Switzerland). The fraction containing the 
highest radioactivity was stored at 4 °C, as [ ^ I ] h C G preparation. 
c) Characterization of [^ ^¾] hCG 
1 0 ^  
(i) Determination of the specific activity o f t h e [ I] h C G preparation: 
1 o � 
The amount of immunoreactive hCG in the [ I] h C G preparation was 
measured with TANDEM-E H C G Immunoenzymetric Assay kit, which is 
based on a sandwich type enzyme-linked immunosorbent method (ELISA). 
The [i25l] hCG preparation was diluted 100, 500 and 1000 fold in 0 .1% BSA 
in O.lM phosphate buffer. 100 ul of each sample (diluted preparations, 
standards, or controls) was added to a 12 x 75 m m polypropylene tube 
containing a bead coated with the monoclonal anti-hCG antibody. This was 
followed by the addition of 100 ul alkaline phosphatase-antibody conjugate. 
After incubation at 37 °C for 90 minutes, the bead was washed three times 
with 2 ml ice-cold phosphate buffer. 200 ul of p-nitrophenyl phosphate 
substrate solution was added and incubated for 30 minutes at room 
i 
temperature. The reaction was stopped by adding 1 ml o f 2 N NaOH, and the 
optical density at 405 nm was measured. The concentration was directly 
proportional to the absorbance. The specific activity was calculated as 
|. amount of radioactivity per microgram of hCG. 
(ii) Percentage binding of [⑵巧 hCG to anti-hCG antibody: 
This was determined by incubating the anti-hCG antibody coated bead with 
1 0 ^  
200 ul of various concentrations of [ I] hCG without (total binding) or with 
(nonspecific binding) 40 IU unlabeled hCG at room temperature for 4 hours. 
After the incubation, the beads were washed three times with 2 ml ice-cold 
phosphate buffer each. The radioactivity bound to the bead was measured. 
The percentage of [⑵工] h C G specifically bound to the bead was calculated 
by subtracting the radioactivity in the absence of non-radioactive hCG from 
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j that in the presence ofnon-radioactive hCG and dividing by the total amount 
•t； 
of t r ace r added. 3 3 i i ^ 
！ Labeled hCG binding to cells grown in monolayers 
Two days before experiments, 60,000 cells were seeded per well of 24-well 
plate. The cells were washed once with 1 ml Hanks ' balanced salt solution 
(HBSS) and incubated in 200 ul HBSS containing 0.5 % BSA and different 
•！ 
amount of [^^^I] hCG in the presence or absence of 100 IU unlabeled h C G at 
3 7 � C in 5 % CO2 incubator for 1 hour. The cells were quickly washed with 
1 ml ice-cold HBSS three times. The bound fractions of [⑵！] h C G were 
extracted by solubilizing the cells with 1 N N a O H solution and measured 
with the gamma counter. A single high affinity model using the program 
LIGAND (NIH) was used to calculate Kd values. 
i' 
t Labeled hCG binding to cells in suspension 
i, 
The culture medium was changed on the day before experiments. The cells 
I： were disaggregated with 0.025 % trypsin-EDTA, resuspended in the growth 
medium and incubated for 4 hours at 37 T in 5 % CO2 incubator to allow 
I . 
i the recovery of the surface receptors. After the incubation, the cells were 
centrifuged down and resuspended in the incubation medium (HBSS, 25 m M 
HEPES, 0.5 % BSA). 200,000 cells were added per 2 ml-microcentrifuge 
i 1 r>t c 
tube containing different amount of [ I] hCG in the presence or absence of 
100 IU unlabeled hCG in a final volume of 0.2 ml, and incubated at 37 °C in 
the 5 % CO2 incubator for 1 hour. After the incubation, 1.6 ml HBSS 
containing 0.5 % BSA was added per tube. The cells were centrifuged at full 
speed for 3 minutes in a bench top microcentrifuge (5413, Eppendorf, 
Hamburg, Germany). The cell pellets were washed once with 1 ml ice-cold 
HBSS, centrifuged and aspirated carefully. The tip containing the pellet was 
cut and placed in a 10 x 75 mm polypropylene tube and radioactivity 
determined in a gamma counter. The Kd was calculated as mentioned above. 
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2. Establishment of cells expressing functional receptor for hCG 
； Although several gastrointestinal cell lines (T84, FHs 74 int, PANC-1) were 
tested for the presence of LH-CGR by means of radioreceptor assay, but 
none of these cell lines possessed LH-CGR. Therefore, we tried to produce 
cells which transiently expressed functional receptor for h C G in COS-1 
cells. COS-1 cells were transfected with M C l + 2 LH-CGRy^TSH chimera 
receptor, which have been shown to behave similarly to cells with wild type 
LH-CGR^4 Initial transfection was performed at NIH on COS-7 cells 
(another transformed Monkey kidney cell l i n e / ^ however COS-7 cells did 
not grow properly in our laboratory. The COS-1 cells were transfected either 
with M C l + 2 D N A in pSG5 expression plasmid or with pSG5 plasmid alone 
(negative control). Two methods for transfection were used. The calcium 
107 
phosphate method was based on that described by Kingston (1990) . hi the 
electroporation method, under a high-voltage electric field, cell membrane 
can be temporarily broken down, creating pores through which D N A can 
pass into the cells. The reclosure of the membrane pores is a natural decay 
process which is delayed at 0 °C^^^. Therefore, putting cells in ice helps to 
108 
increase time period for DNA to enter the cells 
Culture ofCOS-1 cells 
COS-1 cells were cultured in D M E M containing 25 m M HEPES, 10 % fetal 
calf serum, L-glutamate, penicillin and streptomycin at 37 "C in the 5 % CO2 
incubator. 
Transfection by Calcium Phosphate 
COS-1 cells were grown to 40 - 50 % confluency in 10 cm petri dish. 25 ug 
ethanol precipitated chimera M C l + 2 plasmid DNA or pSG5 plasmid DNA 
was resuspended in 450 ul sterile water and 50 ul 2.5M CaCl2 added. Whilst 
bubbling sterile air through 500 ul of HEPES-buffered saline (280 m M 




5 was added dropwise. The final mixture was vortexed for 5 seconds. The 
precipitate was allowed to stand at room temperature for 20 minutes. The 
precipitate was next added dropwise to cells and the dish was agitated gently 
sideways. The cells were incubated for 6 hours in the 5 % CO2 incubator 
before the removal of the medium. The cells were washed twice with PBS 
followed by the addition of 10 ml D M E M growth medium. One day after the 
transfection, the medium was aspirated and the cells were disaggregated by 
trypsinization. After washing with the culture medium, approximately 
60,000 cells were added per well of a 24 well plate in one ml complete 
D M E M medium for cAMP study. For determination of total inositol 
phosphate (TIP), 60,000 cells were grown in D M E M without inositol, but 
i. ^ containing 1.5 uCi/ml of [ H] inositol. For iodide release experiment, 
120,000 transfected cells were plated in 3.5 cm petri dish. 
Transfection by Electroporation 
In the initial trial, the electroporation transfection was based on the gene 
pulser settings (0.3 kV and 25 uF) determined by Dr Kohn ' s group at NIH 
for transfecting COS-7 cells. Unfortunately, although the transfection was 
successful when dealing with COS-1 cells, the consecutive work on iodide 
release using the transfectant did not give promising result. Therefore, 
different gene pulser settings were tested. They were 0.1 kV/25 uF, 1 kV/3 
uF and 1 kV/1 uF. For the subsequent work, the optimized settings of 1 kV/1 
uF were used. COS-1 cells at about 50 % confluency were harvested 
following trypsinization. The dislodged cells were centrifuged at 240 x g. 
The cell pellet was washed with electroporation buffer (272 m M sucrose, 7 
m M NaH2PO4, 1 mM MgCl2, pH 7.4), and 7.5 x 10^ cells were resuspended 
in 0.8 ml electroporation buffer. The cell suspension was added to a gene 
pulser cuvette containing 25 ug plasmid DNA, M C l + 2 plasmid or pSG5 
plasmid, in 10 ul sterile water, and mixed thoroughly. The cells were left at 
4 °C for 10 minutes and then pulsed with settings at 1 kV and 1 uF. The cells 
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were left at 4 T for another 10 minutes. The cells were next resuspended in 
the D M E M growth medium. Approximately 60,000 cells were added per 
well of a 24 well plate in one ml growth medium for cAMP study. 120,000 
transfected cells were plated in 3.5 cm petri dish in 2 ml growth medium for 
iodide release assay. 
HCG stimulated cAMP production and TIP production bv transfected 
cells 
a) The cAMP assay 
Two days after setting up the 24 well plates, the medium was aspirated and 
cells washed once with Hanks ' balanced salt solution (HBSS). The 
transfected cells were incubated with different concentrations (in triplicate or 
quadruplicate) o f h C G (0, 10^ 10^ 10^ 10^ or 10^ RJ/L ) in the incubation 
medium (DMEM containing 0.5 % BSA and 0.5 m M isobutyl methyl 
xanthine, pH 7.3) at 37 °C in 5 % CO2 incubator for one hour. The assay 
was terminated by aspirating the incubation medium followed by the 
addition of 1 ml 1.7 % HC1 in ethanol (HCl/EtOH) and storage at -20 "C 
ovemight. HCl/EtOH extract was dried by speed vacuum, reconstituted in 
Tris-EDTA buffer (50 m M Tris-HCl, 4 m M EDTA, pH 7.5) and assayed for 
intracellular cAMP by the protein kinase binding assay^^^. 
b) The TIP assay 
Two days after setting up the 24 well plates, the medium was aspirated and 
cells washed once with Hanks' balanced salt solution (HBSS). 200 ul of 
D M E M containing 10 m M LiCl, 0.5% BSA and various concentrations of 
hCG (0, 1.5 X 102, 1.5 X 104 or 1.5 x 10^ IU/L) was added per well. All 
assays were done in triplicate or quadruplicate at 37 °C for one hour. The 
incubation was terminated by the addition of 1 ml of 5.0 % perchloric acid 
(PCA). After neutralization of the cell extract, 1 ml of the cell extract was 
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chromatographed on Dowex gel, for the assay of TIP according to the 
method ofBerr idge et al (1983)uo. 
3. Effect of hCG on f^ ^^ I1 iodide efflux from COS-1 cells transiently 
expressing MCl+2 LH-CG/TSH chimera receptor 
This assay is based on the method of Venglarik et al (1990) for monitoring 
1 ro • 
C r efflux . Two or three days after transfection, the growth medium was 
aspirated and cells washed once with 2 ml HEPES-phosphate-buffered-
Ringer solution (HPBR) containing (in mM) 135 NaCl, 5 KC1, 3.33 
NaH2PO4, 0.83 Na2HPO4, 1 CaCl2, 1 MgCl2, 10 glucose, and 5 HEPES (pH 
7.4). The cells were loaded with 2 uCi of ' ' ' r in 1 ml of HPBR at 37 T for 
one hour. The medium was aspirated and cells washed four times quickly 
with HPBR and with one additional 1 ml which was left in contact with cells 
for 1 min. After aspiration of the last wash, the experiment was started by 
the sequential addition and removal of 1 ml HPBR after 1 minute. The 
hormone dissolved in 1 ml HPBR containing 0.1% BSA was introduced 
once after two basal readings. The iodide released during the minute was 
determined by the gamma counter. After the last collection, the cells were 
lysed with 5.0 % PCA and the residual activity determined and the rate 
constant of tracer release (r) was calculated, according to the equation: 
r = [ln("i) - lnCR2)] X 100% , where Ri and R2 are the percentage of (t2 - 0 
counts remaining in the cells at times 1 (/i) and 2 (¾), respectively. For the 
control incubations, 0.1% BSA was used. 
4. Anion secretion from by MLTC-1 cells with wild type LH-CGR 
Rationale for using TPP to study anion secretion 
Effect of hCG on anion secretion was further investigated in cells having 
wild type LH-CGR. MLTC-1 cells were chosen for this purpose. Initially, 
125 [ I ] iodide release assay was tried. However, the basal uptake of 
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radioactive iodide by MLTC-1 cells was too low to allow significant release 
of iodide during the experimental period. Therefore, TPP uptake assay was 
used instead. TPP is a lipophilic cation, uptake of which is driven by the 
ii 
electrical potential between the inside and the outside of the plasma 
membrane. Tritiated TPP has been used to measure the membrane 
potential46. The membrane potential of a resting Leydig cell is about -35 
mV43. Under a similar force, TPP will be taken up by MLTC-1 cells. The 
decrease of TPP uptake indicates a decrease of membrane potential (interior 
less negative). The TPP uptake assay was modified f rom the method 
developed by Grollman et al^^. In their experiments, the movement of a 
similar lipophilic cation triphenylmethylphosphonium (TPMP) was used to 
monitor the hyperpolarizing effect of TSH on the thyroid cell membrane, 
and the uptake of TPMP was linked to the intracellular chloride status. Later 
we found that release of TPP (modified f rom iodide efflux assay) could be 
used to monitor the transient effect of hCG on the membrane potential of 
MLTC-1 cells. 
Culture ofMLTC-1 cells 
The cells were grown in RPMI-1640 containing 25 m M HEPES, 10 % fetal 
calf serum, L-glutamate, penicillin and streptomycin. Two days before the 
experiments, the cells were disaggregated by trypsinization and 300,000 
cells were plated in a 3.5 cm petri dish in the growth medium. 
Effect of hCG on TPP uptake bv MLTC-1 cells 
The growth medium was aspirated and cells washed once with HBSS. 1 ml 
of HBSS with 0.5 % BSA, 5 uM non-radioactive TPP, 1 uCi [㊀！!] TPP 
without or with hCG was added and incubated for 5 minutes at room 
temperature. At the end of the incubation, the medium was aspirated and 2 
ml chilled 0.8 M NaCl with 0.1 M Tris.HCl, pH 7.5, was added, and 
aspirated immediately. This was repeated three more times. After the fourth 
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wash, the cells were lysed with 5.0 % PCA and the p-radioactivity in the 
lysate determined in a liquid scintillation counter (LS 9800 series liquid 
scintillation systems, Beckman Instruments Inc., Irvine, USA). 
Effect of hCG on TPP reiease bv MLTC-1 cells 
This assay was similar to [^^^I] iodide efflux assay except that cells were 
loaded with 1 uCi of [^U] TPP in HPBR containing 5 u M non-radioactive 




Effect of chloride ion on TPP uptake bv MLTC-1 cells 
Although uptake of TPP has been linked to the intracellular chloride status, 
the effect of hCG on the movement of TPP may be due to the efflux of other 
anions, or due to the influx of cations. In order to confirm that the effect of 
hCG was caused by the stimulation of chloride secretion, the effect of 
chloride on the uptake of TPP in the presence or absence of hCG was 
studied by depleting the intracellular chloride and allowing the TPP uptake 
to take place in either chloride rich medium (HBSS) or chloride free medium 
(HPBR with C r substituted by NOs" and SO4^"). MLTC-1 cells were 
depleted of intracellular chloride by incubating cells for 1 hour at 37 °C in 
chloride free medium. Before TPP uptake, the cells were quickly washed 
once with 2 ml HBSS for chloride replete experiment or with chloride free 
medium for chloride free experiment. The inhibitory effect of hCG on TPP 
uptake was expressed as Inhibition Index and calculated according to the 
formula: Inhibition Index = 1 - (TPPhcc/TPPcontroi), where TPPhco and 
TPPcontroi is thc uptakc of [^H] TPP in the presence or absence of 1 x 10^ 
IU/L hCG, respectively. 
4 0 
Statistics 
The data were analyzed using paired Student 's t-test (2 tails), sign test (2 
tails), or Wilcoxon 's rank sum test where appropriate. The mean 土 SD o f K d 








..)丨 4 1 
Results 
1. Presence of LH-CGR in various cell lines 
Specific hCG binding bv cells in either monolavers or cell suspension 
None o f t h e human gastrointestinal cell lines (T84, FHs74 int and PANC-1) 
demonstrated any specific binding for [ ^ I ] hCG, irrespective o f w h e t h e r the 
cells were in monolayers or cell suspension during the incubation with the 
tracer. Only the positive control cell line (MLTC-1) demonstrated the 
presence of LH-CGR. In monolayers, the Kd and density were found to be 
30 土 24 n M and 8 土 5 x 10^^ receptors/well respectively (n = 2, figure 1.1). 
In cell suspension, the Kd and density were found to be 15 土 6 n M and 8.1 土 
2.5 X 10^ receptors/cell, respectively (n = 2, figure 1.2). 
2. Establishment of cells transiently expressing LH-CG/TSH chimera 
receptors 
Assessment of transfection efficiency bv measuring the cellular response 
to hCG in terms of second messenger production 
a. Calcium phosphate method 
Figure 1.3 (a and b) shows the production of cAMP and TIP per well by 
COS-1 cells transfected by the calcium phosphate method. For the cells 
transfected with M C l + 2 plasmid DNA, hCG upto concentration of 1 x 10^ 
IU/L caused a dose dependent increase in cAMP production, with cAMP 
levels rising 4 fold higher than zero control. At higher concentrations, there 
was no further increase in cAMP. Increase in TIP production was only 
observed with 1.5 x 10^ IU/L hCG. No significant response was observed in 
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Figure 1.1. Typical Scatchard plots for hCG binding with different cells in 
monolayers and the Kd value for MLTC-1 cells. 
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Figure 1.2. Typical Scatchard plots for hCG binding with different cells in 
suspension and the Kd value for MLTC-1 cells. 
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Figure 1.3. The effect of hCG on the producton of second messengers -
cAMP (a) and TIP (b) by COS-1 cells transfected with M C l + 2 plasmid or 
pSG5 control plasmid DNA by the calcium phosphate method. The results 
(mean 土 1 SD) are expressed relative to the basal production (unstimulated 
controls). For cAMP, n = 4, except those stimulated with 100 IU/L or 1000 
IU/L hCG (n = 2); for the TIP, n = 3. 
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b. Electroporation under different conditions 
Figure 1.4 (a, b, c and d) summarizes the effect of electroporation conditions 
(i.e. voltage and capacitance) on transfection of COS-1 cells by M C l + 2 
plasmid DNA. Amongst the conditions, cells transfected at a setting of 1 kV 
and 1 uF gave the highest response to hCG. The response to h C G was dose-
dependent and the accumulated cAMP rose 14 fold higher than the zero 
control. Compared to the calcium phosphate method, the increase in cAMP 
production was 3.5 fold greater. The COS-1 cells transfected with pSG5 
plasmid did not show any significant response to hCG. 
3. Effect of hCG on anion secretions bv COS-1 cells transiently 
expressing MCl+2 LH-CG/TSH chimera receptor 
[12¾] iodide efflux from transfected COS-1 cells 
The effect o f h C G on ⑵！- efflux f rom COS-1 cells transfected with M C l + 2 
plasmid DNA using the calcium phosphate method is shown in figure 1.5a. 
Both doses, 1.5 x 10^ and 1.5 xlO^ IU/L of hCG caused a prompt release of 
the anion. However, this result was not reproducible. Figure 1.5b shows the 
release of ⑵！- f rom COS-1 cells transfected with M C l + 2 DNA by the 
electroporation method, when stimulated with hCG. H C G significantly 
increased the iodide efflux at the dose of 10^ IU/L (p = 0.001) or 10^ IU/L (p 
< 0.001) in a dose dependent manner. The peak response occurred two 
minutes after the introduction o f h C G . 
4. Effect of hCG on anion secretions bv MLTC-1 cells 
TPP uptake bv MLTC-1 cells 
Figure 1.6 shows the uptake of TPP in the presence of different 
concentrations of hCG. Compared to zero controls, the cells incubated with 
hCG had lower uptake of the lipophilic cation. The maximum inhibitory 
effect of hCG was achieved at a concentration of 1 x 10^ IU/L. 
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Figure 1.4 (a and b). The effect of pulse-voltage settings on the hCG 
stimulated cAMP produciton by COS-1 cells transfected with M C l + 2 
plasmid or pSG5 control plasmid DNA. The results (mean 土 1 SD) are 
expressed relative to the basal productions (unstimulated controls). 
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Figure 1.4 (c and d). The effect of pulse-voltage settings on the hCG 
stimulated cAMP produciton by COS-1 cells transfected with M C l + 2 
plasmid or pSG5 control plasmid DNA. The results (mean 土 1 SD) are 
expressed relative to the basal productions (unstimulated controls). 
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Figure 1.5. The iodide efflux (mean 土 1 SD) from COS-1 cells transfected 
with M C l + 2 plasmid DNA by the calcium phosphate method (a), n = 2, and 
electroporation method (b), n = 6, before and after addition (arrow) of 
different amounts o f h C G . * p < 0.001 (sign test, 2 tails), compared with the 
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Figure 1.6. The [^E] TPP uptake (mean 土 1 SD) by MLTC-1 cells during 5 
minute incubation without or with various concentrations of hCG. The 
results are expressed relative to the controls. * p = 0.01; ** p , 0.05; *** p < 
0.005 (Wilcoxon's rank sum test, 1 tail), compared with the control group (0 
IU/L hCG). 
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TPP release bv MLTC-1 cells 
Figure 1.7 shows the effect o f h C G on the TPP release f rom MLTC-1 cells. 
H C G significantly stimulated the TPP release at the dose of 10^ IU/L (p 二 
0.004) or 106 IU/L (p 二 0.002) in a dose dependent manner. The peak 
response occurred one minute after the introduction o f h C G . 
Effect of chloride on TPP uptake by MLTC-1 cells 
Figure 1.8 (a, b) and Table 1.1 summarize the effect of depletion of 
extracellular and/or intracellular chloride on the uptake of TPP by MLTC-1 
cells. In all cases, hCG inhibited the uptake of TPP. Removal of extracellular 
C r reduced the inhibitory effect of hCG (Inhibition Index: 0.149 versus 
0.219, p = 0.0475). The inhibitory effect o f h C G was highest, when chloride 
rich pre-incubation medium and chloride rich incubation medium were used 
(Inhibition Index: 0.216) and lowest when the cells were pre-incubated in 
chloride free medium with the incubation in chloride rich medium 
(Inhibition Index: 0.063). 
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Figure 1.7. The ( ¾ ] TPP release (mean 土 1 SD) by MLTC-1 cells in the 
absence or presence of different concentrations of hCG (n = 8). The arrow 
indicates the addition of culture medium containing 0.5% BSA with different 
amount of hCG. * p < 0.005 (sign test, 2 tails), compared with the control 
group (0 IU/L hCG). 
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Figure 1.8. The [^H] TPP uptake (mean 土 1 SD) during 5 minute incubation 
without or with hCG by MLTC-1 cells pre-incubated in either chloride free 
or chloride rich medium. The diagrams show the uptake in chloride free 
medium (a) and chloride rich medium (b). n = 7. * p < 0.05; ** p < 0.02; 
*** p < 0.01; **** p = 0.001, compared with the corresponding controls; •:• 
p = 0.001, difference in uptake inhibition caused by hCG as a result of 
preincubation in chloride free medium and chloride rich medium 
(Wilcoxon's rank sum test, 1 tail). 
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Table 1.1. The inhibiton index for [^U] TPP uptake by MLTC-1 cells with 
respect to different concentrations of chloride in the pre-
incubation and uptake media. 
Preincubation medium 
hCG INHIBITON INDEX p value* 
chloride free chloride rich 
TPP uptake chloride free 0.127 0.149 0.98^ 
medium chloride rich 0.063 0.216 0.002' 
! 
p value 0.03' 0.0475^ 
* p value is calculated with Wilcoxon's rank sum test, 
a p value of 2 tail probability 
b p value of 1 tail probability 
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Discussion 
Because of the anatomical location f rom where vomiting occurs, i.e. the 
UGIT and our hypothesized action triggered by hCG, an attempt was made 
to investigate the presence of h C G receptors in some established cell lines 
f rom the gastrointestinal system. T84 has been commonly used as a model 
for C r secretionio2 io3. We therefore first examined the presence of LH-CGR 
on T84 cells, but no binding was observed. We later examined their presence 
in two other cell lines f rom the gastrointestinal system, i.e. FHs74 int and 
PANC-1 cells, which are both epithelial cells. They were also found to lack 
LH-CGR. On the other hand, MLTC-1 cells (positive control) gave | 
I I 
consistently positive results for LH-CGR, irrespective of whether binding 
studies were performed with cells in either monolayers or suspension. The 
use of cell suspension was to exclude the possibility of the receptors being 
located on the basal side o f t h e cells, i.e. the side in contact with surface of 
culture plates. Although the three cell lines studied were f rom the 
gastrointestinal system (pancreas, small intestine, and colon) and appeared 
not to have LH-CGR, however that does not preclude the presence of the 
LH-CGR in the pancreas, small intestine and colon because i) the properties 
of a tumor cell line (PANC-1 cells and T84) usually differ f rom normal 
1 1 ^ cells ； ii) an established normal cell line (FHs74 int) usually undergoes 
1 1 Q * 
transformation leading to the loss or change of properties ； iii) a cell line is 
derived from a single cell, which only has the properties of that specific cell 
type, which may not have possessed LH-CGR. 
We next investigated the use of transfection to incorporate the LH-CG/TSH 
chimera receptors in COS-1 (COS-7) cells. To all intents and purposes the 
COS-1 (and COS-7) cells transfected with the LH-CG/TSH chimera receptor 
show second messenger (and binding) responses to glycoprotein hormones 
similar to cells with wild type TSH or LH-CGR receptors^^, which have 
been confirmed with regard to hCG in the present study. 
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COS-1 cells transfected by either method of transfection gave positive 
cAMP responses to hCG, however the yield was higher in cells transfected 
by electroporation. The ⑵厂 eff lux was quite marked but unreproducible in 
cells transfected by the chemical method. On the other hand ⑵厂 eff lux was 
lower, but nonetheless consistent in the cells transfected by electroporation. 
The discrepant ^^ 1^" efflux in COS-1 cells probably resulted f rom variable 
coupling between the receptor and the cAMP signaling pathway. 
Alternatively, the ^ r efflux may not be coupled to cAMP. The C1" eff lux 
48 
f rom different epithelial cells is coupled to different signaling pathways . In 
FRTL-5 cells, 1' eff lux by TSH and other agonists involves archidonic acid 
release or calcium-dependent activation of phospholipase A2 and not 
adenylate cyclase-cAMP"i . 
When using transfected cells to study the characteristics of a receptor, there 
are a few assumptions made. One is that all cells will demonstrate similar 
second messenger cascades and autocrine/paracrine systems (e.g. 
prostaglandin paracrine system). Secondly, it is assumed that coupling 
between transfected receptors and a signaling pathways is intact, as 
aforementioned. Furthermore, when using transfected cells to study the 
! 
possible cellular physiological function of a receptor protein, there is another 
assumption made, that all cells (or only the cells with the native receptor and 
the cells chosen for transfection) have the same set of proteins required for 
carrying out the cellular function which is measured in the experiments. 
Since different cell types are highly differentiated in a manner to carry out 
specific physiological cellular functions, the last assumption should be 
carefully verified. In our experiments, we assumed that COS-1 cells had the 
same set of anion transporters, which are controlled by the same sets of 
second messenger cascade and autocrine/paracrine systems, as the wild type 
cells naturally expressing functional LH-CGR proteins. 
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Besides the above assumptions, the degree of expression of the transferred 
genetic materials also affects the final experimental results. When using 
Chinese hamster ovary (CHO) cells permanently transfected with human 
TSH receptor (hTSHR) cDNA, hCG was shown to have a thyrotropic 
potency 70 fold higher than in the experiments using human thyroid 
follicles39. One possible explanation was that the transfected CHO cells 
expressed more hTSHR (2 x 10^ -10^ TSHR/cell) than a normal thyrocyte 
(2000 TSHR^dl)39 it is difficult to control the degree of transfection, as 
well as the degree of transient gene expression in each single cell. The 
degree is highly variable. Some cells will be more sensitive to the agonists 
than the others. The situation becomes worse when the transfected cells used 
in the experiments are only transiently expressing the transferred gene. The 
expression of the transferred gene decreases with the time because of the 
gradual inactivation of t ransferred genetic materials. When studying a certain 
cellular response, a minimum critical expression level of the transferred gene 
may be required. 
In order to obviate the difficulties encountered with transfection and variable 
expression of receptor proteins and their coupling to the second messenger 
systems and the effector mechanism, MLTC-1 cells with wild type LH-CGR 
were used. The presence of the latter was confirmed in this study by 
Scatchard analysis. Although MLTC-1 cells with native LH-CGR obviated 
1 0 ^  
transfection, however the cells demonstrated little F uptake, indicating 
different iodide transporters for COS-1 cells and MLTC-1 cells. On the 
other hand, MLTC-1 cells took up considerable amount of [^H] TPP. The 
TPP uptake is membrane potential driven^^ and has been linked to chloride 
diffusion potential for a related lipophilic cation (TPMP)^^. The uptake of 
TPP allowed us to monitor the amount of intracellular chloride indirectly. 
The inhibitory effect of hCG on TPP uptake suggested that hCG caused a 
decrease of intracellular chloride, probably through active secretion. Since 
57 
h C G inhibited the uptake of TPP, it was logical to predict that h C G could 
stimulate the release of TPP. The latter would be dragged out o f t h e cells in 
parallel with chloride secretion. The results showed that our prediction was 
correct. H C G increased the release of TPP in a dose dependent manner. 
However, the effect of h C G on the increase in the secretion was not as 
prominent as that on the iodide efflux of transfected COS-1 cells. Probably, 
that was because TPP was sequestered in the mitochondria^^, leading to a 
delay in the release of TPP. 
Although movement of TPP has been linked to chloride diffusion potential 
of cells, TPP is a lipophilic cation, which moves into a cell by virtue of the 
membrane potential46. The decrease of TPP uptake suggests a decrease in the 
membrane potential (depolarization) through either the net efflux of anions 
or the net influx of cations. Therefore, we needed to confirm whether the 
hCG stimulated TPP secretion was due to the secretion of chloride. Our 
studies with manipulation of intracellular and extracellular chloride 
concentrations yielded interesting results. With normal chloride levels in 
cells, the reduction of extracellular chloride decreased the inhibitory effect | 
o f h C G on TPP uptake. This suggested the inhibitory effect of hCG on TPP | 
uptake was partly caused by the reduction of C1' influx. The hCG stimulated 
reduction must have been caused by the decrease of active influx of C1", and 
not due to the decrease of membrane permeability to C1". If latter were the 
case, hCG would have stimulated TPP uptake in chloride free medium, 
because in this medium, there would normally be net efflux of C1" from 
MLTC-1 cells. The decrease in membrane permeability to C1" by hCG (if 
present) would have resulted in reduction in C1" efflux when compared with 
the control, but this was not the case. Depletion of intracellular chloride 
before TPP uptake in chloride free medium further enhanced the inhibitory 
effect of hCG although the difference was not statistically significant. 
Interestingly, when the uptake was performed in chloride rich medium, the 
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inhibitory effect was significantly reduced by intracellular C1' depletion, 
which could be due to i) the fact that the inhibitory effect of h C G was partly 
caused by the stimulation of active C1" efflux. Another possibility was that 
the expected increased influx of C1' into the cells may have masked the 
depolarizing effect of h C G when the chloride depleted cells were bathed in 
chloride rich medium. The highest inhibitory effect was obtained when both 
the extracellular and intracellular chloride levels were in normal 
physiological range. Our results suggested that hCG contributed to the 
depolarization process by stimulating active chloride secretion. However, 
this chloride manipulation experiment could not answer whether the 
movement of TPP was also related to other ions, or not. 
The experiments on iodide efflux, TPP uptake and release, indirectly showed 
that hCG can stimulate chloride secretion from COS-1 and MLTC-1 cells 
expressing LH-CG/TSH chimera receptor and wide type LH-CGR 
respectively. The inhibitory effect of TPP uptake on COS-7 expressing the 
same M C l + 2 LH-CG/TSH chimera receptor was also observed in the 
preliminary experiments^^ In another preliminary photometric study 
employing a C1" sensitive probe - 6-methoxy-N-(3-sulphoproyl) 
quinoliniumii4 - we demonstrated C1" efflux from rat epidydimal cells by 
hCG44. TSH action on thyrocytes also involves the (uptake and) efflux of Y 
before its incorporation into thyroglobulin and thyroid hormone release"i , 
an action mimicked by hCG which can induce thyrotoxicosis^^. Therefore in 
view of these findings and the report by Duchatelle and Joffre (1990)^^, 
anion efflux from cells with functional receptors for hCG appears to be a 
universal response to hCG. 
In conclusion, although the three established cell lines from the 
gastrointestinal tract did not possess LH-CGR, nevertheless it appears that 
hCG causes the efflux of anions from cells with functional LH-CGR. The 
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possibility of cells with LH-CGR in the rat gastrointestinal tract is 







Sect ion 2 P r e s e n c e of L H - C G R in t h e u p p e r 
g a s t r o i n t e s t i n a l t r a c t of r a t 
Introduction 
In the previous section, we have shown that secretion of anion(s) is a 
universal effect o f h C G on cells with functional LH-CGR. Since a humoural 
agent normally brings forth its biological actions in the cells by interacting 
with its receptor, it stands to reason that, whatever agent is inducing 
vomiting, mediates its action via receptors located on secretory cells in the 
UGIT. Therefore, it is important to know whether LH-CGR (receptor for 
hCG) is present in the UGIT for hCG to trigger vomiting via copious 
secretion of fluid and electrolytes. 
Besides the known target organs - the ovary and testis, functional LH-CGR 
have been reported in non-gonadal tissues. LH-CGR has been found in 
prostate82, ep idydimis&�non-pregnant human fallopian tube^^ human^^, 
rat7i, rabbit73 and porcine^^ uterus, human placenta?。，fetal m e m b r a n e ? � a n d 
decidua7o, human umbilical cord^^, blood vessels of all these target 
tissues55 56 7o,76, iymphocytes of pregnant women^^ and rat brain�？. Recently, 
Pabon et. al. (1996) has demonstrated the presence of LH-CGR in human 
ademal gland^^. Although LH-CGR were claimed to have been isolated f rom 
rat liverii5, rat liver has been used as a negative control tissue for the past 
few years55 56. 
The aim of this study was to investigate the presence of LH-CGR along the 
GIT of female rats as an animal model; to characterize the physicochemical 
properties of these gastrointestinal LH-CGR; and to localize the distribution 
of LH-CGR in the target tissues. 
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Materials and Methods 
Materials 
Sprague Dawley rats and New Zealand white rabbits were obtained f rom the 
animal house of our institute. Iodogen was obtained f rom Pierce (Rockford, 
USA). Iodine-125 for iodination (iodide in N a O H solution, specific activity 
17.2 mCi/ug) and ECL Wes tem blotting detection reagents were obtained 
f rom Amersham International PLC (Amersham, England). Fine Sephadex G-
25 gel was obtained f rom Pharmacia (Sollentuna, Sweden). Rotofor 
preparative ioelectric focusing cell, Mini Protean II electrophoresis cell and 
I 
I 
the respective electroblotting accessories were obtained f rom Bio-rad 
(Hercules, USA). hCG (3000 IU/mg and 14000 IU/mg), Freund's adjuvants 
(complete and incomplete), Coming cultureware and Cyanogen bromide-
activated sepharose 4B gel were obtained f rom Sigma Chemical Co (St. 
Louis USA). Growth media, fetal calf serum and trypsin-EDTA were 
obtained f rom either Gibco (Gaithersburg, USA) or Sigma Chemical Co. (St. 
Louis, Missouri, USA). MLTC-1 cells (testis, Leydig carcinoma, Murine) 
were obtained from American Type Tissue Collection (Rockville, Maryland, 
i 
USA). Two peptides corresponding to amino acids 24-33 (N1: 
GPRAGLARLS) and 239-249 (N2: SKEKFTSLLVA) of rat ovary LH-CGR, 
I 
as deduced from cDNA^^^, were synthesized chemically and covalently 
linked to maleimide activated diphtheria toxoid through an extra cysteine 
residue at the carboxyl end of the peptides. The synthetic peptides and 
peptide-diphtheria toxoid conjugates were prepared by A Chiron Company 
(Clayton, Australia). All other chemicals were reagent grade compounds 
obtained from commercial sources. 
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Methods 
1. Screening for hCG binding sites along the rat GIT 
In order to investigate the presence of LH-CGR in UGIT, a radioreceptor 
assay using tissue homogenate was established. The method was as 
described in the previous section. In the early attempts, fine homogenates 
were prepared f rom different parts of the GIT of female rats, and used for 
radioreceptor assays for LH-CGR. The use of fine homogenates was to 
determine whether LH-CGR was present on the cell surface o f t h e tissues. 
Preparation of tissue homogenates 
Female rat weighing 230 - 260 grams were used. A vaginal smear was taken 
and spread on a microscopic slide and fixed with 95 % alcohol. The cells 
were stained with hematoxylin and eosin, and the estrous stage determined 
f rom the morphology of the cells^^^. The rat was anaesthetized with ether 
and killed by cervical dislocation. The GIT was removed and the following 
regions were separated: upper half of the stomach, lower half of the 
stomach, the duodenum (the 3-cm-region adjacent to the lower stomach), the 
je junum (the next 5-cm-region), the ileum and the colon. All were cut open 
and washed in an ice-cold buffer A (40 m M Tris/HCl, 5 m M MgCl2, 5 m M | 
i • 
N-ethylmaleimide (NEM), 10 m M EDTA.Na4, 0.2 m M phenyhnethyl 
sulphonylflouride (PMSF)). The tissue was cut into small pieces and 
homogenized on ice in 6 v/w buffer A with a Polytron-Aggregate (Kinetica, 
Switzerland) with a 11 mm cutting probe at a speed setting of 4.5 for 15 
seconds. The homogenate suspension was diluted 1.4 fold with the ice-cold 
buffer A. The large homogenate particulates were allowed to settle to the 
bottom under gravity. 500 ul o f t h e fine homogenate was aliquoted to a pre-
weighed microcentrifuge tube for measurement of hCG binding activity. 
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The assay 
The fine homogenate was centrifuged at full speed in a bench top 
microcentrifuge (5415C, Eppendorf, Hamburg, Germany) for 5 minutes. The 
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pellet was re-suspended in 500 ul buffer A containing 0.5 uCi [ I] hCG, 0.1 
% BSA, in the absence or presence of 125 IU unlabeled hCG (3 IU/ug). The 
suspension was incubated at room temperature for 4 hours. After the 
incubation, the homogenate was centrifuged and washed 3 times with 1 ml 
ice-cold buffer A. After aspirating the last washing, the tube containing the 
pellet was weighed. The tip of the microcentrifuge tube containing the final 
washed pellet was cut out and transferred to 12 x 75 mm polypropylene tube 
for the determination of radioactivity in a gamma counter (Cobra auto-
gamma, Packard Instrument Co. Inc., Switzerland). Each assay was done in 
i duplicate. 
2. Detection of Triton X-100 soluble plasma membrane hCG binding j 
protein along the rat GIT 
The presence of specific hCG binding sites in the tissue homogenate, does : 
not necessarily imply the presence of LH-CGR. The specific binding might 
be contributed by interaction with other biomolecules, for example 
gangliosides. hCG can be specifically bound by ganglioside Gi /^^ . In order 
i 
to establish categorically that hCG binding was due to its receptor, a 
radioreceptor assay for solubilized receptor proteins, modified from the 
method developed by Dufau et al (1973)u9 was established. The LH-CGR 
were solubilized from the crude plasma membrane preparation in a buffer 
containing Triton X-100, protease inhibitor (to prevent the degradation of 
1 or^  
receptor proteins from the endogenous protease ), N-ethylmaleimide 121 
(NEM, to prevent to the formation of receptor dimers ) and glycerol (to 
increase the stability of the solubilized receptor protein^^^). For the 
radiorecepter assay, 10.7 % polyethylene glycol (PEG) was used to 
precipitate the bound hCG^^^, which has the property of precipitating 
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proteins with molecular weight in excess of 110 kD, i.e. hCG-receptor 
complexs. 
Preparation of plasma membrane proteins 
Different organ tissues f rom female or male rats were homogenized with 
polytron at a speed setting of 4.5 in 3 ml of buffer A. The volume of the 
crude homogenate was adjusted to 10 ml with buffer A, and centrifuged at 
120 X g for 5 minutes at 4 � C to remove debris. The supernatant was 
centrifuged at 27,000 x g at 4 � C for 30 minutes and a crude plasma 
membrane pellet obtained. The pellet was resuspended in 1.5 ml solubilizing | 
buffer (buffer A containing 20 % glycerol and 1 % Triton X-100) and mixed | 
i I 
I I 
gently for 1 hour. In the preliminary experiments following solubilization, 
the suspension was diluted 10 fold with buffer C (buffer A containing 20 % 
i 
glycerol) and subjected to ultra-centrifugation at 240,000 x g at 4 � C for 1 j 
hour. The supernatant was termed as the Triton X-100 extract. Jn later 
1 • i 
experiments, the detergent-plasma membrane suspension was centrifuged at 
27,000 X g at 4 � C for 30 minutes instead of ultracentrifugation. The protein | 
concentration was measured by the Bradford 's Coomassie protein dye 
binding m e t h o d ^ . 
i 
The assay 
100 ul Triton X-100 extract was incubated with 0.1 uCi of [ ^ I ] hCG (70-80 
uCi/ug) in the absence (total binding) or presence (nonspecific binding) of 
100 IU unlabeled hCG at room temperature for 4 or 16 hours in a final 
volume of 200 ul. After the incubation, 500 ul of bovine-y-globulin solution 
(50 m M sodium phosphate, 0.9 % NaCl, 0.1 % NaN3, 1 % bovine-y-
globulin, pH 7.0) was added. The [⑵！] hCG bound was separated from the 
free fraction by precipitating the bound fraction with 350 ul of polyethylene 
glycol 8000 (PEG) solution (50 mM sodium phosphate，0.9 % NaCl, 0.1 % 
NaN3, 20 % PEG, pH 7.0). The mixture was put in an ice-water bath for 10 
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minutes, and centrifuged at full speed in an Eppendorf 5415C 
microcentrifuge for 5 minutes. The pellet was redissolved in 300 ul Triton 
X-100 solution (10 m M Tris.HCl, 1 m M MgCl2, l m M CaCl2, 0.1 % Triton 
X-100, pH 7.2), precipitated with 350 ul of PEG solution, and centrifuged. 
The supernatant was carefully aspirated. The tip of the microcentrifuge tube 
containing the pellet was cut off and transferred to a 12 x 75 m m 
polypropylene tube for the determination of radioactivity in a gamma 
counter. The specific binding was calculated by subtracting the radioactivity 
bound in the absence of non-radioactive hCG from the that in the presence 
of non-radioactive hCG. 
I I I 
I 




j I Scatchard analysis was performed to measure the binding affinity o f t h e hCG 
I I 1 
binding protein with hCG. The Scatchard analysis was similar to the 
radioreceptor assay used in the screening experiments. In the experiments, 
the Triton X-100 extract was incubated with different amount of [⑵巧 hCG i 
in the absence or presence of excess unlabeled hCG. The bound fractions | 
were isolated by PEG precipitation. The affinity constant, Kd, was then 
calculated with the LIGAND program, a versatile computerized approach for ‘ 
characterization of ligand-binding systems (NIH)^^^. 
The assay 
For Scatchard analysis, 100 ul of duodenal, pancreatic or ovarian (positive 
control) Triton X-100 extract was incubated with increasing doses of [⑵工] 
hCG (70-80 uCi/ug) in the absence or presence of 100 IU unlabeled hCG at 
room temperature for 16 hours. The bound and the free fractions were 
separated as mentioned above. A single high affinity model using the 
LIGAND program was used to calculate Kd values. 
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4. Determination of the isoelectric points for the duodenal hCG binding 
protein and ovarian LH-CGR 
The isoelectric point (pI) of a protein is the pH at which its net charge is 
zero. The pI value is determined by the amino acid sequence of the 
protein^24 jf ^ e hCG binding protein in the rat GIT is LH-CGR, it should 
have the pI value similar or close to that for the rat ovarian LH-CGR. The pI 
value was estimated by isoelectric focusing (IEF). The principle for the IEF 
is that a protein at pH equivalent to its pI value, has no net charge and stops 
* • 123 migrating • In this project, the Rotofor preparative isoelectric focusing 
j 
I system, which was originally designed by Egen et al ( 1 9 8 4 ) ^ , was used. i I . I 
The electrofocusing cell incorporates a cylindrical focusing chamber ‘ 
possessing a ceramic cooling finger with electrodes and ion exchangers at 
I 
both ends. Separation occurs within the annulus formed by the inside wall of 
the chamber and the cooling finger. The pH gradient is established with the 
ampholytes under the attractive force from either electrodes and the 
repulsive force f rom either ion exchangers. The proteins can be separated 
while establishing the pH gradients, or after the establishment. Rotation of 
the focusing chamber at 1 rpm around the focusing axis stabilizes convective 
and gravitational disturbances. The 19 parallel, monofilament polyester 
membranes divide the focusing chamber into 20 discrete compartments, each 
holding one fraction. After focusing, the solution in each compartment is 
rapidly collected without mixing, which is prevented by the monofilament 
polyester membranes. The merit of the Rotofor system is that the final 
focused proteins are in free solution in focusing compartments instead of in 
gel matrix, and can easily be harvested into test tubes. Furthermore, the 
Rotofor system also allows us to determine which pH compartment 
contained the focused hCG binding protein by aqueous phase radioreceptor 
assay. 
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Isoelectric focusing of piasma membrane proteins 
For the preparative isoelectric focusing, either the 3 cm duodenal segments 
or the ovaries f rom 5 female rats regardless of the stage of estrous cycle 
were pooled and processed separately. The crude membrane pellet was 
solubilized in 10 ml solubilizing buffer. The suspension was centrifuged at 
27,000 X g for 30 minutes. The supernatant was saved. The Rotofor cell was 
filled with 40 ml focusing buffer (1 % Triton X-100, 20 % glycerol, 1 % 
glycine and 2 % Bio-lyte ampholytes : pH 3-10) The cell was pre-focused at 
12 W (constant power) for 1 hour to establish the pH gradient. 10 ml of 
Triton X-100 extract was injected into the chamber at pH around 7.4. The 
proteins were focused for 2 hours. After the isoelectric focusing, the solution ‘ 
f rom each chamber was collected and pH determined by means of a pH 
meter with a glass combination electrode. 
Determination of hCG binding activity of each fraction bv radioreceptor 
assay 
The salinity o f t h e fractions was brought up to 1 M with 10 M NaCl. The 
salted fractions were dialyzed ovemight with 2 litres of buffer containing 40 
m M Tris.HCl, 5 m M MgCl2, 5 m M NEM, 10 m M EDTA, 0.2 m M PMSF, 
0.1 % Triton and 20 % glycerol, pH 7.4. The specific [ ^ I ] hCG binding 
activity of each fraction was determined as mentioned above but with slight 
modification. 100 ul of the dialyzed fractions was incubated with 0.05 uCi 
[i25l] hCG in the absence or presence of 50 IU non-radioactive hCG in a 
fmal volume of 125 ul at room temperature for 16 hours. 
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5. Developement of antibodies to LH-CGR 
To confirm if the gastrointestinal hCG binding protein was LH-CGR, we 
decided to perform Western immunoblotting. Since there were no 
commercial sources for anti-LH-CGR antibodies and our attempts to obtain 
antisera f rom two research groups (D. Segaloff and J. Luborsky) were 
unsuccessful, we produced our own antibodies. 
Rationale of using synthetic peptides for polyclonal antibody production 
For the production of antibodies, there are two main questions to be 
answered. The first concerns the antigen used for immunization. The second 
is whether to produce a polyclonal or monoclonal antibody. Attempts have ‘ 
been made to raise antibodies against LH-CGR. Luteal cell membrane^^^ 
* 115 127 5 5 
purified LH-CGR ， and synthetic peptide have been used. Furthermore, 
with the help of cDNA cloning technique, glycoprotein hormone receptors or 
only part of the protein can be produced in huge amount, which can then be 
used as antigens, for example, TSHR extracellular domaini28. The nature of 
the antigen will then determine the choice between polyclonal or monoclonal 
approaches. Lee and Ryan (1974) produced polyclonal antibodies against 
LH-CGR by injecting affinity purified rat ovarian LH-CGR protein into 
rabbits and goats^^^ However, in such preparations, it is logical to expect the 
presence of cross-reaction problem because of 60 - 70 % and 18 to 26 % 
homology of protein sequence of transmembrane domain of LH-CGR with 
transmembrane domains of glycoprotein hormone receptors^^ and receptors 
in G-protein-coupled receptor f a m i l y " 6 , respectively. Furthermore, although 
the N- and C- terminal domains are the least homologous among the 
glycoprotein hormone receptors, there is the presence of a 20 - 40 % 
identity49 Even if extracellular domain of LH-CGR, which can be produced 
by molecular cloning, is used for the production of polyclonal antibodies, the 
cross-reaction with TSHR and FSHR can still result. Therefore, when using 
an intact LH-CGR protein (or even only the extracellular domain) as the 
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antigen, monoclonal approach is preferable to solve the problem of cross-
reaction, especially when high cross-reactivity is expected to be present. 
Although a monoclonal antibody is superior, there needs to be a good 
screening system to pick up the appropriate clones. Competition of the 
* • 12 5 
antibodies with [ I] hCG for luteal membrane binding has been used as a 
1 ^ /C 
tool for selection . However, the selected monoclonal anti-LH-CGR 
antibodies all will have blocking activities. Furthermore, the chance of cross-
reaction with TSHR and FSHR would still be present because the regions for 
binding the common a-glycoprotein hormone subunit are well conserved^^^. 
Recently, the use of synthetic peptides as antigens has been attempted. 
Polyclonal anti-LH-CGR antibodies, raised against synthetic peptides 
corresponding to sequences 1 to 11 and 15 to 38 of rat LH-CGR, have been 
extensively used in receptor localization and characterization 
studies69 79 8i,82,84 j j ^ ^ mcrit of using synthetic peptides is that the epitope 
recognized is known. Therefore, using synthetic peptides corresponding to 
the unique region of the protein will solve the problem of cross-reaction 
owing to the sequence homology. As a result, it may not be necessary to 
produce monoclonal antibodies. Considering the aforementioned 
information, synthetic peptides were used for the production of polyclonal 
antibodies in this study. 
Determination of amino acid residues used as antigens in antibodv 
production 
To have more defined immunogenicity of the antibodies produced, the size 
of synthetic peptide used as immunogens should be as small as possible, so 
that the polyclonal antibodies produced have high specificity similar to 
monoclonal antibodies. Peptides composed of as few as 7 amino acid 
residues are capable of eliciting immunological response, and 11-residue 
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peptides can elicit even higher antibody response^^^ and therefore peptides 
of about ten residues were chosen for this study. 
However, a prerequiste for this approach is that the sequence chosen should 
be uniquie to LH-CGR. The amino acid sequences of rat TSHR, FSHR and 
LH-CGR are compared in figure 2.a. The extracellular domains exhibit 
about 40 % homology, while about 70 % residue conservation is found in 
the transmembrane domains. In the N-terminal end of the extracellular 
domain, the amino acid sequence of LH-CGR from P r o l 6 to Val39 is 
unique. In the C-terminal end of the extracellular domain, the amino acid 
sequence o f L H - C G R from Pro264 to Tyr309 is unique, however, this region 
is heavily glycosylated. Since it is not known whether glycosylation of a 
peptide will change or mask its epitopes, the sequence f rom Pro264 to 
Tyr309 was not considered. For the sequence from P r o l 6 to Val39, the 
region is free of glycosylation. Therefore, this region should be appropriate. 
Moreover, this region is highly conserved among the LH-CGR from 
human, pig and rat. Because a synthetic peptide encompassing amino acids 
f rom Arg21 to Pro38 effectively inhibited the binding of hCG to LH-CGR, 
this region has been suggested to be the specific binding site for the P_ 
subunits of LH and hCG^^\ A synthetic peptide Ser9-Asn30 of rat FSHR, 
which has almost no homology to LH-CGR and TSHR, can specifically bind 
FSH, but not TSH and LH^^\ Polyclonal antibodies raised against Lys l9-
Arg29 peptide can differentially recognize FSHR but not LH-CGR, and 
inhibit the binding of FSH to FSHR^^^. That also suggested that a peptide 
composed of 11 amino acid residues was long enough in producing specific 
antibodies. After considering the aforementioned factors, the sequence 
Gly24-Ser33 of rat LH-CGR was chosen in this study. The polyclonal 
antibodies against this region were predicted to be highly specific to LH-
CGR with blocking activity. 
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Figure 2.a. Alignment of the amino acid sequences of the rat glycoprotein hormone receptors. 
Amino acids are shown in singe letter code. The dashes indicate identical amino acids and the 
periods indicate gaps introduced for optimal alignment. Conserved cysteines are shown in bold 
and are marked with asterisks. Conserved cysteine residues are shown in blod and are marked 
with asterisks. Consensus sequences for N-linked glycosylation are shaded. The putative 
transmembrane regions are enclosed in rectangles and labeled I-VII.^^ 
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It is logical to think that anti-receptor antibody with blocking activity may 
behave with negative bias in immunohistochemical experiments when the 
receptor protein is already preoccupied by the ligand. Therefore, another 
unique peptide sequence which is not involved in binding, needed to be 
selected. A synthetic peptide of rat LH-CGR from Lys242-Ser255 has been 
used in the production of polyclonal antibodies. The polyclonal antibodies 
produced did not inhibit the binding of hCG to Leydig cell membrane 
receptors, but bound LH-CGR and stimulated testosterone production in rat 
Leydig cellsi33. A synthetic peptide of LH-CGR from Tyr253-Phe272 has 
been shown to inhibit the binding of hCG to LH-CGR^^^ The region 
Leu25 l -Phe260 is highly conserved among the glycoprotein receptors, and 
has been suggested to be the binding determinant for glycoprotein receptors 
for the common a-glycoprotein hormone subunit. Furthermore, the region 
Leu234-Pro238 is highly conserved in all three rat glycoprotein receptor 
proteins. Based on this information, a sequence Ser239-Ala249 of rat LH-
CGR was chosen in this study. The region Ser239-Ala249 does not overlap 
with the region that binds the a-subunit, and shows little sequence homology 
with the corresponding regions in rat TSH receptor and rat FSH receptor. 
However, the region Ser239-Ala249 is also less conserved among the rat, pig 
and human LH-CGR^^. Polyclonal antibodies raised against the region 
Ser239-Ala249 were predicted to be able to recognize the LH-CGR, and 
have non-blocking property (i.e. not interfere with ligand-receptor binding), 
and may be able to stimulate the signal transduction o f L H - C G R . 
The sequences of Gly24-Ser33 and Ser239-Ala249 were checked for 
homology with known mammalian protein sequences from the SwissProt 
data bank with computer software (BLASTP). No other mammalian proteins, 




Preparation of peptide-diphtheria toxoid conjugates 
Two peptides corresponding to 24-33 (N1: GPRAGLARLS) and 239-249 
(N2: SKEKFTSLLVA) of rat ovary LH-CGR, which was deduced f rom its 
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cDNA , were synthesized chemically and covalently linked to maleimide 
activated diphtheria toxoid (DT) through an extra cysteine residue at the 
carboxyl end of the peptides. The preparative work was performed by A 
Chiron Company. 
Immunization of rabbits 
For each conjugate, one male rabbit and one female rabbit was first 
immunized by subcutaneous injection of 1 ml of the conjugate, containing 
100 ug conjugate dissolved in equal volume of Freund's complete adjuvant 
and physiological saline. The conjugate was injected into four different sites 
on the back. For the second immunization, four weeks later, the conjugate 
was administered in a solution containing equal volume of Freund's 
incomplete adjuvant and physiological saline. For the third immunization, 
another 4 weeks later, the conjugate was administered in physiological 
saline. Animals were bled from the ear vein ten days after the third 
immunization and the sera were stored at -70 °C until required. The antisera 
collected are termed as N l M , N l F , N2M and N2F (peptide-sex). 
Antibody titre determination bv ELISA 
The titres of the antibodies were quantified with a sandwich type enzyme 
linked immunosorbent assay (ELISA). The method used in this study was 
modified from a well established protocol^^^. The antigens (peptide-DT 
conjugates) were coated to wells to capture specific antibodies. The captured 
rabbit antibodies were detected by peroxidase conjugated swine anti-rabbit 
immunoglobulins • 
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a. Coating procedure 
The 96-well-plate was coated with peptide-DT conjugate or DT by 
incubating each well with 0.1 ug conjugate or DT in 100 ul coating buffer 
(32 m M Na2CO3, 68 m M NaHCO3, pH 9.6) at 4 °C ovemight. The following 
day the conjugate solution was removed, and wells were washed once with 
200 ul blocking buffer (0.25 % BSA, 0.05 % Tween 20, 40.5 m M Na2HPO4, 
9.5 m M NaH2PO4, 100 m M NaCl, pH 7.4). Finally the wells were incubated 
with 200 ul blocking buffer at room temperature for 2 hours, aspirated, and 
washed with 200 ul blocking buffer once. 
b. The assay 
For the detection of antipeptide antibodies, the rabbit antisera were diluted 
with incubation buffer (blocking buffer containing 0.1 % DT). For the 
detection of anti-DT antibodies, the antisera were diluted in blocking buffer 
only. All affinity purified antibodies were diluted serially in the blocking 
buffer only. Twenty microliters of serum or purified antibody preparations 
with serial two or four fold dilutions were added to wells in duplicate and 
incubated at 37 °C for 1 hour. The wells were then washed 3 times with 200 
ul washing buffer (0.5 % Tween 20, 40.5 m M Na2HPO4, 9.5 m M NaH2PO4, 
100 m M NaCl, pH 7.4). One hundred microliters of 0.000008 % peroxidase-
conjugated anti-rabbit immunoglobulins in blocking buffer was added to 
each well, and incubated at 37 °C for 0.5 hour. After the incubation, the 
wells were washed 4 times with 200 ul washing buffer. Finally, 100 ul of 
substrate solution (0.66 mg/ml o-phenylenediamine, 0.045% H2O2, 24 m M 
citric acid, 52mM Na2HPO4, pH 5.2, prepared fresh before use) was added 
per well. After 20 minutes incubation at room temperature, the optical 
density at 450 nm was measured for each well. The titre was defined as the 
dilution factor at which the antiserum gave 50 % of the maximum 
absorbance. For affinity purified antibodies, the titre was defined as the 
concentration at which the antibodies gave 50 % of maximum absorbance. 
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The concentration values have a reverse relationship with the dilution 
factors. 
Characterization of stimulatory and blocking activities of synthetic 
peptides and anti-peptide antibodies 
a. Culture ofMLTC-1 cells 
Sixty thousand MLTC-1 cells in RPMI 1640 containing 25 mmol/L HEPES 
were seeded per well of a 24-well-plate, and grown at 37 T in 5 % CO2 
incubator. Two days after setting up of cultures, the medium was aspirated 
and cells washed once with Hank 's balanced salt solution before use in the 
following experiments. 
b. The stimulatory effect of synthetic peptides, anti-peptide antibodies 
and hCG on the cAMP production by MLTC-1 cells 
Immunoglobulins f rom the rabbit antisera were precipitated with 10 % 
polyethylene glycol 8000 (PEG). Two hundred microliters of incubation 
medium (Dulbecco's modified Eagle 's medium, containing 0.5 % bovine 
serum albumin and 0.5 m M isobutyl methyl xanthine , pH 7.3) containing 5 
ug of either N 1 or N2 peptide; or precipitated immunoglobulins reconstituted 
to their original serum concentration; or 10 IU/L hCG was added per well 
containing MLTC-1 cells. The control incubations lacked the stimulants. All 
assays were done in triplicate at 37 °C for one hour. The assay was 
terminated by aspirating the incubation medium followed by the addition of 
1 ml 1.7 0/0 HC1 in ethanol (HO/EtOH) and storage at - 2 0 � C overnight. 
HCl/EtOH extract was dried by speed vacuum, reconstituted in Tris-EDTA 
buffer (50 m M Tris-HCl, 4 mM EDTA, pH 7.5) and assayed for intracellular 
cAMP by the protein kinase binding assay^^^. 
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c. The blocking effects of peptides and anti-peptide antibodies on hCG 
stimulated cAMP production by MLTC-1 cells 
Different amounts of the N1 or N2 peptides were dissolved in the incubation 
medium containing 1 or 5 IU/L o f h C G and pre-incubated for one hour at 37 
°C. After the pre-incubation, the reaction was started by the addition of the 
mixtures to cells. All assays were performed at 37 °C for one hour, and the 
cells processed as above for the determination of cAMP. For studying the 
blocking effects of the anti-peptide antibodies, the MLTC-1 cells were 
incubated with 10 IU/L hCG together with the immunoglobulins 
(reconstituted to their original serum concentrations) for one hour at 3 7 � C 
without any pre-incubation of the reagent mixtures. The assay was 
terminated as described above and cAMP measured. 
Purification of anti-peptide antibodies 
a. Preparation of peptide and DT affinity column 
0.3 gram of cyanogen bromide activated sepharose 4B gel was swollen in 50 
ml 1 m M HC1 at room temperature for 30 minutes. The swollen gel was 
washed with 1 litre 1 m M HC1, then with 1 litre bicarbonate buffer (0. l M 
NaHCO3, 0.5M NaCl, pH 8.3). The gel was further incubated in the 
bicarbonate buffer for 30 minutes at room temperature. Excess buffer was 
removed. Five mg DT protein or 500 ug peptide in the bicarbonate buffer 
was added to the gel in a final volume of 2 ml. The mixture was incubated 
for 2 hours with end to end rotation. After the incubation, the aqueous phase 
was collected and the protein concentration was measured to monitor the 
coupling efficiency. The gel was washed with 100 ml 0.5 M NaCl, 0.1 M 
NaHCO3, pH 8.0, and resuspended in 5 ml 0.2 M glycine, 50 m M sodium 
phosphate, pH 8.0 to block the unreacted sites. The mixture was incubated 
with end to end rotation at 4 °C ovemight. After the incubation, the gel was 
washed with 100 ml 0.5 M NaCl, 0.1 M NaHCO3, pH 8.0 and 100 ml 0.5 M 
NaCl, 0.1 M acetic acid, pH 4.0, alternately 3 times. The final peptide-
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sepharose or DT-sepharose was washed with 100 ml phosphate buffered 
saline (0.1 M NaCl, 50 m M sodium phosphate, pH 7.4) containing 0.1 % 
NaN3, and stored at 4 T until use. 
b. Affinity chromatography of anti-peptide and DT antibodies 
The antiserum was incubated with the affinity gel for 2 hours at room 
temperature. The aqueous phase was removed and saved for measurement of 
unbound antibodies. The gel was washed with 100 ml PBS and then with 50 
ml high salt PBS (0.5 M NaCl, 50 m M sodium phosphate, pH 7.4) at a f low 
rate of 10 ml per 5 minutes. The bound antibodies were eluted under gravity 
with 0.2M Na2CO3 solution by applying one ml at a time, and the eluate was 
collected into a tube containing 1 ml PBS. After each collection, the final pH 
was adjusted to 7 by adding 4 N HC1 solution. The protein mass in the each 
o f t h e fractions was measured by Bradford 's Coomassie brilliant blue protein 
* * 122 binding dye method . The fractions with protein concentrations higher than 
15 ug/ml were pooled, and concentrated by ultrafiltration with a centriprep-
10 concentrator (Amicon, Inc., Beverly, USA). The buffer content of the 
concentrate was replaced by PBS-NaN3 solution (PBS containing 0.1 % 
NaN3) by sequential dilution with PBS-NaN3 solution and concentration by 
ultrafiltration. The final protein concentration was measured and diluted to 
40 ug/ml with PBS-NaN3 solution and stored at 4 °C. The column was then 
washed with 100 ml PBS containing 0.1 % NaN3, which was ready for 
another affinity extraction. The affinity purified anti-DT antibody 
preparation was subjected to a second affinity chromatography before use. 
6. Western blotting to determine the molecular weight ofthe LH-CGR 
Sixteen micrograms of Triton X-100 extracted membrane proteins from 
different organs were mixed with 5-fold concentrated loading buffer (0.0625 
M Tris-HCl, 2 % sodium dodecyl sulphate, 10 % glycerol, bromophenol 
blue) without or with 5 % 2-mercaptoethanol and separated on 4-7.5 % 
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discontinuous SDS-PAGE (Laemmli buffer system) with the Bio-rad Mini-
Protean II cell at 200 volts for 45 minutes. The samples with 2-
mercaptoethanol were heated in a boiling water bath for 1 minute. The 
samples without the reducing agent were incubated at room temperature for 
30 minutes. The proteins were electroblotted to nitrocellulose membrane 
(0.45 micron) in 25 m M Tris, 192 m M glycine and 20 % methanol with the 
Bio-rad Mini-Trans-Bolt cell at 100 volts for 1 hour. The membrane was 
washed twice with buffer A (50 m M sodium phosphate, 500 m M NaCl, pH 
7.4) for 5 minutes, and then washed twice with buffer A containing 0.05 % 
Tween-20 for 5 minutes. The non-specific binding sites of the membrane 
were blocked with phosphate buffered saline (50 m M sodium phosphate, 
100 m M NaCl, pH 7.4) containing 10 % glycerol, 5 % Carnation instant dry 
milk powder and 0.25 % gelatin for 1 hour at room temperature, followed by 
an ovemight incubation at 4 V . The next day the membrane was washed 
twice with buffer C (10 m M sodium phosphate, 100 m M NaCl, 10 % 
glycerol and 0.1 % BSA, pH 7.4) for 5 minutes, and the membrane 
incubated with 20 ug/ml affinity purified anti-LH-CGR antibodies (N2F) in 
buffer C at room temperature ovemight. After incubating with primary 
antibodies, the membrane was washed twice with buffer B for 5 minutes and 
then twice with buffer C for 5 minutes to wash away the unbound 
antibodies. The membrane was then incubated with HRPO-anti rabbit Igs (1: 
200) in buffer C at room temperature for 1 hour. The membrane was finally 
washed once with buffer A for 5 minutes, twice with buffer B for 10 minutes 
and four times with buffer A for 5 minutes. The membrane was immersed in 
the 2 fold diluted ECL Westem blotting detection reagent mixture for 1 
minute and exposed to a X-Omat AR x-ray film (Kodak Co., N.Y., USA) 
for 3 minutes. The x-ray film was developed and fixed. 
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7. Immunohistochemical localization ofLH-CGR in the UGIT 
Preparation of tissue sections 
Female Sprague-Dawley rats weighing about 250 grams at different stage of 
the estrous cycle including diestrus, estrus before ovulation, estrus after 
ovulation, and a 7-day-pregnant rat were used. The liver, pancreas, 
duodenum, ovaries, fallopian tubes and uterus were removed. The tissues 
were fixed in PBS buffered-formalin (50 m M sodium phosphate, 100 m M 
NaCl and 10 % formaline) at 4 T ovemight. The fixed tissues were 
processed as routine clinical samples, paraf fm embedded and cut at 4 
micrometers. The sections were mounted on glass slides coated with chrome 
alum gelatin and dried at 37 ^C ovemight. Sections were deparaffinized and 
rehydrated through xylene and graded series of ethanol to distilled water 
before use. 
Antigen retrieval bv microwave irradiation 
Antigen retrieval was performed by microwave irradiation in 10 m M citrate 
13 5 
buffer, pH 6.0 . Sections were placed in the buffer and irradiated with two 
consecutive boiling periods of 5 minutes each. The buffer level was 
replenished by distilled water after the first irradiation. After the last 
microwave treatment, tissue sections were left in the buffer for 15 minutes to 
retum to room temperature. 
Immunohistochemical staining 
This procedure was performed by an avidin-biotin immunoperoxidase 
method at room temperature. Briefly, endogenous peroxidase activity of the 
microwave treated tissue sections was blocked by incubating in 3 % aqueous 
hydrogen peroxide for 5 minutes. The sections were sequentially incubated 
with 2 % normal swine serum in 0.05 M Tris-buffered saline, pH 7.6 (TBS) 
for 10 minutes; affinity purified N l M , N l F , N2M or N2F antibodies at a 
concentration of 4 ug/ml in incubation buffer (TBS containing 3 % BSA) 
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ovemight at 4 °C; 1:300 biotinylated swine anti-rabbit polyclonal antibodies 
in incubation buffer for 35 minutes, and finally 1:100 horseradish peroxidase 
conjugated streptavidin in incubation buffer for 45 minutes. For the negative 
control sections, the anti-peptide antibodies were omitted and only the plain 
incubation buffer was used. The end-products were visualized by incubation 
with 0.05 % diaminobenzidine and 0.03% H2O2 in TBS for 10 minutes. 
Finally, the sections were lightly counterstained with Mayer ' s haematoxylin, 
dehydrated, cleared and mounted. 
Statistics 
The data were analyzed using Wilcoxon's rank sum test (2 tails). The mean 
土 SD of Kd values for hCG binding protein f rom duodenum, pancreas and 
ovary was calculated by grouping multiple curves. 
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Results 
1. hCG binding activities along the rat GIT 
Table 2.1 summarizes the specific hCG binding in tissue homogenate f rom 
different regions of GIT, at various stages of estrous cycle. The tissue 
homogenate f rom ovary, a positive control tissue, consistently showed 
specific binding of hCG. Along the GIT, the duodenum was the most 
prominent region showing specific binding o f h C G regardless o f t h e stage of 
the estrous cycle. The moming of diestrus or proestrus was the most 
prominent stage for the presence of hCG binding activities in the GIT and 
the positive control tissue - ovary. 
2. Detection of Triton X-100 plasma membrane hCG binding protein 
along the rat GIT 
Table 2.2 summarizes the preliminary experiments of extraction of hCG 
binding protein with the detergent, Triton X-100. The data indicated that 
along the GIT from female rats at diestrus, the duodenum and the positive 
control tissue - ovary were the only organs containing considerable amount 
o f h C G binding protein. The ovarian extract had a binding capacity about 10 
fold higher than the duodenum extract. The results showed that the stomach 
(upper or lower portion) and the ileum were the two regions possessing 
lowest amount of hCG binding activities, similar to the liver. There was a 
four fold higher binding following ovemight incubation compared to four 
hour incubation. 
Specific [i25i] hCG binding activities in different Triton X-100 tissue 
extracts from duodenum, pancreas, spleen, and ovaries of female or/and 
male rats are summarized in Table 2.3. The positive control tissue, ovary, 
was shown to have the highest specific hCG binding activity in plasma 
membrane proteins. There was 6 to 7 fold higher binding activity in the 
pancreatic extract than the duodenal extract. The spleen demonstrated 
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Table 2.1. Specific hCG binding (dpmAng wet weight) in tissue homogenate f rom 
different regions of GIT, at various stages of estrous cycle 
Trial estrous stage upper lower duodenum jejunum ileum colon ovary 
stomach stomach 
1 diestrus 0 ~ ^ 54 243 U64 
I 2 diestrus 0 1 ^ ^ 0 l3 5152 
I —«>^^^_^^^_««_««_«^^^^_^^^^^_««^^_««^^^^^_^^^^__^^^^^_^^^^^_______^________^^^_^^^^^^^^^^^^_^^_^_______^^^^^_^^^^^____^_^^__ 
3 late diestrus 0 0 4 ^ m 599 6960 
I 
I 4 diestrus - I I Yl 2424 0 m 2515 
i proestrus 
I 5 diestrus - 153 0 459 0 42 120 5829 
proestrus 
6 diestrus - 1366 0 1261 97 341 456 5102 
1 proestrus 
7 diestrus - 139 0 580 0 66 0 5834 
proestrus 
I 8 proestrus 169 129 0 161 91 171 8267 
9 proestrus -estrus H s 5 ^ 0 T5 29 
10 proestrus -estrus l6 m ^ H 0 2 ^ ^ 2911 
n early estrus 48 W io 5 l 0 
U estrus m U n U 2 U7 ^ 2676 
U estrus 0 � i ^ 2 i l o 
U late estrus 0 5T! 0 U 0 
15 ~~late estrus 84 H s ^ 0 0 








Table 2.2. Specifc hCG binding activity (fmole [^^¾ hCG /mg protein) for 
Triton X-100 extracts of plasma membrane f rom the ovary and 
different regions of GIT, during diestms 
Trial upper lower duodenum jejunum ileum colon ovary 
stomach stomach 
4 hours i N . D , 0 s l U 0 0 17.0 
o f 2 0.2 0.4 6.5 1.5 0.9 1.7 40 
incubation 3 0 1.0 8.9 0.8 0 1.7 75 
average 0.1 0 ^ ^ 1.1 0.3 1.0 29.2 
16 hours 1 0.2 2.7 16.0 8.3 2.2 3.2 146 
o f 2 N.D. N.D. 27.0 1.9 N.D. 6.4 280 
incubation average 0.2 ^ 7 ^ 5.1 2.2 4.88 213 
a N.D. : not determined 
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Table 2.3. Specifc hCG binding of Triton X-100 extracts of plasma membrane 
from different organs of male and female rats 
Specific binding o f ['^^I] hCG (mole/mg protein” 
male female male female female 
pancreas pancreas duodenum duodenum spleen ovary 
(n = 5) (n = 8) (n = 5) (n = 7) (n = 2) (n = 8) 
9 .18x l0 ]5 5.49x10.15 1.30xl0'^^ 1.13 x 10''^ 9.1 x 10"^ ^ 1.06xl0.i3 
(±2.08 X 10-15) ( 土 4 5 X 10—15) (+2.35 x 10'^ ^) (±1.46 x 10'^ ^) (±6.61 x lQ-^^) 
a Results are average value (±1 SD). 
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the lowest binding. The results also indicated that the final ultra-
centrifugation step could partially purify the h C G binding proteins (10 fold 
for the duodenal hCG binding protein and 2 fold for the ovarian LH-CGR, 
Table 2.2 and 2.3). 
3. Affinity of hCG binding proteins measured bv Scatchard analysis 
Figure 2.1 shows the typical Scatchard plots for the hCG binding proteins 
f rom duodenal, pancreatic and ovarian plasma membrane extracts. By 
grouping multiple curves, the calculated Kd values for the duodenal binding 
protein, pancreatic binding protein and ovarian LH-CGR were 1.9 土 0.6 (n = 
5), 4.7 土 3.5 (n = 2) and 0.11 土 0.02 nM (n = 3) respectively. 
4. pI of duodenal hCG binding protein and ovarian LH-CGR 
The pI value of the duodenal hCG binding protein and ovarian LH-CGR 
were both about 5.5 (n = 2, figure 2.2). 
5. Production of anti-LH-CGR antibodies 
Antibodv titres determination by ELISA 
All rabbits responded to immunization. Figure 2.3 (a and b) summarize the 
titration curves for the anti-peptide antiserum against the peptide-DT 
conjugate. The titres of antibodies against N1 peptide raised in male and 
female rabbits were 8500 and 3500, respectively. The titres of antibodies 
against N2 peptide raised in male and female rabbits were both 3200. The 
titres of the antibodies against DT were all about 10,000, except 25,000 for 
the N l M antiserum (figure 2.4). 
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Figure 2.1. Typical Scatchard plots for the hCG binding proteins f rom the 
duodenum (a), pancreas (b) and ovary (c) and their respective Kd values. 
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Figure 2.2. Typical isoelectric focusing profiles of the rat duodenal and 
ovarian hCG binding proteins. 
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Figure 2.3. The dilution curves for the four anti-peptide antibodies. The 
amount of anti-peptide antibodies was measured by ELISA with the peptide-
DT conjugate coated ELISA plate. The binding of anti-DT antibodies in the 
antisera to the conjugate was prevented by inclusion of 0.1 % of free DT 
during incubation. The non-specific binding was measured with the DT 
coated ELISA plate. 
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Figure 2.4. The dilution curves for anti-DT antibodies in the four rabbit sera. 
The amount of anti-DT antibodies was measured by ELISA with the DT 
coated ELISA plate. 
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Stimulating and blocking activities ofsvnthetic peptides and anti-peptide 
antibodies 
a. Stimulatory effect of the synthetic peptides, anti-peptide antibodies 
and hCG on cAMP production by MLTC-1 cells 
With 10 IU/L h C G as the stimulant, the intracellular cAMP was 10 fold 
higher than the unstimulated cells. Compared to the hCG controls, neither 
the peptides nor their respective antibodies showed any stimulatory effect on 
the production o f c A M P by MLTC-1 cells (figure 2.5). 
b. Blocking effect of the anti-peptide antibodies on hCG stimulated 
cAMP production by MLTC-1 cells 
The antibodies - N l F , N 2 M and N2F significantly inhibited the stimulatory 
effects of 10 IU/L hCG on cAMP production (figure 2.6). The percentage 
reductions in cAMP production were 28 % (p < 0.001), 12 % (p = 0.002) 
and 17 % (p 二 0.03), respectively. The antibody N l M did not impede the 
action o f h C G . 
c. Blocking effect of the synthetic peptides on hCG stimulated cAMP 
production by MLTC-1 cells 
N 1 peptide at concentrations of 25 and 250 ugy^ml caused significant 
reductions in cAMP production by 1 IU/L of hCG. The reductions were 29 
(P = 0.007) and 35 % (p = 0.015) respectively. N2 peptide caused significant 
inhibition only at a concentration of 250 ug/ml with a reduction of 19 % (p = 
0.025, figure 2.7a). With 5 IU/L hCG as the stimulant, only N1 peptide at a 
concentration of 250 ugy^ml significantly inhibited cAMP production causing 
a 27 % reduction in the intracellular concentration (p = 0.025, figure 2.7b). 
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Figure 2.5. The cAMP production by MLTC-1 cells in the absence or 
presence of 25 ug/ml synthetic peptides or PEG precipitated 
immunoglobulins from anti-peptide antisera at serum concentrations. The 
results (mean, n = 3) are expressed relative to the stimulated positive 
controls (10 KJ/L hCG). 
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Figure 2.6. The effect of PEG precipitated immunoglobulins f rom different 
antipeptide antisera at serum concentrtions on the production of cAMP by 
MLTC-1 cells under the stimulation by 10 IU/L hCG. n = 7. The results 
(mean 土 1 SD) are expressed relative to the hCG stimulated controls in 
presence o f I g s f rom rabbit sera before immunization, n = 12. * p < 0.002; 
** p = 0.03, Wilcoxon's rank sum test (2 tails). 
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Figure 2.7. The effect of peptide N1 or N2 on the production of cAMP by 
MLTC-1 cells under the stimulation by hCG at concentrations of 1 KJ/L (a), 
n = 7, or 5 IU/L (b), n = 8. The results (mean 土 1 SD) are expressed relative 
to the hCG stimulated controls. * p < 0.01; ** p < 0.025, Wilcoxon's rank 
sum test (2 tails). 
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Purification of anti-peptide antibodies 
Figure 2.8 demonstrates a typical elution profile of antibodies following 
affinity chromatography. Most of the adsorbed antibodies were eluted with 
0.2 M Na2CO3 used as eluent. The titres for the anti-peptide and the anti-DT 
antibodies are shown in figure 2.9 and 2.10. The contamination by the anti-
DT anti-bodies was negligible in all of the affinity purified anti-peptide 
antibody preparations. The titres for different anti-peptide antibody 
preparations were almost the same with protein concentrations of about 0.13 
ug/ml, except 0.3 ug/ml for the NIM preparation. 0.13 ug/ml was therefore 
equivalent to titre value 8500 of neat N l M antiserum, 3500 of neat N l F 
antiserum, 3200 o f t h e neat N 2 M and N2F antisera. Therefore 400 ug/ml of 
the affinity purified anti-peptide antibodies had the antibody activity 
equivalent to neat anti-N2 peptide antiserum. The titre for the double affinity 
chromatographic purified anti-DT antibodies is 0.095 ug/ml. Table 2.4 
summarizes the purification efficiency for the affinity chromatography. 
6. Determination of molecular weight of LH-CGR bv Western blotting 
using affinity purified N2F antibodies 
Under non-reducing condition, dimer forms of LH-CGR, predominantly 150 
and 170 kD were detected in pancreas, duodenum and spleen, and the 
control tissues, ovary and uterus (figure 2.11A). There was a less intense 
band at 75 kD in both the ovarian and uterine extract, and a weaker 50 kD 
band in the ovarian extract only. The liver extract gave a very similar, but 
weaker staining profile than the ovarian extract. Under reducing condition, 
the predominant forms of LH-CGR were 60 and 65 Kd, which were only 
detected in control tissues, together with a trace amount of 80 kD receptor. 
However a 80 kD LH-CGR was detected in duodenal extract (figure 2.11B). 
After reduction, the total intensity of the stained bands were greatly 
decreased for all tissue extracts, except for the duodenal extract. 
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Figure 2.8. Typical elution profiles of anti-peptide antibodies or anti-DT 
antibodies adsorbed to the affmity gel and eluted with different eluents. 
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Figure 2.9. The dilution curves for anti-peptide and anti-DT antibodies in 
the affinity purified antibody preparations. 
97 
~ 丨|丨丨| 丨丨丨丨丨 |丨丨丨| 丨 棚 丨 丨 |丨|丨丨丨 ZZI V 7 
~ ^ -
==二:::::=二:::::二==::::::二二=”)::二[::::: 
$ 三 兰 | | | 运 三 _ | ^ 至 兰 3 | | | | $ 三 三 ; 5 : ; # 三 三 三 _ 
= = = : : : = = = = : = = = = = = = r : : : = = = = = : 
= = : : : = = = = = = : : = = t : t = = : 
^ 匸 三 三 三 三 三 三 三 ： 季 ： 三 三 三 ： ^ y � - - " 
I 至 目 目 兰 目 自 目 目 
n • 二 — — m 
E = = I : : : : : : Z Z : : I I : : : : : : Z Z Z Z : : : 7 : = Z Z : : : : : : = : Z : Z : : : : : : 3 / 
E ==二:===二::::===7(::===。;:二===:::: 
X ^ ^K5-. 
‘ 目 至 目 目 : 目 _ : 目 目 目 目 
I ; « ) - • _ _______ 
= = = = : : = ~ + ; 广 : : = = = : : : : : = 二 = 口 「 = = 二 = : : : : ^ ^ 
,Ui i^ l f i l l l l l l l | lllllll| l l l _ | I lllllll| 
0.0001 0.001 0.01 0.1 1 10 
Protein concentration (ug/mL in log10 scale) 
Figure 2.10. The dilution curve for anti-DT antibodies in the double affinity 
purified anti-DT antibody preparation. 
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Table 2.4. Purity and specific activity of polyclonal anti-peptide antibodies and anti-
diphtheria toxoid antibodies 
specific activity^ recovery 
purification protein mass percentage of 
serum purified fold (ug per ml serum) binding activity (%) 
NlM^ ^ J l U i^5 3 
~~mF^ o H o ^ n o 4I 
~ N 2 M ^ ^ 7.7 82 ^ 0 ^ 
~~N2Fb ^ ~ \ ^ ^ 28 
an t i -Dr ^ 1 ^ 46 440 30 
a Specific activity is defined as the reciprocal of total protein concentration at 50% binding in the 
ELISA. 
b antibodies purified once 
c antibodies purified twice 
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Figure 2.11. Western blotting for LH-CGR in membrane protein extracts of 
different rat organs without (A) or with (B) 2-mercaptoethanol treatment. 
The separated LH-CGR protein was detected with affinity purified N2F 
antibodies. P: pancreas; Ov: ovary; Ut: uterus; Sp: spleen; Duo: duodenum; 
L: liver; ti: trypsin inhibitor added during extraction. 
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7. Immunohistochemical localization ofLH-CGR in UGIT 
a. Verification of specificitv of anti-LH-CGR antibodies 
Figures 2.12 and 2.13 show the staining pat tem of the control tissues (i.e. 
ovary, fallopian tube, uterus and decidua) with different ant i -LH-CGR 
antibodies. All antibodies gave similar staining patterns. The intensity of 
immunochemical staining is summarized in Table 2.4. In the ovary, the 
corpus luteum (figure 2.12a - e) and the blood vessels (figure 2.12f - j ) were 
the tissues that gave the most intense staining with N l F , N l M and N2F, but 
not with N 2 M antibodies. The granulosa cells and the theca intema were 
weakly stained with N l M , N l F and N2F, however, the theca extema was 
not stained with any of the antibodies (figure 2.12a - e). In the fallopian 
tubes (both ampulla and isthmus), the smooth muscle strongly stained with 
N l M and N l F antibodies, and moderately with N2F antibodies; the mucosal 
epithelium was moderately stained with N2F antibodies and weakly stained 
with N l M antibodies (figure 2.13a, b, f, g, k and 1). In the uterus, the smooth 
muscle of the myometrium of non-pregnant rats was strongly stained with 
N l M antibodies (figure 2.13d) and moderately with N l F and N2F antibodies 
(figure 2.13i), but the myometrium of the 7-day-pregnant rat was only 
weakly stained with N l M , N l F and N2F antibodies (figure 2.13p and r); the 
endometrial epithelium (including the glandular epithelium) were moderately 
stained with N 2 M and N2F antibodies (figure 2.13j) and weakly with N l M 
(figure 2.13e). Cellular granules were strongly stained in the mucosal 
epithelium of isthmus and endometrial epithelium with N 2 M and N2F 
antibodies (figure 2.13j). The blood vessels in the fallopain tubes (figure 
2.13 c, h and m) and uterus (figure 2.13d, i and n) were intensely stained 
with N l M , N l F and N2F antibodies, but weakly with N2M antibodies. The 
decidua of the 7-day pregnant rat was strongly stained with N l M and N l F 
antibodies (figure 2.13p and q), but moderately with N2M and N2F 
antiboodies (figure 2.13r and s). 
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Figure 2.13. Immunohistochemistry for LH-CGR O r^own stain) of rat fallopian tube and uterus at 
diestrus (a - o) and uterus at 7-day-gestation (p - s) with affinity purified N l M (a - e and p - q) or N2F 
(f - j and r - s) antibodies. Anti-LH-CGR antibodies were omitted in negative controls (k - o). 
Ampulla: a, f and k; isthmus: b, g and 1; blood vessels of fallopian tube: c，h and m; myometrium: d, i 
and n; endometrium: e, j , and o; uterus: p and r; decidua: q and s. D: decidua; EE; endometrial 
epithelium; GE: glandular epithelium; ME: mucosal epithelium; SM; smooth muscle; arrow head: 
blood vessel. Magnification: X 270: a, b, d - g，i -1, n and o; X 200: p and r; X 400: c, h, m, q and s. 
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Table 2.4. Immunohistochemcal staining ofLH-CGR in control tissues - ovary, fallopian 
tube, uterus and decidua 
Tissue / female rats NlM NlF N2M N2F 
ovarian blood vessel diestrus ^ 5 2 5 
estrus before ovulation 5 4 2 3 
estrus after ovulation 4 4 2 3 
7 days ofgestation 5 5 1 4_ 
corpus luteum diestrus 3.5,4 一 3.5,2 1,2 [5] 2, 3 \5] 
estrus before ovulation 3 2 2 2 
estrus after ovulation 3j_2 ^ 2 ^ 2 ^ 
7 days ofgestation 一 2.5 1,2.5 2 ,1 2, 1 
granulosa cells diestrus ^ 2 1 2 
estrus before ovulation 3 2 2 3 
estrus after ovulation 2 2 1 3 
7 days ofgestation 3 ^ 1 1 
theca intema diestrus ^ 3 1 2 
estrus before ovulation 2 1 1 1 
estrus after ovulation 1 1 1 1 
7 days of gestation 3 ^ 1 1 
theca extema diestrus 0 0 _0 0 
estrus before ovulation 0 0 0 0 
estrus after ovulation 0 0 0 0 
7 days of gestation 0 0 0 0 
fallopian tube — blood vessel diestrus 5 5 3 4 
estrus before ovulation 5 5 1 3 
estrus after ovulation 5 5 1 3 
7 days of gestation 4 5 1 3 
ampulla ~ mucosal epithelium diestrus 3 1 2 4 
estrus before ovulation 1 1 2 2 
estrus after ovulation 1 1 2 2 
7 days of gestation 2 2 ^ 3 
ampulla - smooth muscle diestrus 4 4 1 3 
estrus before ovulation 4 4 1 3 
estrus after ovulation 5 4 1 3 
7 days of gestation 4 4 1 3 
isthmus ~ mucosal epithelium diestrus 2 1 2 [5] 3 [5] 
estrus before ovulation 1 1 2 [5] 2 
estrus after ovulation 1 1 2 [4] 3 
7 days ofgestation — 1 1 2 [5] 3 [51 
isthmus ~ smooth muscle diestrus 4 4 2 4 
estrus before ovulation 4 4 2 4 
estrus after ovulation 4 4 1 3 
7 days of gestation 4 4 2 3 
uterine blood vessel diestrus 5 5 4 4 
estrus before ovulation 5 5 | 2 
estrus after ovulation 5 5 3 4 
7 days ofgestation 5 5 2 3 
myometrium diestrus 4 3 2 4 
estrus before ovulation 4 1 1 3 
estrus after ovulation 4 3 0 3 
7 days ofgestation 2 1 0 1 
endometrium diestrus 2 [4] 1 2 [5] 4 [5] 
- glandular epithelium estrus before ovulation 1 0 2 [4] 3 \4] 
estrus after ovulation ]_J 1 2 [4] 2�41 
7 days ofgestation 1 0 — 3 [51 2 [4] 
endometrial epithelium diestrus 3 2 2�51 4 [5,few] 
estrus before ovulation 2 2 1 3 
estrus after ovulation 1 1 1 3 
decidua 7 days ofgestation 4 4 2 3 
[]:granular staining; ® The intensity of staining is graded from 0 to 5, where 0 is no staining, and 5 is the 
highest. 
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In summary, N l M antibodies gave a similar staining pat tem as N l F 
antibodies, but generally N l M gave stronger signals. N 2 M antibodies gave a 
similar pat tem as N2F antibodies, but generally N2F gave stronger signals. 
The overall staining pat tem of the organs f rom the rat at diestrus was 
stronger than at estrus or during early pregnancy (figure 2.14). 
b. Localization of LH-CGR in the pancreas, duodenum and liver 
Figure 2.15 shows the staining of the pancreas, duodenum and liver 
ressected from a female rat at diestrus. Table 2.5 summarizes the intensity of 
immunohistochemical staining. The blood vessels of the pancreas (figure 
2.15e, m and u), duodenum (figure 2.15g, o and v) and liver (figure 2.15b, j 
and r) were positively stained. In the pancreas, besides the blood vessels, the 
exocrine tissue was also stained (figure 2.15c, k and s). The cytoplasm o f t h e 
acinar cells was slightly stained by both the N l M and N2F antibodies (figure 
2.15c, k and s), A strong staining pattem resembling a "flower" was 
observed in each acinar with N l M antibodies (figure 2.15c). However, many 
moderately stained "tiny dots" in acinar cells were observed with N2F 
antibodies (figure 2.15k). For the intralobular ducts, weak staining was 
obtained with N l M antibodies (figure 2.15e), but almost no staining with 
N2F antibodies (figure 2.15m). There was a weak staining of islets with N2F 
(figure 2.151), but not with N l M (figure 2.15d). In the duodenum, smooth 
muscles were stained with both N l M (figure 2.15f and g) and N2F (figure 
2.15n and o) antibodies. The parasympathetic ganglion, Brunner 's gland and 
the crypt cells, all were stained moderately with N l M (figure 2.15f and g) 
and N2F (figure 2.15n and o) antibodies. The mucosal epithelium of 
duodenum was strongly stained with N2F antibodies (figure 2.15p), but only 
slightly stained with N l M antibodies (figure 2.15h). 
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Figure 2.14. Immunohistochemistry for LH-CGR O^rown stain) of rat corpus luteum (a - h) and 
ampulla (i - p) at diestrus (a，e, i and m), estms^efore ovulation 0^ f, j and n), estrus/after ovulation 
(c, g, k and o) and 7-day-gestation (d, h, 1 and p) with affinity purified N l M (a - d and i -1) or N2F (e -
h and m - p) antibodies. ME: mucosal epithelium; SM; smooth muscle. Magnification; X 100: a - h; X 
270: i -p . 106 
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Figure 2.15. Immunohistochemistry for LH-CGR O r^own stain) of rat liver (a, b, i, j , q and r), pancreas (c - e, k -
m and s - u) and duodenum (f - h, n - p，v and w) at diestrus with affinity purified N l M (a - h) or N2F (i - p) 
antibodies. Anti-LH-CGR antibodies were omitted in negative controls (q - w). BD: bile collecting duct; PD: 
pancreatic duct; EXO: exocrine tissue; IS: islet; SM: smooth muscle; PG: parasympathetic ganglion; BG: 
Bmnner,s gland; C: crypt; ME: mucosal epithelium; arrow head: blood vessel. Magnification: X 270: a, b, h -j，p -
r and w; X 400: c - g, k - o and s - u; X 100: v. 107 
Table 2.5. Immunohistochemcal staining ofLH-CGR in duodenum, pancreas and 
liver 
Tissue N l M N2F 
duodenum blood vessel 5^  4 
smooth muscle 3 ^_ 
ganglion 3 2 
Brunner's gland 3 2 
crypt 3 2 
mucosa 1 4 
pancreas blood vessel 5 4 
acinus cytoplasm - 2 cytoplasm - 2 
with pattern ‘‘flower” - 5 with “tiny dots” - 3 
intralobular duct 3 0 / 1 
islet 0 1.5 
liver blood vessel 4 2 
hepatocyte 1 2 (some 3) 
a The intensity o f staining is graded from 0 to 5, where 0 is no staining, and 5 is the highest. 
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D i s c u s s i o n 
Using the rat tissue homogenates to study hCG binding activities allowed us 
to screen for the hCG binding site along the GIT. The preliminary 
experimental results demonstrated that there was specific h C G binding 
activity present in the GIT of female rats, with the duodenal homogenate 
showing the highest binding, throughout the estrous cycle. The homogenate 
binding studies could only show that binding sites for hCG were present and 
in limited capacity. However, the nature of binding sites was uncertain. The 
binding sites could have been carbohydrate chains. For example, ganglioside 
GMi, which is a carbohydrate chain, binds cholera toxin specifically. The 
binding sites could also be proteins like LH-CGR. Furthermore, there is a 
disadvantage in using tissue homogenate to study receptor protein. The 
ligand binding sites are anchored in the plasma membrane^^. The degree of 
homogenization, which is affected by the speed of the homogenizer and the 
hardness of the tissue, will affect the size of the particulates. Incomplete 
homogenization will lead to the decrease in the surface area to volume ratio, 
which will cause lower hCG binding activity per mass tissue. For the tissues 
f rom the GIT, it was difficult to achieve a uniform and consistent 
homogenization because of the presence of a tough muscular wall. 
Because the classical receptor for hCG is a protein molecule, we tried to 
further look for a gastrointestinal plasma membrane protein which could 
bind hCG. We were able to solubilize a plasma membrane hCG binding 
protein f rom the GIT, and the duodenum was the region containing the 
greatest amount. The preliminary results led us to concentrate our further 
work in the duodenal region. The results also indicated that ovemight 
incubation was necessary to allow hCG to saturate the specific hCG binding 
1 ^ c sites despite using saturating dose of [ I] hCG. 
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The last ultracentrifugation step was replaced with the high speed 
centrifugation to simplify the procedure and allowed us to handle more 
samples at a time. However, the results indicated that a final 
ultracentrifugation step could partly purify the hCG binding proteins and the 
ovarian LH-CGR. Unexpectedly, in the latter experiments, besides the 
duodenum, an hCG binding protein was found in the pancreas and in 
relatively high amounts. Its presence in pancreas may be because the 
pancreas arises f rom foregut during embryonic development^^^ The hCG 
binding protein was also found in the pancreas and duodenum of male rats, 
which indicated that there is no sex-difference in the expression of the hCG 
binding proteins along the GIT. The spleen, which showed a low levels of 
h C G binding protein, probably could serve as a weak positive control in this 
study. The spleen contained a lot of lymphocytes. Lymphocytes f rom 
pregnant women have been shown to have LH-CGR recently6i. 
By Scatchard analysis, the measured Kd values of ovarian LH-CGR, 
duodenal and pancreatic hCG binding proteins were of similar magnitude as 
reported for LH-CGR (0.03 to 50 nM)^^^, which indicated that i) our method 
for Scatchard analysis was reliable, and ii) the binding affinity of the 
duodenal/pancreatic hCG binding protein is comparable to the ovarian LH-
CGR. The hCG binding affinity of the duodenal and pancreatic proteins 
were, however, 18 and 44.5 fold lower than that of ovarian LH-CGR, 
respectively. The relatively lower binding affinity could be due to their 
endogenous properties, the presence of inhibitory substances in the Triton X-
100 extracts, or enzymatic degradation of receptor proteins. The enzymatic 
degradation might probably account for the lower affinity in the pancreatic 
1 "3 Q 
extracts because of proteolytic enzymes . Despite higher Kd values, the 
Scatchard analyses demonstrated that hCG binding proteins in both 
duodenum and pancreas are present in limited amount and have high hCG 
binding affinity. These findings fulfill the basic criteria of a receptor 
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proteini38 Furthermore, by isoelectric focusing, the pI value of the duodenal 
h C G binding protein, was similar to the ovarian LH-CGR. To our knowledge 
the pI of LH-CGR protein has never been reported before. The similar 
physicochemical properties between the gastrointestinal hCG binding protein 
and the ovarian LH-CGR, strongly suggests that the former may indeed be 
LH-CGR. 
To produce anti-LH-CGR antibodies, peptides corresponding to the amino 
acid sequences 24 to 33 (N1) and 239 to 249 (N2) of rat LH-CGR were 
synthesized. Both peptides inhibited the effect of hCG on cAMP production, 
which suggested the binding o f t h e hormone to peptide. Therefore, it appears 
that the regions o f h C G bound by these two peptides play important function 
in the binding of hCG to the LH-CGR and subsequent signal transduction. 
The blocking effect o f N l peptide encompassing amino acids 24-33 is not 
surprising since it lies within the region of 21-38, which has been suggested 
1 ^Q 
to be an important P-hCG binding determinant . Although the N 1 peptide 
was comprised of only 11 amino acid residues, the result suggests that it is 
long enough for forming a binding site for hCG. Surprisingly, although the 
N2 peptide sequence, 239-249, comes from a region not responsible for hCG 
binding (but is close to a region binding the a-subunit), it demonstrated a 
weak inhibitory activity. Our result is in contrast to the finding of Roche et 
1 o o al . The discrepancy may be due to the difference in the sensitivity of the 
assays. In our assay, the minimum dose of hCG used was 1 IU/L, which is 
1， 
equivalent to 2 x 10" mol/L hCG. However, in the Roche's radioreceptor 
assay the concentration of [^^¾ hCG used was 5 x l O ] � m o l / L , which was 
250 fold higher, thus making our assay more sensitive. Since the N1 peptide 
was more effective that the N2 peptide in blocking hCG binding to the 
receptors, the result suggests that the region 239-249 probably plays an 
accessory role in binding and signal transduction. Furthermore, the 
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contention that only certain regions of a receptor protein are involved in 
binding o f l i gand may not be as clear as has been suggested^^^. 
W e produced four polyclonal antibodies, two against each peptide. The 
stimulating and blocking properties of the anti-LH/CGR antibodies were 
investigated before using them in any experiments. Our results demonstrated 
that none of the antibodies possessed stimulatory activity. Three antibodies, 
one against N1 epitope and both antibodies against N2 possessed blocking 
activities. The interaction of glycoprotein hormones with their respective 
receptors usually involves three putative steps: i) the recognition of P_ 
subunit by the receptor; ii) its high affinity binding; iii) stimulation of the G 
protein-coupled transducing mechanism. The latter action also involves the 
interaction of the receptor with functional groups on the a-subunit - the 
surface amino acid residuesi4o " i and the carbohydrate moieties^^^'^^^ The 
chances of antibodies emulating the hormonal properties of glycoprotein 
hormones are remote, but they do exist as exemplified by stimulating 
antibodies to TSHR in Graves' disease. Therefore, it is not surprising that 
none of the antibodies directed against either the recognizing or the non-
recognizing regions of LH-CGR demonstrated stimulatory effects. The 
negative results with N2-peptide antibodies are in contrast to the findings of 
Ohwaki et al^^^ who reported that rabbit polyclonal antibodies against 
residue 242-255, a region overlapping with N2 sequence (i.e. 239-249), had 
stimulating activity. The discrepancy could be due to rabbits expressing non-
identical HLA haplotypes as described by Desai et al^^^. 
The blocking activity o f N l F antibodies was consistent with that reported for 
the antibodies directed against the N-terminal end of FSHR^^^. The lower 
avidity of N l M antibodies could be one of the explanations for its non-
blocking effect. Both antibodies directed against N2 epitope inhibited the 
effect of hCG on cAMP production by MLTC-1 cells, which suggests 
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impairment o f b i n d i n g o f h C G to LH-CGR and/or transduction o f i t s signal. 
It has however been reported that polyclonal antibodies against a similar 
region, 242-255 did not inhibit hCG binding to LH-CGR^^l The discrepancy 
between the studies, as well as the blocking activities of N l M and N l F 
antibodies could be again due to the immunological response of the rabbits. 
Although the N2 sequence is f rom a region in the extracellular domain 
which is less important for binding of hCG, it is nevertheless close to the 
binding determinant, 253-272, which binds the a-subunit of hCG^^^ The 
binding of N2 antibodies to this region thus may create steric hindrance for 
binding o f h C G to its receptor. Despite this, the presence of large amounts of 
N l / N 2 antibodies did not completely abolish the binding of hCG to LH-
CGR, suggesting a lower affinity of the anti-peptide antibodies towards LH-
CGR, compared to hCG. On one hand, none of the antibodies possessed 
stimulating activity, but on the other hand, blocking activities were present 
in N l F , N 2 M and N2F antisera, but not in N l M . Taken together, this 
implies that there is no relationship between the stimulating and blocking 
activities of anti-receptor antibodies and the ligand-binding properties of the 
corresponding epitopes. 
Using the affinity purified N2F antibodies, the plasma membrane proteins of 
liver, spleen, duodenum, pancreas, ovary and uterus were analyzed with 
Westem immunoblotting. The molecular weight of the protein core of LH-
CGR was found to be 75 kD^^, and the apparent molecular weight of well 
glycosylated LH-CGR in SDS-PAGE was 95 kD^^ Petaja-Repo et al (1993) 
reported that treatment by neuramindase (which removes the sialic acid) 
decreased the size of LH-CGR to 79 kD, and treatment of N-glycosidase F 
further decreased the size to 62 k D " � . The two major bands (150 kD and 
170 kD) observed in the positive control tissues (uterus and ovary) under 
non-reducing condition were probably due to the presence of dimer forms of 
LH-CGR in the extract. The 75 kD proteins in the ovarian and the uterine 
113 
extract was most likely the LH-CGR, which is consistent with the published 
molecular size of LH-CGR determined by SDS-PAGE^^^'^^^ and close to the 
values of 80 kD for the human p l acen taP , the human fallopian tubal^^ and 
the rat testicular LH-CGR^^ LH-CGR proteins with molecular size of 50 kD 
have been detected as the dominant forms in human myometrial smooth 
muscle cells75, human umbilical cords^^ and JAR human choriocarcinoma 
cells87. Since the size of a totally deglycosylated LH-CGR molecule is about 
62 kD, the reported 50 kD LH-CGR should have been the truncated LH-
CGR, which were also found in our ovarian extracts. 
The dimer forms of LH-CGR were also detected in the plasma membrane 
extracts f rom the rat spleen, duodenum, and pancreas. The plasma membrane 
protein extract f rom the liver gave a very similar, but much weaker staining 
profile as the ovary. The presence of LH-CGR in the rat liver is, however, 
controversial. High affinity hCG binding protein was found in the liver of 
hCG primed female ratsU5. Recently Hill et. al. (1996) have shown that hCG 
n 
is able to regulate liver blood flow . Rat liver has been used as negative 
control tissue for LH-CGR in a number of experiments, in which no LH-
CGR protein and mRNA transcripts were found^^'^^'^^ Recently, 
lymphocytes f rom pregnant women have been shown to possess LH-CGR^^ 
which might have contributed to the immunoreactive proteins in the rat 
spleen and liver. The spleen is the largest lymphoid organ of body and the 
liver is well supplied with blood. 
Under reducing condition, the 150 and 170 kD bands in the ovarian and 
uterine extracts disappeared and two major bands at 60 and 65 kD positions 
were detected. This observation suggests the splitting of the dimer form of 
the receptor to the monomer form. The smaller 60 and 65 kD proteins 
suggest unglycosylated LH-CGR. A faint 80 kD band was detected in 
ovarian extract under reducing condition, probably represented glycosylated 
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LH-CGR protein. The tissues used in our experiments were resected f rom 
female rats at diestrus stage of the estrous cycle. The diestrus is a period 
corresponding to the late luteal phase of the menstrual cycle when the LH-
C G R start to re-appear after being down-regulated by LH surge^^^. It has 
been shown that in hCG primed rats, the LH-CGR expression is down 
regulated and the dominant forms of LH-CGR are truncated proteins with 
molecular weights ranging from 50 to 65 kD^^^. This may explain why 
unglycosylated/truncated LH-CGR was detected in our study. The apparent 
absence of stained bands in the pancreatic extract under reducing condition, 
could be due to a decrease in staining reaction following reduction, since 
even the positive control tissue extracts showed decreased staining. 
Unexpectedly, a strong 80 kD protein band in the duodenal extract was 
detected under reducing condition. The total intensity was higher than that 
obtained without 2-mercaptoethanol treatment. This suggests that the 
epitopes for anti-N2 antibodies in the duodenal LH-CGR proteins were 
unmasked under reducing conditions. The strong 80 kD band suggested the 
presence of a full functional form of LH-CGR in the duodenum. Therefore, 
tentatively it would appear that there are LH-CGR in the duodenum and 
pancreas of female rats. 
Immunohistochemically, all four affinity purified anti-LH-CGR antibodies 
stained the corpus luteum, granulosa, theca intema and the blood vessels in 
the ovary which are all known to possess LH-CGR^^^. The uterus, 
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possessing LH-CGR，was also positively stained. Although the tissue 
distribution of LH-CGR in the rat uterus and fallopian tube has not been 
reported before, the staining pattem for LH-CGR obtained for the fallopian 
tube and uterus in the present study were similar to the patterns reported for 
the human fallopian tube and uterus^^'^^. LH-CGR has been reported in the 
blood vessels , smooth muscle cells and mucosa cells of the human fallopian 
tube55, and the blood vessels, myometrium and endometrium of human 
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uterus70 76. Futhermore, the decidua f rom a 7 day pregnant rat showed 
positive staining for LH-CGR. This stage of pregnancy is a period when 
maximal production of uterine LH-CGR"6, similar to the rat corpus 
luteum49, occurs. The similarities in staining patterns therefore support the 
specificity of the antibodies developed against LH-CGR in the present study. 
Higher levels of LH-CGR were observed in the reproductive tissues obtained 
at diestrus than at estrus. This was consistent with the observation that the 
gastrointestinal and the ovarian homogenates showed highest h C G binding in 
the moming of diestrus or proestrus. It is known that ovarian LH-CGR, 
undergo up- and down- regulation during different stages of estrous (for the 
rat) or menstrual (for the human) cycle, which is influenced by sex 
steroids49. It has been shown that undifferentiated granulosa cells isolated 
f rom the small antral follicles do not possess LH-CGR, which only appear 
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under stimulation by estrogens and FSH during the maturat ion， . However, 
an ovulatory dose of LH/CG leads to a down-regulation of LH-CGR levels, 
which reappear upon luteinization of the follicle^^. In rats, the LH surge is 
triggered on the day of proestrus between 2 and 4 p.m., and ovulation occurs 
10 to 12 hours later^^^ This then suggests that the levels of LH-CGR start to 
be down-regulated in the af temoon on the day of proestrus, and may explain 
why high levels of ovarian LH-CGR were observed in the moming of 
diestrus or proestrus. The uterine LH-CGR were shown to be at their highest 
at metestrus7i. That probably could be explained with a similar rationale as 
for ovarian LH-CGR. The gastrointestinal LH-CGR were also present at 
high levels at diestrus, which suggests that the gastrointestinal LH-CGR 
expression might also be under similar hormonal control as for the ovarian 
LH-CGR. 
Higher staining intensity was observed with N1 antibodies. The higher 
staining intensity was probably due to the presence of truncated forms of 
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LH-CGR. Since all truncated forms o f L H - C G R must contain the N-terminal 
portion of the protein, but not the C-terminal p o r t i o n i , more N-terminal 
epitopes than the C-terminal epitopes would be present in a pool of truncated 
and complete LH-CGR protein mixture. We also observed that the N l M 
gave a higher staining intensity than N l F . This could be explained by the 
fact that N l F had hCG blocking properties (as discussed previously), 
whereas N l M did not. Probably, the blocking properties made N l F 
antibodies not bind to the LH-CGR which were pre-occupied by the 
gonadotropins, LH/CG. The prevention of binding in tum resulted in a 
negative bias for immimostaining. 
The immunostaining for LH-CGR in the liver tissue yielded interesting 
patterns. The blood vessels were positively stained, which is consistent to a 
recent report by Hill et. al. (1996), who reported that hCG can regulate the 
blood f low of rat liver in vivo^\ The LH-CGR in the blood vessels probably 
account for the weak bands in the Westem blotting of the liver extract. 
Generally speaking, the hepatocytes were only slightly stained, but with N2F 
antibodies some hepatocytes were stained moderately. If the scattered 
positive staining was due to the presence of LH-CGR, it suggests that LH-
CGR are produced at only certain stage of a cell cycle. This probably also 
explains why hCG binding protein has been reported in the livers of hCG 
1 1 C , H c c nc primed rats , but not in rats without priming ’，. 
In the pancreas, besides the blood vessels, the exocrine tissue was stained. 
The cytoplasm o f t h e acinar cells was slightly stained by both the N l M and 
N2F antibodies. Interestingly, a strongly stained "flower" pattern was 
observed in each acinar with N l M antibodies. Many moderately stained 
"tiny dots" in all single acinar cells were observed with N2F antibodies. We 
suspect that the "flower" and "tiny dots" patterns were due to the staining of 
terminal ducts of the pancreatic ductal system. The "flower" pattem might 
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have been due to the staining of the truncated LH-CGR in the cytoplasm of 
the terminal ducts. The "tiny dots" might have been due to the staining o f t h e 
complete LH-CGR on the plasma membrane or protrusions of the terminal 
duct cells. Similarly, weak staining of the intralobular duct was observed 
with N l M antibodies, but very weak or no staining was observed with N2F 
antibodies. For the islets, the weak staining with N2F antibodies might have 
been due to cross-reaction since the islets were not stained with N l M 
antibodies. 
In the duodenum, again the blood vessels and smooth muscles showed the 
strongest reaction for LH-CGR with both antibodies. The presence of LH-
CGR in the smooth muscles suggests that hCG might be involved in the 
regulation of UGIT movement as in the myometrium^^. The nerve ganglia, 
Brunner 's gland and the crypt cells were moderately stained. The moderate 
staining suggested the presence of low levels of LH-CGR. One interesting 
observation was that the mucosal epithelium of duodenum was strongly 
stained with N2F antibodies, but only slightly stained with N l M antibodies. 
hi the positive control tissues - the fallopian tube and uterus, the mucosal 
epithelia were generally stained more strongly with N2 antibodies. It 
therefore seems that LH-CGR are also present in the duodenal mucosa 
epithelium. 
In conclusion, LH-CGR were found in the duodenum and pancreas. This to 
our knowledge is the first report of LH-CGR in the GIT. The presence of 
LH-CGR in the GIT adds further support to our hypothesis that hCG can act 
directly on the gut, and one of this action may be secretion of electrolytes 
and fluid, which is investigated in the next section. 
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Section 3 hCG and in vivo secretion of 
electrolytes from pancreas / duodenal 
region in rats 
Introduction 
In the previous two sections, we have shown that anion secretion by cells 
possessing functional LH-CGR apppears to be a universal cellular response 
to h C G in vitro, and LH-CGR are present in the pancreas and the duodenum 
of rats. To complete the picture with regard to the proposed hypothesis, it is 
next important to know whether hCG can stimulate the secretion of fluid and 
electrolytes f rom the UGIT, namely pancreas and duodenum. 
Pancreas and duodenum are the two organs that are actively involved in the 
bicarbonate secretion, normally in response to release of gut hormones 
(secretin, VIP, etc.,) which in tum are secreted after the entry of acidic 
gastric chyme into the duodenum. The alkaline pH in the duodenum 
neutralizes the acid gastric chyme and provides an optimum pH for 
digestion. One of the hallmarks of vomiting during pregnancy is that there is 
loss of fluid and electrolytes from the gastrointestinal tract, accompanied by 
acidosis, which is partly caused by the ejection of alkaline intestinal j u i ce \ 
Therefore, it is logical to suspect that hCG can stimulate the pancreatic and 
duodenal bicarbonate secretion, and this could be the reason for the 
metabolic acidosis which occurs during hyperemesis gravidarum. 
Pancreas has been reported to possess steroid hormone receptors')^ and 
ovariectomy in rats decreased acinar cell zymogen content^^ Conversely, 
estrogens administrated to dogs lowered the protein, zinc and bicarbonate in 
pancreatic juice^^. Since pituitary gonadotropin secretion is under negative 
feedback control by sex hormones, the apparent “secretory’ effects on 
119 
pancreatic zymogen, protein, zinc and bicarbonate in the aforementioned 
studies could be ascribed to gonadotropins. 
The aim of the final part of my study is to investigate whether hCG can 
stimulate secretions f rom the duodenum and pancreas. Bacterial toxins, 
neurotransmitters, and hormones that increase cAMP production can 
stimulate bicarbonate secretion f rom mammalian ileum and colon in v/v6>"9. 
However, when investigated in the Ussing chamber, cAMP only stimulated 
net chloride secretion^^'^, which suggests that the secretion of chloride and 
bicarbonate are closely related. Athough we have shown indirectly that hCG 
can stimulate chloride secretion from cells with functional hCG receptors in 
vitro, hCG may have an in vivo effect on the bicarbonate secretion from the 
UGIT, since bicarbonate is the main anion secreted by the UGIT. Because 
cellular response observed in in vitro experiment may not be observed in 
vivo, in vivo experiments were chosen. Female rats were used as the 
experimental subjects because emesis/hyperemesis gravidarum is a female 
associated problem. Two groups of experiments were designed. One was in 
vivo perfusion experiments, to study the acute effect of hCG on electrolyte 
and fluid secretions from the upper gastrointestinal tract. The other was to 
study the changes in the pancreatic contents and the levels of amylase and 
electrolytes in the circulation in ovariectomised rats unreplaced or replaced 
estradiol and progesterone. The former group simulated a condition of high 
gonadotropins as seen during first trimester of pregnancy. 
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Materials and Methods 
Materials 
Sprague Dawley rats were obtained from the animal house of our institution. 
h C G (3000 IU/mg), estradiol and progesterone were obtained from Sigma 
Chemical Co (St. Louis USA). All other chemicals were reagent grade 
compounds obtained from commercial sources. 
Methods 
1. The effect of hCG on the secretion of electrolytes into bile and 
pancreatic/duodenal effluent 
Rationale for using a perfusion approach to measure the UGIT secretion 
The ultimate way to monitor the secretion from the UGIT is to measure the 
electrolyte levels continuously instead of only at certain time point. 
Continuous in vivo measurement can be achieved by inserting micro-ion 
selective electrodes into the bile duct, pancreatic duct and duodenal lumen. 
Unfortunately, the bile duct and the pancreatic duct is extremely narrow. 
Micro-ion selective electrodes that are thin enough for insertion and without 
blocking the fluid f low are not commercially available. Therefore, we 
switched to a perfusion approach. The in vivo perfusion experiments were 
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modified from the method described by Grossman et al (1983) . The biliary 
secretion of electrolytes was studied by collecting the bile juice separately. 
The duodenal/pancreatic secretions were studied by collecting the perfusate. 
Preparation of the animal for perfusion study 
a. Unvagotmised rats without bile juice divertion 
Female Sprague Dawley rats weighing 200-250 grams at metestrus/diestrus 
stage were anesthetized with pentobarbital (10 mg/100 g body weight). The 
duodenum was ligated at the pylorus end o f t h e stomach and about 1.5 cm 
below the entry of the common bile/pancreatic duct into the duodenum. 
Polyethylene tubing (1.57 mm O.D. and 1.14 mm I.D.) through a peristaltic 
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pump (P-1, Pharmacia, Sweden) was inserted just below the proximal 
ligation site and tied. The duodenum was resected just above the distal 
ligation site and flushed with PBS (100 m M NaCl, 9.5 m M NaH2PO4, 40.5 
m M Na2HPO4, pH 7.4) to remove food debris, before insertion of the lower 
catheter (homemade plastic tube, 1.5 mm O.D. and 0.75 mm I.D.) into a 
polyethylene tubing (1.57 mm O.D. and 1.14 mm I.D.). After ensuring the 
proper f low of perfusion fluid - PBS through the duodenum, the incision site 
was covered with cotton gauze soaked in physiological saline. The injection 
site was prepared by removing about 1 cm^ of skin and exposing the femoral 
vein on the right leg. 
b. Unvagotomised rats with bile juice diversion 
The operation procedure was as mentioned above, except that the bile duct 
was catheterized to divert the bile juice before catheterizing the duodenum. 
Catheterization of bile duct 
The bile duct was first ligated with a 0.7 metric polyamide 6 suture (Ethilon, 
Ethicon Ltd, Edinburgh, Scotland) at a site just before its entry into the 
pancreas. Then another suture was put underneath the bile duct at a position 
proximal to the liver and 5 mm above the first suture. The bile duct was 
resected carefully with a pair o f f m e scissors just between the sutures. A fine 
catheter (0.5 mm O.D. x 32 mm, micropipette tip, T-1906, Sigma) connected 
to a rubber tubing (2mm O.D. and 1.5 mm I.D.) was inserted into the bile 
duct via the opening, and its position fixed with the two sutures. Proper flow 
of the bile juice into the tubing indicated successful cathetherization. 
c. Vagotomised rats with bile jucie diversion 
The operation procedure was as for unvagotomised rats with bile jucie 
diversion, except that the rats were vagotomised before opening the 
abdomen. The rats were vagotomised by bilateral severing of the vagus 
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nerves (after careful separation of the carotid arteries with a blunt end of a 
forcep) in the neck region via a ventral route. 
Collection of secretions from the upper gastrointestinal tract and 
injection of hCG 
The catheterised portion of the duodenum was perfused with the PBS 
solution at a rate of 2 ml per hour by means of a peristaltic pump (P-1, 
Pharmacia, Sweden). The bile juice was either allowed to drain into the 
duodenum via the pancreatic duct or diverted from the pancreatic effluent 
and collected separately, without the use of external force, simultaneously 
with the duodenal/pancreatic perfusate. After 1 or 2 basal collection(s), 1000 
IU hCG dissolved in physiological saline was injected into the femoral vein 
to give a blood concentration about 1 x 10^ IU/L (based on total blood 
volume of 10 ml). Three further collections o f t h e perfusate/bile juice were 
made. Control animals received physiological saline only. The total volumes 
o f t h e bile juice and the perfusate were measured. The bicarbonate content in 
the hourly collections were measured immediately. The bile juice and the 
perfusate were kept at 4 ()C with ice-water bath during the collection and 
before the measurement of bicarbonate content. The rest of the perfusate was 
stored at - 4 0 � C until the levels of chloride, potassium, sodium ions and 
amylase could be measured. 
Measurement of bicarbonate concentration 
Bicarbonate is a difficult molecule to measure, and therefore a reliable 
method for measurement is required. Bicarbonate ion in aqueous phase can 
associate with hydrogen ion to give carbonic acid, which eventually 
dissociates into water and gaseous carbon dioxide. This phenomenon is 
summarized by a well known chemical equation: H+ + HCO3" • H2CO3 
<=> CO2 + H2O. Since gaseous CO2 can escape from the aqueous phase 
easily if the sample is not properly handled, there may be a negative bias in 
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the measurement of bicarbonate concentrations. However, if the escape of 
caibon dioxide f rom the sample is minimized, the bicarbonate concentration 
in blood sample can be measured indirectly by the measurement of pH and 
partial pressure of CO2 gas (pCO2) in the blood and the calculation using the 
Henderson-Hasselbach equation: pH^pK + Xog [所 ( ) 3 ] However, if 
^ pCO, X 0.23 
some bicarbonate salt is dissolved in perfusion buffer and the bicarbonate 
concentration is measured in the above manner, the value obtained will be 
lower than the expected value because, some dissolved bicarbonate may 
have been converted to dissolved CO2 and CO2 gas. If the loss of CO2 gas is 
prevented, the total sum of the CO2 and bicarbonate molecules is 
approximately equal to the amount added. This sum will be the total CO2 
(tCO2) value measured with a blood gas analyzer system. pK of the 
bicarbonate buffer is about 6.1 for arterial blood at pH 7.4 and 37 °C^^^ The 
exact value of pK varies with pH, temperature and total charge of 
cationsi49'i50 Using a perfusion buffer having the total charge of cations and 
pH as normal arterial blood, this allowed us to measure the total amount of 
bicarbonate secreted from upper gastrointestinal tract by simply measuring 
the t C 0 2 value o f t h e collected perfusate with a blood gas analyzer. 
Bicarbonate concentrations in the perfusate and bile juice were measured 
twice with a 238 blood gas analyzer (Ciba-Coming). The accuracy of the 
measurement of bicarbonate content in the perfusate was verified by spiking 
known amounts of NaHCO3 salt to the perfusion buffer with pH adjusted 
slowly and carefully with HC1 to 7.4. This was achieved by using ten fold 
concentrated standards. The loss of bicarbonate as carbon dioxide during 
addition of acid was avoided. The solutions were kept ovemight at 4 °C. 
Before the measurement, the concentrated solution was diluted with the 
perfusion buffer and added to tubes used for perfusate collection, in 2 ml 
aliquots. The tubes were loosely sealed with parafilm and left in ice-water 
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bath for 1 hour before measurement in order to simulate the experimental 
condition during the collection ofperfusa tes . 
Measurements of chloride, sodium ion, potassium ion and amylase 
The measurements of chloride, sodium, potassium ions and amylase were 
performed with the Dimension AR Chemistry Analyser (DuPont Diagnostic, 
Wilmington, DE, USA). The chloride, sodium and potassium ions were 
measured directly by ion selective electrodes. The amylase was measured by 
a chromogenic enzymatic reaction. The method involved a a-amylase 
specific chromogenic substrate, 2-chloro-4-nitrophenol linked maltotriose. 
The direct reaction of a-amylase with the substrate resulted in the formation 
of 2-chloro-4 nitrophenol, which was monitored spectrophotometrically 
using a bichromatic (405, 510 nm) rate technique. 
2. Effect of ovariectomy on pancreatic content and electrolyte levels in 
blood 
To study the long term effects of LH on pancreatic content and levels of 
amylase and electrolyte in the blood circulation, ovariectomised rats were 
used. Since estrous cycle of Sprague Dawley rats is very short, lasting only 
for 5 days, it is difficult to study the long term effect of LH. However, this 
can be achieved by ovariectomy. As a result of the removal of the feedback 
effect by sex steroids on the hypothalamic-pituitary axis, circulating levels 
of LH will increase. Conversely giving estrogens and progestogens to the 
ovariectomised rats, the circulating LH levels will be suppressed, to provide 
a group with long term depletion of LH. 
Ovariectomy and sex steroid replacement 
Ten Female Sprague Dawley rats weighing 230 - 260 grams were 
ovariectomised following pentobarbital anesthesia. One week after the 
operation, half of the rats were replaced with estradiol (E2) and progesterone 
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(P) by injecting 0.5 mg E2 and 2 mg P suspended in 0.1 ml vehicle (peanut 
oil) once a week for three weeks. The control group animals were injected 
with the vehicle only. One week after the last injection, experiments were 
performed. 
Blood collection and measurement of whole blood tCO7 and plasma Na, 
K，C1 and serum amylase 
The ovariectomised rats without or with sex steroid replacement were lightly 
anesthetized with diethyl ether. Cardiac puncture was performed through the 
left or right ventricles to collect either the deoxygenated or oxygenated blood 
in a heparin tube. The tube was filled to top wihout air and capped. The 
blood samples were kept in an ice-water bath, and the blood gas values were 
measured as soon as possible with the 238 blood gas analyzer. The levels of 
plasma cations - sodium and potassium, the anion - chloride and the serum 
amylase were measured as mentioned above. Under anesthesia, blood was 
also collected from normal cycling rats by cardiac puncture. The serum 
sodium level was measured. 
Measurement of pancreatic contents including pH, chloride, amylase and 
zymogen granules 
a. Measurement of zymogen granules 
1) Principle o fzymogen granule quantification by UV scattering 
The method used in our experiments was modified from the method 
developed by Grossman et al ( 1 9 8 3 / ^ The zymogen granules were 
indirectly quantified by the measurement of protein concentrations using UV 
absorption at A280 and A260. It was shown that the protein concentration of a 
water soluble pancreatic extract gave a higher value than the value obtained 
with Lowry protein assay, but this phenomenon was not observed in liver 
extracts. The difference was due to the presence of small microsomes in the 
pancreatic extract, which scattered the UV light, resulting in higher 
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absorbance. The number of microsomes in tum was related to the number of 
zymogen granules in the pancreas. Therefore, the positive bias in protein 
quantification with U V method gives a indirect measurement of the amount 
of zymogen granules in the pancreas. 
2) The assay 
After the cardiac puncture, the rats were killed by cervical dislocation. The 
pancreas was carefully resected and homogenized in 2 v/w phosphate buffer 
(10 m M sodium phosphate, pH 7.4) for 30 seconds on ice using a Polytron-
Aggregate (Kinetica, Switzerland) with a 7 mm cutting probe at full speed. 
The suspension was centrifuged at 20,000 x g for 15 minutes. One mL of 
supemant was saved, and the remainder was centrifuged at 50,000 x g for 1 
hour. The supemant was saved. The UV absorbance at 280 and 260 nm of 
the 500 fold diluted supematants were measured with a RESPONSE UV-
VIS spectrophotometer (Gilford, A Coming Laboratory Science Co.). The 
protein concentration in each supernatant preparation was calculated with 
the equation: protein concentration = 1552 x A280 - 757.3 x A260, derived by 
Warburg, 0 . and Christian, W. (1942)^^\ The amount of zymogen granules 
were indirectly estimated with the scattering index in the 20,000 x g 
supernatant. After centrifuging at 50,000 x g, most of the zymogen granules 
had been removed, the protein concentration measured with the U V method 
gave reliable results comparable to the value obtained with other methods. 
The ratio of the protein concentrations of the 20,000 x g and 50,000 x g 
supematants reflected the number of the zymogen granules in the 20,000 x g 
supernatant. Assuming that the scattering index of a supernatant without 
zymogen granules is zero, the scattering index can thus be calculated from a 
• [protein concentration]ll , , , 
equation: scattering index = — — 1，where [protein concentration\^^ ^^^ ^ ^ 
[protein concentration] o^,ooo x g and [protein concentration] g " � � � � ^ ^ are the 
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measured proteins concentrations o f t h e 20,000 and 50,000 x g supematants, 
respectively, by the U V method. 
b. Measurment of pH, amylase and chloride 
The 50,000 x g supernatant was centrifuged once again at 50,000 x g for 1 
hour. The final supernatant was saved and its pH, amylase and chloride 
content were measured as mentioned above. 
3. Statistics 
All data were analyzed with the Wilcoxon's rank sum test. 
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Results 
1. Upper gastrointestinal tract perfusion experiments 
Verification of bicarbonate concentration measurement using the 
Corning 238 blood gas analvzer 
Figure 3.1 shows the measured total CO2 plotted against the initial 
bicarbonate concentrations of the standards (figure 3.1). The slope of linear 
regression was equal to 1.007 which indicated that tCO2 value measured was 
equal to the initial amount of bicarbonate molecules added into the perfusion 
buffer. The regression coefficient, r, was 0.999. The results indicated that 
the method could accurately quantify the amount of bicarbonate molecules 
secreted into the perfusion buffer. The loss o f t h e bicarbonate in the form of 
CO2 was negligible, even if the standards were not tightly sealed, but just 
kept at 4 ()C in an ice-bath. 
Effect of hCG on the volume, amylase and eiectroiyte contents of the 
perfusate and the bile iuice 
a. Bicarbonate and fluid secretion in unvagotomised rats without bile 
juice diverted from the pancreatic effluent 
The basal secretion o f t h e bicarbonate into the UGIT lumen was 32.5 土 4.4 
umole per hour. Within the three hour monitoring period, the amount of 
bicarbonate ions increased slowly in both the hCG and saline injected 
control groups (figure 3.2), and the volume of the perfusate stayed constant 
across the time in both group (figure 3.3). No difference in the bicarbonate 
secretion from the upper gastrointestinal tract was observed between the 
hCG injected group and the saline injected control group. 
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Figure 3.1. The correlation of the measured total CO2 values by the Ciba-
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Figure 3.2. The total bicarbonate concentration (mean 土 1 SD) in the 
duodenal/pancreatic perfusate without bile juice diversion in unvagotomised 
female rats at 0.5 and 1.5 hour after injection of vehicle (saline, n = 6) or 
hCG (n = 5). The results are expressed relative to basal concentrations. The 
time of injections is indicated by the arrow. 
131 
1 . 2了 
T T 
1 -- •.……-…-…•-----^-^!^^•:•^•^^^^--^•^"^•^ 
0 . 8 - -o 
E 3 
0 
o 0 . 6 -> 
ro 
"3 — # — hOG in saline Q^  
0.4 -- - - -•- - - saline 
0 . 2 - -
o\ 1 1 1 1 1 1 
0 0.5 1 1.5 2 2.5 3 
Time (hour) 
Figure 3.3. The collected volume (mean 土 1 SD) of the duodenal/pancreatic 
perfusate including bile juice in unvagotomised female rats at 0.5 and 1.5 
hour after injection ofvehic le (saline, n = 6) or hCG (n = 5). The results are 
expressed relative to basal values. The time of injections is indicated by the 
arrow. 
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b. Bicarbonate and fluid secretion in unvagotomised rats with bile juice 
diverted from the pancreatic effluent 
The basal secretion of biliary and pancreatic-duodenal bicarbonate in 
unvagotomised rats with b i le ju ice diverted f rom the pancreatic effluent were 
31.4 土 6.7 and 11.1 土 2.8 umole per hour, respectively, giving a total value 
of 42.3 土 7.9 umole per hour. This was significantly higher than the value 
obtained in the experiments without bile juice diversion in unvagotomised 
rats (p = 0.003，Table 3.1). During the first hour after the injection of either 
h C G or saline, no significant difference in the bicarbonate content of the 
perfusates was observed (figure 3.4a and b). However, the bicarbonate 
content in the perfusates suddenly increased dramatically during the second 
hour after injection in some of the rats in both groups (figure 3.4a). On 
average, the bicarbonate content in the perfusates increased in both groups of 
rats during the second hour after injection. No significant difference was 
observed between the hCG injected and the saline injected control groups 
(figure 3.4b). Figure 3.4c demonstrates the rate of increase in bicarbonate 
content in the collected perfusates at the time of injection and one hour later. 
In both groups of rats, the rate of increase in the bicarbonate secretion rose 
with time. No difference was observed between the two groups of rats. The 
perfusate volume remained unchanged during the three hour experimental 
period in both groups of rats (figure 3.5) 
c. Bicarbonate and fluid secretion in vagotomised rats with bile juice 
diverted from the pancreatic effluent 
The basal secretion of biliary and pancreatic-duodenal bicarbonate in 
vagotomised rats with bile juice diverted from the pancreatic effluent were 
27.1 土 4.9 and 7.3 土 2.1 umole per hour, respectively, giving a total value of 
34.4 土 5.8 umole per hour. This was not significantly different (p = 0.44, 
Table 3.1) from the unvagotomised rats without bile juice diversion, but was 
significantly lower (p = 0.02, Table 3.1) than the unvagotomised rats with 
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Table 3.1. The effect of bile juice diversion and vagotomy on basal secretion of 
bicarbonate into bilejuice and duodenal/pancreatic perftisate. The results 
are expressed as mean 土 1 SD. The numbers of rats are indicated in the 
brackets. 
Experiments 1 2 3 
vagotomy N o N o Yes 
bile juice diversion N o Yes Yes 
Basal Biliary T ^ 31 .4±6 .7 27.1 ± 4 . 9 ~ ~ 
secretion of {9} (20) 
bicarbonate pancreatic, duodenal NA 11.1 土 2.8 7.3 ± 2.V 
(umole per 0 ^ (20) 
hour) Biliary, pancreatic, 32.5 + 4.4 42.3 + 7.9^ 34 .4±5 .8 ' 
duodenal (16) Q} (20) 
* NA: not applicable 
a significantly different from the Experiment 2, p < 0.005 
b significantly different from the Experiment 1, p < 0.005 
e significantly different from the Experiment 2，p = 0.02 
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Figure 3.4a and b. The individual (a) and mean 土 1 SD (b) bicarbonate 
concentration in the duodenal/pancreatic perfusate without bile juice in 
unvagotomised female rats at 0.5 and 1.5 hour after injection of vehicle 
(saline, n =4) or hCG (n = 6). The results are expressed relative to basal 
concentrations. The time of injections is indicated by the arrow. 
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Figure 3.4c. The rate of increase in duodenal/pancreatic bicarbonate 
secretion (mean 土 1 SD) in unvagotomised female rats with bile juice 
diverted from the pancreatic effluent injected with hCG (n = 6) or saline 
only (n = 4). The rate of increase is calculated from the equation: rate of 
increase = (relative [HCO3"]t2 - relative [HCO3 ]ti) / (t2 - tl), where relative 
[HCO3"]tn is the relative bicarbonate concentration i n the perfusate 
(expressed as a ratio ofbasal value) at time n (hour). 
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Figure 3.5. The collected volume (mean 土 1 SD) o f t h e duodenal/pancreatic 
perfusate without bile juice in unvagotomised female rats at 0.5 and 1.5 hour 
after injection of vehicle (saline, n = 4) or hCG (n = 6). n = 7. The results are 
expressed relative to basal values. The time of injections is indicated by the 
arrow. 
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bile juice diversion. The basal pancreatic-duodenal bicarbonate secretion in 
the vagotomised rats with bile juice diversion was also signifcantly lower (p 
二 0.0015, Table 3.1) than the unvagotomised rats with bile juice diversion. 
However, the total biliary and duodenal/pancreas bicarbonate secretion in 
the vagotomised rats with bile juice diversion was not different f rom the 
unvagotomised rats without bile juice diversion (Table 3.1). Figure 3.6a 
shows that after vagotomy and bile juice diversion, the bicarbonate content 
in the perfusates decreased almost linearly in saline injected control group 
during the three hour experimental period. After the injection of hCG, there 
was no difference in the bicarbonate content in the perfusates of the control 
and hCG injected rats during the first hour after injection. However, during 
the second hour, the bicarbonate concentration of perfusates in the hCG 
injected group was significantly higher (p = 0.015, figure 3.6a). The rate of 
decrease in the bicarbonate concentration in the perfusates rose with time. 
However, in the hCG injected group a reverse trend was observed. The 
decrease in the rate of bicarbonate concentration in the hCG injected group 
measured at 1 hour after injection, was lower than that measured at the time 
of injection and was significantly lower than that measured in the control 
group (p = 0.013, figure 3.6b). Therefore, hCG reduced the decrease in the 
rate of bicarbonate secretion in vagotomised female rats. The volume of the 
perfusates, however remained unchanged in both the hCG injected group and 
saline injected group (figure 3.7), No significant difference was observed in 
the biliary bicarbonate concentration or volume between the hCG injected 
group and the saline injected control group. The bicarbonate concentrations 
o f t h e bile juice increased slowly during the experimental period (figure 3.8). 
In contrast, the volume of the bile juice collected decreased slowly during 
the experimental period (figure 3.1 la). 
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Figure 3.6a. The bicarbonate concentration (mean 土 1 SD) in the 
duodenal/pancreatic perfusate without bile juice in vagotomised female rats 
(n = 7) at 0.5 and 1.5 hour after injection of vehicle (saline, n = 7) or hCG (n 
= 7 ) . The results are expressed relative to basal concentraions. The time of 
injections is indicated by the arrow. * p < 0.02, Wilcoxon's rank sum test (1 
tail). 
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Figure 3.6b. The rate of decrease (mean 土 1 SD) in duodena^pancreatic 
bicarbonate secretion in vagotomised female rats with bile juice diverted 
f rom the pancreatic effluent injected with hCG (n 二 7) or saline only (n = 7). 
The rate of decrease is calculated with the equation: rate of decrease = 
(relative [HCO3"]ti - relative [HCO3"]t2) / (t2 - t l ) , where relative [HCO3 ] tn is 
the relative bicarbonate concentration in the perfusate (expressed as a ratio 
of basal value) at time n (hour). * p < 0.015, Wilcoxon's rank sum test (1 
tail). 
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Figure 3.7. The collected volume (mean 土 1 SD) of the duodenal/pancreatic 
perfusate without bile juice in vagotomised female rats at 0.5 and 1.5 hour 
after injection of vehicle (saline, n = 7) or hCG (n 二 7). The results are 
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Figure 3.8. The bicarbonate concentration (mean 土 1 SD) in the bile juice 
diverted from the pancreatic effluent in vagotomised female rats at 0.5 and 
1.5 hour after injection of vehicle (saline, n =7) or hCG (n = 7). The results 
are expressed relative to basal concentraions. The time of injections is 
indicated by the arrow. 
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c. Amylase, sodium, chloride and potassium secretion in vagotomised 
rats with bile juice diverted from the pancreatic effluent 
The amylase concentrations in the perfusates increased with time in both 
groups of rats and there was no significant difference between the two 
groups (figure 3.9a). The concentrations ofchlor ide and sodium ions in the 
perfusate also remained constant during the experimental period in both 
groups of rats (figure 3.9b and c). However, the concentration of potassium 
ion decreased with time in both groups, a pattem similar to bicarbonate 
content (figure 3.9d and 3.6a). In the saline injected control group, the 
concentrations dropped linearly with time. In the hCG injected group, the 
mean concentrations deviated from the linear decrease trend during the 
second hour after injection, and was higher than the control group despite its 
statistical insignificance. The rate of decrease in the potassium concentration 
in the perfusate is shown in figure 3.10. The rate of decrease was almost 
constant for the control group during the experimental period, but in the 
hCG injected group, it decreased significantly at 1 hour after the injection. 
Similar to the effect on bicarbonate secretion, hCG reduced the rate of 
decrease in potassium secretion (p 二 0.0325). 
No significant difference was observed in the concentrations of chloride, 
sodium and potassium ions in the bile juice between the hCG injected group 
and the saline injected control group (figure 3.11). The concentrations of 
chloride (figure 3.11b) and sodium ion (figure 3.11c) remained the same 
during the experimental period, however, a slow increasing trend in the 
potassium concentrations was observed (figure 3.11d). 
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Figure 3.9. The increase in the rate of amylase secretion (mean 土 1 SD, a) from 
the pancreas, and the concentrations (mean 土 1 SD) of chloride (b), sodium (c) and 
potassium (d) ions of the duodenal/pancreatic perfusate without bile juice in 
vagotomised female rats at 0.5 and 1.5 hour after injection of vehicle (saline, n = 
7) or hCG (n 二7). The results are expressed relative to basal concentraions. The 
time of injections is indicated by the arrow. 
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Figure 3.10. The rate of decrease (mean 土 1 SD) in the duodenal/pancreatic 
potassium ion secretion in vagotomised female rats with bile juice diverted 
f rom the pancreatic effluent injected with hCG (n = 7) or saline only (n = 7). 
The rate of decrease is calculated with the equation: rate of decrease = 
(relative [K+]u - relative [K+]t2) / (t2 - t l ) , where relative [K+]tn is the relative 
bicarbonate concentration in the perfusate (expressed as a ratio of basal 
value) at time n (hour). * p = 0.0325, Wilcoxon's rank sum test (1 tail). 
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Figure 3.11. The volume (a) and the concentrations (mean 土 1 SD) of chloride 
(b), sodium (c) and potassium (d) ions in the bile juice diverted from the 
pancreatic effluent in vagotomised female rats at 0.5 and 1.5 hour after injection 
of vehicle (saline, n = 7) or hCG (n = 7). The results are expressed relative to 
basal concentraions. The time of injections is indicated by the arrow. 
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2, Effect of ovariectomy on pancreatic content and electrolyte and 
amylase levels in hlond 
Effect of ovariectomy on concentrations of sodium, potassium, chloride, 
tC02, and amylase in blood 
Table 3.2. summarizes circulating concentrations of sodium, potassium, 
chloride, amylase and whole blood tCO2 of the ovariectomised rats without 
or with E2 and P replacement. No significant difference between the two 
groups was observed for the plasma tCO2 values (replaced group: venous -
4 1 . 7 5 ± 0 . 7 , arterial - 2 5 . 7 ± 1 . 0 ; non-replaced group: venous - 39.45 ± 
0.8, arterial - 24.18 土 4.2 mmol/L), chloride concentrations (replaced group: 
101.0 土 1.6; non-replaced group: 101.7 土 1.3 mmol/L) and potassium 
concentrations (replaced group: 4.03 土 1.04; non-replaced group: 4.09 土 
0.66 mmol/L). The amylase level was lower in the unreplaced rats 
(replaced group: 1322 土 254; non-replaced group: 1212.5 土 169 U/L), but 
the difference was not statistically significant. The unreplaced rats had lower 
sodium levels (138.8 土 1.9 mmol/L), compared with the replaced rats (141.2 
土 1.2, p < 0.005) or normal cylcing rats at different stages (140.8 土 1.3, p < 
0.005). The replaced rats had the same sodium levels as the normal cycling 
rats (a mixed population of rats at different stages), but significantly lower 
than the normal cycling rats at diestrus (142.7 土 1.2, p < 0.05). 
The effect of ovariectomy on amylase, chloride, pH and scattering index 
of pancreas 
The pH values, the levels of amylase, chloride in the 50,000 x g supernatant 
of the pancreatic extracts, and the scattering index of the pancreas are 
summarized in Table 3.3. The amylase levels were higher in the replaced 
group (replaced group: 1042 土 700; non-replaced group: 602 土 1120 U/ml), 
however, the difference was not statistically significant. The amount of 
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Table 3.2. The summary of the blood concentrations of the sodium, potassium, 
chloride, amylase, and the whole blood tCO2 values of the 
ovariectomised rats without or with replacement of estradiol and 
progesterone, and sodium in normal cylcing rats. The results are 
expressed as mean 土 1 SD. The number of subjects are indicated in the 
brackets. 
Na K C1 whole blood tC02 amylase 
(mmol/L) (mmol/L) (mmoI/L) (mmol/L) (U/L) 
venous arterial OVX' 138.8+1.9^ 4.1+0.7 101.0±1.6“39.5 + 0.8~"24.2 + 4.2 1213±169 (10) (¾ (10) (3) (3^ " (1¾ 
OVX 141.2 + 1.2 4.0±0.4 101.7+1.3~~41.8±2.1 ~~25.7±1.0~~1322±254 
+ E2 and P' (10) 00} i M 01 Q1 (10) 
normal^  140.8 + 1 .3� ^ D . K a K a ? m i m m 
diestrus4 142.7+1.21)� N.D. N.D. N.D. N.D. N.D. 
W 
1 ovariectomised rats without sex steroid replacement 
2 ovariectomised rats with estradiol and progesterone replacement 
3 female rats with normal cycling and at different stages 
4 female rats with normal cycling and at diestms 
a p < 0.005 and ^ p < 0.05, compared with OVX + E2 and P groups 
e p < 0.005, compared with OVX group 
148 
Table 3.3. The levels of amylase, chloride and zymogen granules and the pH in 
the pancreatic extracts of the ovariectomised rats without or with 
estradiol and progesterone replacement. The results are expressed as 
mean 土 1 SD. The number of subjects are indicated in the brackets. 
amylase chloride pH scattering index 
(U/ml extract) (mmol/L extract) (zymogen granules) 
OVX^  602±1120 L. D.* 6.7±0.04 0.38 + 0.07 
(3 (3 W (¾ OVX 1042±700 L.D. 6.85土0.03 0.67±0.05 
+ E2 and p2 {3} (3} ^ (]} 
1 ovariectomised rats without sex steroid replacement 
2 ovariectomised rats with estradiol and progesterone replacement 
* L.D. : lower than detection limit 
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chloride in the pancreatic extract was too low for accurate determination (< 
10 mmol/L). The pH values of the pancreatic extract were higher in the 
replaced group (replaced group: pH 6.85; non-replaced group: pH 6.7 土 
0.04), but because of small subject numbers, statistical analysis was not 
possible. However, the observation suggests that the pancreatic content o f t h e 
pancreata of the non-replaced group was more acidic. There were twice as 
many zymogen granules in the pancreatic extract of the replaced groups, as 
the average scattering index of the UV light was nearly doubled (replaced 
group: 0.67 ± 0.05; non-replaced group: 0.38 土 0.07, figure 3.17). Although 
the number of experiments for the scattering index again were too few for 
statistical analysis, all the values for the replaced group were higher than 
those for the non-replaced group. 
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Discussion 
Among all the parameters measured, only the secretions of bicarbonate and 
potassium ions f rom the upper gastrointestinal tract were significantly 
increased under the influence of hCG. This difference was apparent only in 
animals who had undergone vagotomy and in whom the bile juice was 
diverted away f rom the pancreatic effluent. The hCG effect on the 
duodenal/pancreatic secretions in the unvagotomised animals without the 
diversion of bile juice, may have been masked by bicarbonate in the bile 
juice, which accounted for almost 80 % of the total bicarbonate secreted. 
Furthermore, bile juice diversion in unvagotomised animals caused a marked 
fluctuation in the duodenal/pancreatic secretion, and also an increase in the 
duodenal/pancreatic bicarbonate secretion. The observed stimulatory effect 
of bile juice diversion on bicarbonate secretion may have occurred as a result 
of increased secretion of CCK. With the normal f low of bile juice through 
the pancreas, the luminal feedback mechanism which inhibits the secretion 
of CCK would be in operation^^^'^^^. The inhibition is maximum when both 
• 1 CO 
the bile and pancreatic juices are present in duodenal lumen . Therefore, in 
the unvagotomised animals, the release of the luminal feedback inhibition 
via bile juice diversion may have caused an increased duodenal/pancreatic 
bicarbonate secretion, thus also masking the effect of hCG. Furthermore, 
vagotomy in rats has been reported to negate the action of CCK^^^. Our 
results also demonstrated that vagotomy was effective in negating the 
stimulatory effect of bile juice diversion, as the total bicarbonate secretion 
was similar to the unvagotomised rats without bile juice diversion. 
The stimulatory effect of hCG on the duodenal/pancreatic bicarbonate 
secretion in the vagotomised rats (with bile juice diverted) is consistent with 
the in vitro finding of hCG stimulated anion secretion. The source(s) of the 
bicarbonate ions may be the pancreatic exocrine tissue or the duodenal 
mucosa. The similarity in the secretory patterns of the bicarbonate and 
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potassium ions suggested that latter were secreted in parallel with 
bicarbonate secretion. The secretion of potassium could be due to either an 
active secretion stimulated by hCG, or passive release f rom the potassium-
leak-channels to maintain the membrane potential^^^ in response to a 
decrease in membrane potential of a cell following efflux of bicarbonate 
ions. Because the duodenum does not actively secrete potassium ions^^\ the 
h C G stimulated potassium secretion might not have occurred in the 
duodenum. Stimulant-evoked potassium release has been demonstrated in 
the human pancreatic acinus^^^. It has also been suggested that potassium 
secretion is the first step involved in the initiation of acinar fluid secretion^^^, 
and is related to secretions of chloride and to lesser extent, bicarbonate. 
Therefore, the pancreatic exocrine tissue is probably the site for hCG 
stimulated bicarbonate-potassium secretion. There was no observed increase 
in fluid secretion in vivo. On the contrary, there was a net uptake of the 
perfusion buffer during the experiment. One reason for this may have been 
to compensate for the loss of bile juice and excessive insensible loss from 
the exposed area. Another possible reason could have been that the hCG 
preparation used may not be the most appropriate. As the bioactivity of hCG 
is governed by the appropriate glycosylation of the protein core, there may 
be only certain hCG variants which may be responsible for the electrolyte 
and fluid secretion from the UGIT. Since the commercial hCG preparation 
used was extracted from the urine of normal pregnant women, it might only 
contain a small amount of the emetic variants. Furthermore, the potency of 
hCG on fluid and bicarbonate secretion in the rat may have been lower, 
though the conservation of LH-CGR between species would suggest 
otherwise. 
In the ovariectomised rats without steroid replacement, in whom the 
expected levels of gonadotropins would be high, the blood sodium 
concentration was significantly lower than the steroid replaced group. The 
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latter group 's blood sodium concentration was not different f rom normally 
cycling rats. Therefore, consistently high levels of LH may cause a decrease 
in the circulating sodium levels. Since bicarbonate secretion f rom the 
pancreatic ductal system and acinus are associated with paracellular sodium 
secretion and/or chloride uptake by the secretory cells to balance the electric 
charge52i56, the low circulating sodium levels in the unreplaced 
ovariectomised rats, may be due to the loss in parallel with the pancreatic 
bicarbonate secretion. However, there was no difference in sodium ion 
secretion in the perfusion experiment in response to hCG. The apparent lack 
of hCG effect on sodium secretion in the perfusion experiment might have 
been masked by the pre-existing sodium ions (150 mM) in the perfusion 
buffer, as the difference in the circulating sodium levels between the 
replaced and unreplaced ovariectomised rats was very small. Apical 
bicarbonate secretion is accompanied with a backward secretion of protons 
f rom the basal side of the pancreatic ductal cells^^ and acinus^^^. The acidic 
pancreatic contents of the pancreas suggested an accumulation of protons in 
the tissue. Therefore, the lower pH values of the pancreatic extracts of the 
unreplaced ovariectomised rats further suggests higher pancreatic 
bicarbonate secretion in the unreplaced ovariectomised rats. 
Although hCG stimulated the secretion of potassium ions from the 
duodenum/pancreas, the circulating potassium levels were indifferent in the 
replaced and unreplaced ovariectomised rats. The lack of response on 
circulating potassium levels may be due to the fact that the circulating 
potassium level is 25 to 30 fold lower than the intracellular potassium level. 
Therefore, the secretion of intracellular potassium into the gastrointestinal 
lumen may not affect the blood concentration of potassium ions. 
Fewer zymogen granules were also observed in the pancreata of the 
unreplaced ovariectomised rats, which suggests that the secretory rate of the 
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pancreatic exocrine was higher in this group. The lower levels of semm and 
pancreatic amylase in the unreplaced rats fits into the overall pat tem of 
higher pancreatic secretions in the unreplaced rats, although the differences 
f rom the control groups were not statistically significant. Since hCG did not 
increase the amylase secretion from the pancreas in our perfusion studies, 
the lack of response may have been due to short duration of the experiment. 
The insignificance of difference in serum amylase levels between the two 
groups may also be because amylase in the circulation consists principally of 
the salivary isoenzyme^^^. It is also known that the total semm amylase 
activity is not significantly lowered even when the pancreatic secretory cell 
• 1 C 1 
mass is reduced by chronic pancreatic disease . The lack of difference in 
pancreatic amylase levels between the two groups may also be due to the 
large intra-group variation. 
Pancreas has been reported to possess steroid hormone receptors^^ and 
ovariectomy in rats decreased acinar cell zymogen content^. Conversely, 
estrogens administrated to dogs lowered the protein, zinc and bicarbonate in 
pancreatic juice^^. Since pituitary gonadotropin secretion is under negative 
feedback control by sex hormones, the apparent “secretory’ effects on 
pancreatic zymogen, protein, zinc and bicarbonate in the aforementioned 
studies could be ascribed to gonadotropins. This argument is supported by 
our current studies. 
In summary, to our knowledge this is the first study where hCG has been 
shown to transiently stimulate the bicarbonate and potassium ion secretion 
from pancreas and/or duodenum. The effect of LH on the pancreatic 




Vomiting during early pregnancy encompasses a wide spectrum, with ten 
percent of pregnant women experiencing no discomfort, ninety percent 
having nauseous symptoms, f i f ty percent having vomiting to some degree 
and 0.2 - 0.3 % having severe vomiting which leads to dehydration, 
electrolyte imbalance, nutrient deficiency and acidosis. Although nausea is 
purely a feeling of a need to vomit, emesis and hyperemesis result in loss of 
fluid an electrolytes. The former suggests the involvement of psychological 
factors, whereas the latter suggests the involvement of humoural factor(s) 
which stimulates processes leading to secretion of fluid and electrolytes and 
subsequent vomiting. 
Emesis/hyperemesis gravidarum has been recognized for almost four 
thousand years, but the exact pathophysiological mechanism is still 
unknown. Recently, hyperolfaction has been proposed as a new contributing 
factor in the etiology of hyperemesis gravidarum^^. Hyperolfaction during 
pregnancy has been suggested to be a mechanism for the mother to seek a 
cleaner, quieter and more temperate environment to increase the survival 
chance in wild. Nausea and vomiting are often preceded by exposure to 
common background odours, such as washing detergents, perfumes, etc, but 
how hyperolfaction can lead to nausea and vomiting is unknown. 
Since vomiting occurs at the time when levels of hCG are raised and wanes 
when the levels of hCG decrease, hCG is thought to be involved!. Because 
thyrotoxicosis can cause vomiting^^, some researchers have regarded 
hyperemesis as the presenting feature of true thyrotoxicosis^^'^^, and that 
hyperemesis gravidarum is an expression of transient pregnancy associated 
hCG-induced thyrotoxicosis in these patients^ i，〕�，]，Qnly 30 % of the 
hyperemetic women, however, have elevated levels of thyroid hormone^^'^^. 
Although it is possible that thyroid hormones may be involved in the 
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etiology of hyperemesis gravidarum in about 30 % of these women, the 70 
% of the women with normal thyroid function would suggest other causes 
for the etiology. Since vomiting involves loss of fluid and electrolytes f rom 
the upper gut lumen, and distension of UGIT by accumulation of fluid and 
electrolytes can trigger vomiting, it is possible that hCG may be acting 
directly on the gut cells to promote the secretion of ion, which may form the 
pathophysiological basis for the pregnancy associated vomiting. This led us 
to propose a hypothesis, which is that hCG acts directly on the UGIT, where 
it stimulates the secretion of electrolytes and fluid. The copious secretions 
cause distension in the UGIT, and the mechanoreceptors located therein 
trigger the vomiting reflex. To fulfill this hypothesis, firstly it must be shown 
that hCG is a potent secretory agent, which can stimulate electrolyte and 
fluid secretion f rom the UGIT during early pregnancy. Secondly, for hCG to 
cause secretion f rom the UGIT, there must be LH-CGR in the UGIT through 
which it brings it secretory effects culminating in vomiting. 
In the in vitro experiments, hCG caused iodide efflux from COS-1 cells 
expressing M C l + 2 LH-CG/TSH chimera receptors, and both the release and 
inhibition o f t h e uptake of TPP by MLTC-1 cells possessing wild type LH-
CGR. The inhibitory effect of hCG on TPP uptake was partly chloride 
dependent. These findings indirectly demonstrated that hCG stimulated 
chloride secretion from cells with functional hCG receptors. Previously, 
Duchatelle and Joffre (1990) had reported hCG stimulated chloride 
conductance in rat Leydig cells, and queried its physiological significance in 
steroid hormone secretion(]. TSH action on thyrocytes also involves the 
(uptake and) efflux of 1" before its incorporation into thyroglobulin and 
thyroid hormone releasei"，an action mimicked by hCG which can induce 
thyrotoxicosis^. Therefore in view of these findings, anion efflux from cells 
with functional LH-CGR appears to be a universal response to hCG. 
Whether the efflux of anion secretion in response to hCG has any 
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physiological significance in steroidogenesis, can not be answered at the 
present moment, but the phenomenon itself may be the basis for the 
pregnancy associated loss of electrolytes, and suggests that hCG is a potent 
secretory agent. 
In order to answer whether hCG has a secretory effect in the UGIT, we 
investigated the presence of hCG receptors along the gastrointestinal tract. 
We found a specific hCG binding protein in the rat duodenum and pancreas, 
which f rom our physicochemical and immunoblotting studies, had properties 
similar to LH-CGR. Later LH-CGR was localized immunohistochemically in 
exocrine tissue and blood vessels of the pancreas, and in smooth muscle, 
mucosal epithelium, crypt cells and blood vessels of duodenum. Since 
exocrine pancreas and duodenal mucosa are important sites for secretion of 
fluid and electrolytes, the presence of LH-CGR in these organs suggests a 
possible secretory role for hCG in the UGIT. The secretory effect of hCG in 
the upper gastrointestinal was confirmed by the in vivo experiments. 
Injection of hCG stimulated the secretion of bicarbonate and potassium ions 
f rom the pancreas or/and duodenum. Bacterial toxins, neurotransmitters, and 
hormones that increase cAMP production by enterocytes stimulate 
bicarbonate secretion from mammalian ileum and colon in vivo. However, in 
the in vitro experiments, cAMP only stimulated net chloride secretion by 
Ussing chambered gut tissue segments^^^. Similarly, we observed hCG 
stimulated chloride secretion by cells with functional hCG receptors in vitro, 
and hCG stimulated bicarbonate secretion by the duodenum and/or pancreas 
in vivo. That suggests that the mechanism for secretion of chloride and 
bicarbonate are closely related. On one hand, the in vivo active secretion of 
duodenal/pancreatic bicarbonate in response to hCG supports our hypothesis 
that hCG can directly stimulate electrolyte secretion from the UGIT. On the 
other hand, it could also be the reason for the hyperemetic women 
developing metabolic acidosis, which hitherto had been ascribed to the loss 
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of alkaline in t e s t ina l ju i ces�Simi la r ly , excessive in vivo potassium secretion 
in response to hCG, besides supporting the secretory function o f h C G in the 
UGIT, could also account for the hypokalaemia, which is normally 
associated with hyperemesis gravidarum. 
This, to our knowledge, is the first study demonstrating secretory effect of 
hCG in the rat UGIT (duodenum and/or the pancreas). However, secretory 
function of the pancreas has been reported to be affected by change in the 
status of sex hormones in animals. Pancreas has been reported to possess 
steroid hormone receptors^^ and ovariectomy in rats decreased acinar cell 
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zymogen content • Conversely, estrogens administrated to dogs lowered the 
protein, zinc and bicarbonate in pancreatic juice^^. Since pituitary 
gonadotropin secretion is under negative feedback control by sex steroid 
hormones, the apparent "secretory" effect of the aforementioned studies 
could be also ascribed to increased gonadotropin levels in the animals, partly 
substantiated for bicarbonate in the perfusion experiments. In our laboratory, 
unreplaced ovariectomised rats had decreased circulating sodium 
concentrations, compared with either the estradiol and progesterone replaced 
ovariectomised rats or normal cycling female rats. There was no difference 
in the sodium concentration between the normal cycling rats and 
ovariectomised rats given sex steroid replacement, which suggests that the 
decrease in sodium concentration upon ovariectomy was, most likely due to 
the increase in LH levels. Unreplaced ovariectomised rats also had decreased 
levels of circulating amylase, as well as its lower content in the pancreas 
(although the difference was insignificant); decrease in zymogen granules 
and lower pH of the pancreatic extract. Since apical bicarbonate secretion is 
accompanied with a backward secretion of protons from the basal side of the 
pancreatic ductal cells^^ and acinus^^^ the acidic pancreatic extract suggests 
bicarbonate secretion. Therefore, the results of the ovariectomy experiments 
imply that long term exposure to high levels of LH/CG may have stimulated 
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the pancreatic exocrine secretions including bicarbonate and sodium ions, 
which further support the secretory function of hCG in the UGIT. The 
depletion of sodium ions in the body, due to long exposure to high levels of 
LH, may also explain why the hyperemetic patients suffer f rom 
hyponatriemia. 
Although the in vivo experiments supported the secretory role of hCG in the 
pancreatic exocrine tissue and/or duodenal mucosa, an effect most probably 
mediated via LH-CGR, the presence of LH-CGR in the duodenal smooth 
muscle needs to be addressed. LH-CGR have been shown in the smooth 
muscle cells o f t h e human myomet r ium?�and fallopian tube^^. The function 
of h C G in the myometrium is to maintain the quiescence of motility in the 
uterus, thus preventing spontaneous abortion^^. The motility of the 
gastrointestinal tract is also reported to be lower during pregnancy^^. The 
presence of LH-CGR in the duodenal smooth muscle may imply a similar 
role for hCG in maintaining the quiescence of the gastrointestinal smooth 
muscle. However, in this instance, the hypomotility of the duodenum may 
have unfavourable consequences. The decrease in duodenal motility may 
favour the accumulation of the electrolytes and fluid. The consequence of 
gut distension may be to activate mechanoreceptors which trigger vomiting. 
Gastric hypomotility^^ and retroperistalsis in the duodenum^^ can cause 
vomiting. It is also possible that the quiescent state of duodenal smooth 
muscle on its own could be a cause for pregnancy associated vomiting. 
In conclusion, this is the first study which demonstrates that i) anion 
secretion is a universal response of cells with functional LH-CGR, ii) LH-
CGR are present in rat UGIT (duodenum and pancreas), and iii) hCG can 
stimulate secretion of bicarbonate and potassium ions from the UGIT of 
female rats. Although we have tentatively demonstrated that hCG stimulated 
UGIT electrolyte secretion can be the underlying mechanism for pregnancy 
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associated vomiting, we still cannot exclude the possibility that hCG triggers 
vomiting by i) affecting the muscular tone o f t h e duodenum, or ii) binding to 
the CTZ, as LH-CGR has been shown to be present in the area postrema of 
2*7 
rat brain . Since we used the rat as an animal model which incidentally is 
known not to vomit during pregnancy, we need to prove that LH-CGR is 
also present in the human UGIT and hCG can also stimulate gastrointestinal 
secretions in human beings. More work is needed in order to evaluate the 
clinical significance of hCG stimulated electrolyte secretion by the UGIT. 
Either an in vitro bioassay using cell line established from a secretory cells 
in the duodenunVpancreas, or an in vivo biossay should be established in 
order to study emetic activity, in term of electrolyte secretion, of hCG in 
non-emetic, emetic or hyperemetic pregnant women. The emetic activity of 
different hCG variants should be measured. 
With the tentative findings, we hypothesize that emesis/hyperemesis which 
afflicts 50 % ofpregnan t women to some degree and 0.3 % more severely is 
induced by hCG interacting with secretory cells in the UGIT through LH-
CGR, stimulating copious secretion of electrolytes (and fluid), resulting in 
distension of the UGIT and the mechanoreceptors located therein, eventually 
triggering the vomiting reflex. The fact that most pregnant women 
experience “moming sickness", could be related to the accumulation of 
secretions in UGIT during the night and upon rising the sudden distension of 
UGIT triggers the vomiting reflex. 
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